Home› India› Ministry of Chemicals and Fertilizers› Ceiling price revision/ Extension of revised ceiling price b...
Date: 2022-03-30 Category: Extra Ordinary State: Union Government Country: India

Ceiling price revision/ Extension of revised ceiling price based on the decision taken in the 96th Authority meeting dated 24.03.2022

Issued by Ministry of Chemicals and Fertilizers · Department of Pharmaceuticals

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

## Policy Analysis Report: Price Revision of Scheduled Formulations (March 30, 2022) **1. Executive Summary:** This report analyzes a notification published by the National Pharmaceutical Pricing Authority (NPPA) on March 30, 2022, regarding the price revision of scheduled formulations under the Drugs Prices Control Order (DPCO), 2013. This notification acts as an *amendment* to previous pricing orders. The core purpose is to revise the ceiling prices of specific drugs based on the annual Wholesale Price Index (WPI) increase of 10.76607%. The key finding is that this amendment directly impacts the affordability and availability of numerous essential medicines for patients and profitability for the pharmaceutical industry. **2. Introduction:** This report provides an informative overview of a government notification (S.O. 1499(E)) issued by the National Pharmaceutical Pricing Authority (NPPA) on March 30, 2022. The report analyzes the notification's content, focusing on its objective, key changes introduced, affected parties, and likely impacts, based solely on the provided text. **3. Policy Overview:** * **Original Policy Being Amended:** The notification amends previous orders issued by the NPPA regarding the pricing of scheduled formulations. These previous orders are referenced by their S.O. Numbers and dates in columns 6a and 6b of the table. * **Core Objective(s):** * To revise the ceiling prices of scheduled formulations listed in the attached table. * To implement the annual Wholesale Price Index (WPI) increase of 10.76607% in the ceiling prices, effective from April 1, 2022. * To ensure that the revised prices are exclusive of Goods and Services Tax (GST). **4. Background and Rationale:** The primary reason for this specific amendment is to adjust the ceiling prices of scheduled drugs to reflect the annual Wholesale Price Index (WPI) increase. This adjustment aims to balance the interests of pharmaceutical companies facing increased production costs and the need to maintain affordable access to essential medicines for the public. The DPCO 2013 provides for such revisions to account for inflation and other economic factors. **5. Key Provisions / Changes:** This notification is an amendment focused solely on revising drug prices. The core changes are as follows: * **Specific Part of Original Policy Changed:** The notification changes the ceiling prices of the scheduled formulations previously fixed by the NPPA (as specified in columns 6a and 6b). * **New Rule/Provision:** A new, revised ceiling price (exclusive of GST) is fixed for each scheduled formulation listed in column 2, with the dosage form, strength, and unit specified in columns 3 and 4, effective from April 1, 2022. These new ceiling prices are mentioned in column 5, and reflect a 10.76607% WPI increase over the existing price. * **Difference/Effect of the Change:** The difference is a direct price increase for each listed drug. This will lead to a greater revenue from the drug, thus possibly affecting affordability and availability for end consumers, as well as altering the profit margins for manufacturers and retailers. **6. Target Audience and Stakeholders:** The primary target audience includes: * **Pharmaceutical Manufacturers:** Directly impacted by the revised ceiling prices for their products. * **Retailers/Distributors:** Affected by the changes in pricing and profit margins. * **Consumers/Patients:** Ultimately impacted by potential changes in the affordability and accessibility of essential medicines due to the price revision. **7. Implementation Aspects (Inferred):** * **Responsible Agency/Bodies:** The National Pharmaceutical Pricing Authority (NPPA) is the responsible agency for implementing and enforcing the price revisions. * **Timelines/Procedures:** The revised prices are effective from April 1, 2022. There are no explicit procedures specified in the text, but it can be inferred that manufacturers and retailers are expected to comply with the new ceiling prices from the effective date. * **Implementation Aspects related to Changes:** The NPPA would likely monitor sales data to ensure compliance with the revised ceiling prices. **8. Expected Outcomes / Impact of Changes:** * The likely intended outcome of these specific changes is to allow pharmaceutical companies to adjust their pricing to account for inflation while ensuring a reasonable level of availability for essential medicines to the public. * Potential impacts: * Marginal increase in the cost of medicines for consumers. * Potentially improved profitability for pharmaceutical manufacturers. * Potential effect on the availability of lower-priced generics if manufacturers prioritize higher-profit products. **9. Conclusion:** The NPPA notification dated March 30, 2022, represents an important amendment to existing drug pricing regulations. By implementing the annual WPI increase, the amendment aims to balance the economic realities faced by the pharmaceutical industry with the need to maintain affordable access to essential medicines. The revised ceiling prices, effective April 1, 2022, will have a direct impact on manufacturers, retailers, and consumers, necessitating careful monitoring to ensure both profitability and accessibility.

Key Entities Referenced

NEW DELHI: Place of publication of the gazette notification, located in India. Drugs Prices Control Order, 2013: A legal document referenced as the basis for the powers exercised in the notification. Government of India: The governing body of India, which issued the S.O. No. 1394E dated the 30th May, 2013. Ministry of Chemicals and Fertilizers: The ministry under which the Department of Pharmaceuticals and the National Pharmaceutical Pricing Authority operate. Department of Pharmaceuticals: A department within the Ministry of Chemicals and Fertilizers. National Pharmaceutical Pricing Authority: The authority responsible for fixing and revising the prices of drugs, under the Ministry of Chemicals and Fertilizers. Goods and Services Tax: A tax applicable to the ceiling prices of scheduled formulations.
Official Source Record View Original Source →
See Full Document Text
रजजस्ट्री स.ं डी.एल.- 33004/99 REGD. No. D. L.-33004/99 सी.जी.-डी.एल.-अ.-30032022-234691 xxxGIDHxxx CG-DL-E-30032022-234691 xxxGIDExxx असाधारण EXTRAORDINARY भाग II—खण् ड 3—उप-खण्ड (ii) PART II—Section 3—Sub-section (ii) प्राजधकार स ेप्रकाजित PUBLISHED BY AUTHORITY स.ं 1456] नई ददल्ली, बुधवार, माच च30, 2022/चत्रै 9, 1944 No. 1456] NEW DELHI, WEDNESDAY, MARCH 30, 2022/CHAITRA 9, 1944 ub Z fnYyh] 30 ekpZ]] 2022 .— 4, 6, 10, 11, 14, 16, 17 18 a b @ (10.76607%) 10.76607% (1) (2) (3) (4) (5) 6(a 6(b 1 5&,feukslys hflfyd ,flM lIqiksftVªh 500 fexzk- fjVsu'ku ,fuek 1 lIqikfstVªh 18.77 1330(अ) 25.03.2021 2 5&,feukslys hflfyd ,flM xkys h 400 fexzk- 1 xkys h 8.30 1330(अ) 25.03.2021 2262 GI/2022 (1)2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 3 5&¶yjw ksjkfly batSD'ku 250 fexzk-@5 fefy- 1 fefy- 2.59 1330(अ) 25.03.2021 4 6&esdsZiVkWI;wfju xkys h 50 fexzk- 1 xkys h 7.17 1330(अ) 25.03.2021 5 ,cdkohj xkys h 300 fexzk- 1 xkys h 52.36 1330(अ) 25.03.2021 6 ,cdkohj ¼,½ $ ysfeoqMhu ¼ch½ xkys h 60 fexzk- ¼,½ $ 30 fexzk- ¼ch½ 1 xkys h 22.30 1330(अ) 25.03.2021 7 ,cdkohj ¼,½ $ ysfeoqMhu ¼ch½ xkys h 600 fexzk-¼,½$300 fexzk- ¼ch½ 1 xkys h 101.18 1330(अ) 25.03.2021 8 ,flVktksykekbM dSIlyw 250 fexzk- 1 dSIlyw 5.02 1330(अ) 25.03.2021 9 ,flVktksykekbM xkys h 250 fexzk- 1 xkys h 4.07 1330(अ) 25.03.2021 10 ,lhVkbylSyhflfyd ,flM bQsjoslsVa @fMLijflcy@,afVªd 1 xkys h 0.20 1330(अ) 25.03.2021 dkfsVM xkys h 100 fexzk- 11 ,lhVkbylSyhflfyd ,flM bQsjoslsVa @fMLijflcy@,afVªd 1 xkys h 1.34 1330(अ) 25.03.2021 dkfsVM xkys h 150 fexzk- 12 ,lhVkbylSyhflfyd ,flM bQsjoslsVa @fMLijflcy@,afVªd 1 xkys h 1.36 1330(अ) 25.03.2021 dkfsVM xkys h 75 fexzk- 13 ,lhVkbylSyhflfyd ,flM xkys h 100 fexzk- 1 xkys h 0.19 1330(अ) 25.03.2021 14 ,lhVkbylSyhflfyd ,flM xkys h 150 fexzk- 1 xkys h 0.45 1330(अ) 25.03.2021 15 ,lhVkbylSyhflfyd ,flM xkys h 325 fexzk- 1 xkys h 0.61 1330(अ) 25.03.2021 16 ,lhVkbylSyhflfyd ,flM xkys h 350 fexzk- 1 xkys h 0.34 1330(अ) 25.03.2021 17 ,lhVkbylSyhflfyd ,flM xkys h 75 fexzk- 1 xkys h 0.34 1330(अ) 25.03.2021 18 ,fDVuksekbflu Mh batSD'ku ds fy, ikmMj 0-5 fexzk- izfr iSd 352.13 1330(अ) 25.03.2021 19 ,flDyksohj vksbaVesVa 3% 1 xzke 11.56 1330(अ) 25.03.2021 20 ,flDyksohj vksjy fyD;wbZM 400 fexzk-@5 fefy- 1 fefy- 1.41 1330(अ) 25.03.2021 21 ,flDyksohj xkys h 200 fexzk- 1 xkys h 7.52 1330(अ) 25.03.2021 22 ,flDyksohj xkys h 400 fexzk- 1 xkys h 13.67 1330(अ) 25.03.2021 23 ,flDyksohj batSD'ku ds fy, ikmMj 250 fexzk- izfr iSd 394.52 1330(अ) 25.03.2021 24 ,flDyksohj batSD'ku ds fy, ikmMj 500 fexzk- izfr iSd 509.56 1330(अ) 25.03.2021 25 ,Msukslkbu batSD'ku 3 fexzk-@fefy- 1 fefy- 109.33 1330(अ) 25.03.2021 26 ,Mªsukykbu batSD'ku 1 fexzk-@fefy- 1 fefy- 17.38 1330(अ) 25.03.2021 27 ,ycsMa ktksy vksjy fyD;wbZM 200 fexzk-@5 fefy- 1 fefy- 1.77 1330(अ) 25.03.2021 28 ,ycsMa ktksy xkys h 400 fexzk- 1 xkys h 8.55 1330(अ) 25.03.2021 29 ,yksI;wfjukys xkys h 100 fexzk- 1 xkys h 2.12 1330(अ) 25.03.2021 30 ,yksI;wfjukys xkys h 300 fexzk- 1 xkys h 8.31 1330(अ) 25.03.2021 31 vkWy&Vªkal jsVhukWbd ,flM dSIlyw 10 fexzk- 1 dSIlyw 90.83 1330(अ) 25.03.2021 32 ,yizksLVkfMy batSD'ku 0-5 fexzk-@fefy- 1 fefy- 6288.11 1330(अ) 25.03.2021 33 ,YVsIyl batSD'ku ds fy, ikmMj 20 fexzk- izfr iSd 21089.89 1330(अ) 25.03.2021 34 ,YVsIyl batSD'ku ds fy, ikmMj 50 fexzk- izfr iSd 44033.63 1330(अ) 25.03.2021 35 ,fe;ksMsjksu batSD'ku 50 fexzk-@fefy- 1 fefy- 24.77 1330(अ) 25.03.2021 36 ,fe;ksMsjksu xkys h 100 fexzk- 1 xkys h 6.35 1330(अ) 25.03.2021 37 ,fe;ksMsjksu xkys h 200 fexzk- 1 xkys h 12.57 1330(अ) 25.03.2021 38 ,fefVªfIVykbu xkys h 10 fexzk- 1 xkys h 2.54 1330(अ) 25.03.2021 39 ,fefVªfIVykbu xkys h 25 fexzk- 1 xkys h 2.50 1330(अ) 25.03.2021 40 ,fefVªfIVykbu xkys h 50 fexzk- 1 xkys h 6.45 1330(अ) 25.03.2021 41 ,fefVªfIVykbu xkys h 75 fexzk- 1 xkys h 6.23 1330(अ) 25.03.2021 42 ,EyksfMikbu xkys h 10 fexzk- 1 xkys h 5.63 1330(अ) 25.03.2021 43 ,EyksfMikbu xkys h 2-5 fexzk- 1 xkys h 1.84 1330(अ) 25.03.2021 44 ,EyksfMikbu xkys h 5 fexzk- 1 xkys h 2.89 1330(अ) 25.03.2021[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 3 45 ,eksDlhflfyu dSIlyw 250 fexzk- 1 dSIlyw 2.45 1330(अ) 25.03.2021 46 ,eksDlhflfyu vksjy fyD;wbZM 250 fexzk-@5 fefy- 1 fefy- 1.50 1330(अ) 25.03.2021 47 ,eksDlhflfyu dSIlyw 500 fexzk- 1 dSIlyw 7.17 1330(अ) 25.03.2021 48 ,eksDlhflfyu ¼,½ $ MªkbZ flji 125 fexzk- ¼,½ $ 31-25 1 fefy- 2.40 1330(अ) 25.03.2021 Dykoqykfud ,flM ¼ch½ fexzk-¼ch½@5 fefy- 49 ,eksDlhflfyu ¼,½ $ vksjy fyD;wbZM 200 fexzzk-¼,½ $ 28-5 1 fefy- 2.00 1330(अ) 25.03.2021 Dykoqykfud ,flM ¼ch½ fexzk-¼ch½@5 fefy- 50 ,eksDlhflfyu ¼,½ $ batSD'ku ds fy, ikmMj 500 fexzk- ¼,½ izfr iSd 99.96 1330(अ) 25.03.2021 Dykoqykfud ,flM ¼ch½ $ 100 fexzk- ¼ch½ 51 ,eksDlhflfyu ¼,½ $ xkys h 500 fexzk- ¼,½ $ 125 fexzk- ¼ch½ 1 xkys h 19.95 1330(अ) 25.03.2021 Dykoqykfud ,flM ¼ch½ 52 ,eksDlhflfyu ¼,½ $ batSD'ku ds fy, ikmMj 1 xzke ¼,½ $ izfr iSd 139.44 1330(अ) 25.03.2021 Dykoqykfud ,flM ¼ch½ 200 fexzk- ¼ch½ 53 ,EQksVsfjflu ch ¼fyfiM½ batSD'ku ds fy, ikmMj 50 fexzk- izfr iSd 3558.99 1330(अ) 25.03.2021 54 ,EQksVsfjflu ch ¼fyikls ksey½ batSD'ku ds fy, ikmMj 50 fexzk- izfr iSd 8290.00 1330(अ) 25.03.2021 55 ,EQksVsfjflu ch&dkWuosu'kuy batSD'ku ds fy, ikmMj 50 fexzk- izfr iSd 343.91 1330(अ) 25.03.2021 56 ,Eihflfyu batSD'ku ds fy, ikmMj 1 xzke izfr iSd 23.69 1330(अ) 25.03.2021 57 ,Eihflfyu batSD'ku ds fy, ikmMj 500 fexzk- izfr iSd 14.60 1330(अ) 25.03.2021 58 ,aVh&Mh bEequksXykscqfyu batSD'ku 300 ,elhth izfr iSd 2370.03 1330(अ) 25.03.2021 59 ,aVh&Mh bEequksXykscqfyu batSD'ku 150 ,elhth izfr ok;y 1847.36 1330(अ) 25.03.2021 60 ,aVh&jscht bEequksXykscqfyu batSD'ku 150 vkbZ;w@fefy- 1 fefy- 3080.46 1330(अ) 25.03.2021 61 ,aVh&jscht bEequksXykscqfyu batSD'ku 300 vkbZ;w@fefy- 1 fefy- 108.60 1330(अ) 25.03.2021 62 ,aVh&VsVul bEequksXykscqfyu 250 vkbZ;w izfr iSd 1233.92 1330(अ) 25.03.2021 63 vlsfZud VªhvkWDlkbM batSD'ku 1 fexzk-@fefy- 1 fefy- 60.29 1330(अ) 25.03.2021 64 vVZes sFkj ¼,½ $yqesQkVªhu ¼ch½ vksjy fyD;wbZM 80 fexzzk-¼,½ $ 480 1 fefy- 4.47 1330(अ) 25.03.2021 fexzk-¼ch½@5 fefy- 65 vVZes sFkj ¼,½ $yqesQkVªhu ¼ch½ xkys h 20 fexzk- ¼,½ $ 120 fexzk- ¼ch½ 1 xkys h 13.90 1330(अ) 25.03.2021 66 vVZes sFkj ¼,½ $yqesQkVªhu ¼ch½ xkys h 40 fexzk- ¼,½ $ 240 fexzk- ¼ch½ 1 xkys h 17.92 1330(अ) 25.03.2021 67 vVZes sFkj ¼,½ $yqesQkVªhu ¼ch½ xkys h 80 fexzk- ¼,½ $ 480 fexzk- ¼ch½ 1 xkys h 25.72 1330(अ) 25.03.2021 68 vVZls uq sV batSD'ku ds fy, ikmMj 120 fexzk- izfr iSd 462.04 1330(अ) 25.03.2021 69 vVZls uq sV batSD'ku ds fy, ikmMj 60 fexzk- izfr iSd 242.69 1330(अ) 25.03.2021 70 vVZls uq sV ¼,½ $ lYQkMkWDlhu xkys h 100 fexzk- ¼,½ $ 1 xksyh ¼750 dkEsch iSd 32.75 1330(अ) 25.03.2021 & fifjesFkkekbu ¼ch½ fexzk- $ 37-5 fexzk-½ ¼ch½ 71 vVZls uq sV ¼,½ $ lYQkMkWDlhu xkys h 150 fexzk- ¼,½ $ 2 xksyh ¼500 dkEsch iSd 44.46 1330(अ) 25.03.2021 & fifjesFkkekbu ¼ch½ fexzk- $ 25 fexzk-½ ¼ch½ 72 vVZls uq sV ¼,½ $ lYQkMkWDlhu xkys h 200 fexzk- ¼,½ $ 2 xksyh ¼750 dkEsch iSd 40.54 1330(अ) 25.03.2021 & fifjesFkkekbu ¼ch½ fexzk- $ 37-5 fexzk-½ ¼ch½ 73 vVslZ uq sV ¼,½ $ lYQkMkWDlhu xkys h 25 fexzk- ¼,½ $ 1 xkys h ¼250 dkEsch iSd 21.83 1330(अ) 25.03.2021 & fifjesFkkekbu ¼ch½ fexzk- $ 12-5 fexzk-½ ¼ch½ 74 vVZls uq sV ¼,½ $ lYQkMkWDlhu 1 xkys h 50 fexzk- ¼,½ $ 1 xkys h ¼500 dkEsch iSd 23.56 1330(अ) 25.03.2021 & fifjesFkkekbu ¼ch½ fexzk $ 25 fexzk-½ ¼ch½ 75 ,LdkZfscd ,flM ¼foVkfeu lh½ xkys h 100 fexzk- 1 xkys h 0.21 1330(अ) 25.03.2021 76 ,LdkZfscd ,flM ¼foVkfeu lh½ xkys h 500 fexzk- 1 xkys h 1.53 1330(अ) 25.03.2021 77 ,Vktsukohj ¼,½$fjVkus sohj ¼ch½ xkys h 300 fexzk- ¼,½ $ 100 fexzk- ¼ch½ 1 xkys h 109.61 1330(अ) 25.03.2021 78 ,Vsukys ksy xkys h 100 fexzk- 1 xkys h 3.87 1330(अ) 25.03.2021 79 ,Vsukys ksy xkys h 50 fexzk- 1 xkys h 1.98 1330(अ) 25.03.2021 80 ,VksjokLVkfVu xkys h 10 fexzk- 1 xkys h 6.09 1330(अ) 25.03.2021 81 ,Vkjs okLVkfVu xkys h 20 fexzk- 1 xkys h 14.75 1330(अ) 25.03.2021 82 ,VksjokLVkfVu xkys h 40 fexzk- 1 xkys h 21.42 1330(अ) 25.03.2021 83 ,VªkD;wfj;e batSD'ku 10 fexzk-@fefy- izfr iSd 58.21 1330(अ) 25.03.20214 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 84 ,Vªksikbu vksbaVesVa 1% 1 xzke 4.20 1330(अ) 25.03.2021 85 ,Vªksikbu batSD'ku 0-6 fexzk-@fefy- 1 fefy- 4.65 1330(अ) 25.03.2021 86 ,Vªksikbu MªksIl 1% 1 fefy- 3.81 1330(अ) 25.03.2021 87 ,tkfFk;ksizhu xkys h 50 fexzk- 1 xkys h 11.26 1330(अ) 25.03.2021 88 ,ftFkzksekblhu dSIlyw 250 fexzk- 1 dSIlyw 11.66 1330(अ) 25.03.2021 89 ,ftFkzksekblhu dSIlyw 500 fexzk- 1 dSIlyw 18.41 1330(अ) 25.03.2021 90 ,ftFkzksekblhu vksjy fyD;wbZM 200 fexzk-@5 fefy- 1 fefy- 3.42 1330(अ) 25.03.2021 91 ,ftFkzksekblhu xkys h 250 fexzk- 1 xkys h 11.72 1330(अ) 25.03.2021 92 ,ftFkzksekblhu xkys h 500 fexzk- 1 xkys h 23.64 1330(अ) 25.03.2021 93 ,ftFkzksekblhu batSD'ku ds fy, ikmMj 500 fexzk- izfr iSd 213.48 1330(अ) 25.03.2021 94 cSDykQs su xkys h 10 fexzk- 1 xkys h 11.94 1330(अ) 25.03.2021 95 cSDykQs su xkys h 20 fexzk- 1 xkys h 16.43 1330(अ) 25.03.2021 96 cSDykQs su xkys h 5 fexzk- 1 xkys h 6.15 1330(अ) 25.03.2021 97 chlhth oSDlhu izfr Mkts 9.92 1330(अ) 25.03.2021 98 cSatkfFku cSutkbZyisfuflfyu batSD'ku ds fy, ikmMj 12 yk[k izfr iSd 20.25 1330(अ) 25.03.2021 ;wfuV 99 cSatkfFku cSutkbZyisfuflfyu batSD'ku ds fy, ikmMj 6 yk[k ;wfuV izfr iSd 13.39 1330(अ) 25.03.2021 100 csutks,y isjkDlkbM Øhe 2-5% 1 xzke 2.59 1330(अ) 25.03.2021 101 csutks,y isjkDlkbM tSy 2-5% 1 xzke 4.16 1330(अ) 25.03.2021 102 csutkby isfuflfyu batSD'ku ds fy, ikmMj 10 yk[k izfr iSd 8.66 1330(अ) 25.03.2021 ;wfuV 103 chVkesFklkus Øhe 0-05% 1 xzke 0.64 1330(अ) 25.03.2021 104 chVkesFklkus Øhe 0-1% 1 xzke 0.93 1330(अ) 25.03.2021 105 chVkesFklkus tSy 0-05% 1 xzke 0.59 1330(अ) 25.03.2021 106 chVkesFklkus yks'ku 0-1% 1 fefy- 0.91 1330(अ) 25.03.2021 107 chVkesFklkus yks'ku 0-5% 1 fefy- 0.59 1330(अ) 25.03.2021 108 chVkesFklkus batSD'ku 4 fexzk-@fefy- 1 fefy- 4.66 1330(अ) 25.03.2021 109 fcdkyqVkekbM xkys h 50 fexzk- 1 xkys h 76.18 1330(अ) 25.03.2021 110 fclkdkWfMy lIqiksftVªh 5 fexzk- 1 lIqikfstVªh 9.37 1330(अ) 25.03.2021 111 fclkdkWfMy xkys h 5 fexzk- 1 xkys h 1.12 1330(अ) 25.03.2021 112 cy;s ksekbflu batSD'ku ds fy, ikmMj 15 ;wfuV izfr iSd 689.25 1330(अ) 25.03.2021 113 ckVs stZ kfec batSD'ku ds fy, ikmMj 2 fexzk- izfr iSd 13656.22 1330(अ) 25.03.2021 114 cqMslkus kbM usty Lisz 100 ,elhth@Mkts 1 Mkts 1.01 1330(अ) 25.03.2021 115 cqMslkus kbM usty Lisz 50 ,elhth@Mkts 1 Mkts 1.13 1330(अ) 25.03.2021 116 cqMslkus kbM jslfijsVkWjh lkys 'q ku QkWj ;wt bu 1 fefy- 11.90 1330(अ) 25.03.2021 uscqykbtj 0-5 fexzk-@fefy- 117 cqMslkus kbM jslfijsVkWjh lkys 'q ku QkWj ;wt bu 1 fefy- 14.34 1330(अ) 25.03.2021 uscqykbtj 1 fexzk-@fefy- 118 cqMslkus kbM bugsy”s ku ¼,eMhvkbZ½ 100 1.41 1330(अ) 25.03.2021 ,elhth@Mkts 119 cqMslkus kbM bugsy”s ku ¼,eMhvkbZ½ 200 1.96 1330(अ) 25.03.2021 ,elhth@Mkts 120 cqMslkus kbM bugsy”s ku ¼MhihvkbZ½ 100 2.22 1330(अ) 25.03.2021 ,elhth@Mkts 121 cqMslkus kbM bugsy”s ku ¼MhihvkbZ½ 200 3.21 1330(अ) 25.03.2021 ,elhth@Mkts 122 cqMslkus kbM ¼,½ $ QksekZVs sjksy bugsy”s ku ¼,eMhvkbZ½ 100 ,elhth 2.09 1330(अ) 25.03.2021 ¼ch½ ¼,½ $ 6 ,elhth ¼ch½[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 5 123 cqMslkus kbM ¼,½ $ QksekZVs sjksy bugsy”s ku ¼,eMhvkbZ½ 200 ,elhth 2.97 1330(अ) 25.03.2021 ¼ch½ ¼,½ $ 6 ,elhth ¼ch½ 124 cqMslkus kbM ¼,½ $ QksekZVs sjksy bugsy”s ku ¼,eMhvkbZ½ 400 ,elhth 3.39 1330(अ) 25.03.2021 ¼ch½ ¼,½ $ 6 ,elhth ¼ch½ 125 cqMslkus kbM ¼,½ $ QksekZVs sjksy bugsy”s ku ¼MhihvkbZ½ 100 ,elhth 4.21 1330(अ) 25.03.2021 ¼ch½ ¼,½ $ 6 ,elhth ¼ch½ 126 cqMslkus kbM ¼,½ $ QksekZVs sjksy bugsy”s ku ¼MhihvkbZ½ 200 ,elhth ¼,½ 5.59 1330(अ) 25.03.2021 ¼ch½ $ 6 ,elhth ¼ch½ 127 cqMslkus kbM ¼,½ $ QksekZVs sjksy bugsy”s ku ¼MhihvkbZ½ 400 ,elhth ¼,½ 7.14 1330(अ) 25.03.2021 ¼ch½ $ 6 ,elhth ¼ch½ 128 cqfiokdsu batSD'ku 0-25% 1 fefy- 2.72 1330(अ) 25.03.2021 129 cqfiokdsu batSD'ku 0-5% ds lkFk 7-5% Xydw kts 1 fefy- 6.89 1330(अ) 25.03.2021 130 cqfiokdsu batSD'ku 0-50% 1 fefy- 4.35 1330(अ) 25.03.2021 131 dSQhu batSD'ku 20 fexzk-@fefy- 1 fefy- 278.70 1330(अ) 25.03.2021 132 dSQhu vksjy fyD;wbZM 20 fexzk-@fefy- 1 fefy- 236.71 1330(अ) 25.03.2021 133 dSykekbu yks'ku ¼vkbZih ds vuqlkj½ 1 fefy- 0.94 1330(अ) 25.03.2021 134 dSfY”k;e dkWcksZusV Xkys h 500 fexzk- 1 xkys h 1.92 1330(अ) 25.03.2021 135 dSfY'k;e QkWyhuVs xkys h 15 fexzk- 1 xkys h 45.29 1330(अ) 25.03.2021 136 dSfY'k;e Xydq kus sV batSD'ku 100 fexzk-@fefy- 1 fefy- 0.61 1330(अ) 25.03.2021 137 dSisflVkckbu xkys h 500 fexzk- 1 xkys h 140.33 1330(अ) 25.03.2021 138 dSizs;ksekbflu batSD'ku ds fy, ikmMj 1 xzke izfr iSd 384.60 1330(अ) 25.03.2021 139 dkckeZ ktkikbu vksjy fyD;wbZM 100 fexzk-@5 fefy- 1 fefy- 0.32 2654(अ) 21.07.2021 140 dkckeZ ktkikbu lhvkj xksyh 200 fexzk- 1 xkys h 2.59 2654(अ) 21.07.2021 141 dkckeZ ktkikbu lhvkj xksyh 400 fexzk- 1 xkys h 5.11 2654(अ) 21.07.2021 142 dkckeZ ktkikbu xkys h 100 fexzk- 1 xkys h 1.13 2654(अ) 21.07.2021 143 dkckeZ ktkikbu xkys h 200 fexzk- 1 xkys h 1.55 1330(अ) 25.03.2021 144 dkckeZ ktkikbu xkys h 400 fexzk- 1 xkys h 3.67 1330(अ) 25.03.2021 145 dkfcZektksy xkys h 10 fexzk- 1 xkys h 4.11 1330(अ) 25.03.2021 146 dkfcZektksy xkys h 5 fexzk- 1 xkys h 2.12 1330(अ) 25.03.2021 147 dkckZIsykfVu batSD'ku 10 fexzk-@fefy- 1 fefy- 59.08 1330(अ) 25.03.2021 148 dkckZsDlhesFkhylys kykts MªksIl 0-5% 1 fefy- 14.19 1330(अ) 25.03.2021 149 dkckZsDlhesFkhylys kykts MªksIl 1% 1 fefy- 19.66 1330(अ) 25.03.2021 150 lQs kMªksDlhy dSIlyw 500 fexzk- 1 dSIlyw 7.94 1330(अ) 25.03.2021 151 lQs kMªksDlhy vksjy fyD;wbZM 125 fexzk-@5 fefy- 1 fefy- 0.70 1330(अ) 25.03.2021 152 lQs kMªksDlhy xkys h 1 xzke 1 xkys h 6.98 1330(अ) 25.03.2021 153 lQs kMªksDlhy xkys h 500 fexzk- 1 xkys h 4.47 1330(अ) 25.03.2021 154 lQs ktkfsyu batSD'ku ds fy, ikmMj 1 xzke izfr iSd 27.26 1330(अ) 25.03.2021 155 lQs ktkfsyu batSD'ku ds fy, ikmMj 500 fexzk- izfr iSd 17.28 1330(अ) 25.03.2021 156 lfsQDlhe dSIlyw 200 fexzk- 1 dSIlyw 16.03 1330(अ) 25.03.2021 157 lfsQDlhe dSIlyw 400 fexzk- 1 dSIlyw 32.47 1330(अ) 25.03.2021 158 lfsQDlhe vksjy fyD;wbZM 100 fexzk-@5 fefy- 1 fefy- 2.39 1330(अ) 25.03.2021 159 lfsQDlhe vksjy fyD;wbZM 50 fexzk-@5 fefy- 1 fefy- 1.62 1330(अ) 25.03.2021 160 lfsQDlhe xkys h 400 fexzk- 1 xkys h 24.50 1330(अ) 25.03.2021 161 lfsQDlhe xkys h 200 fexzk- 1 xkys h 10.66 1330(अ) 25.03.2021 162 lQs ksVsDlkbe batSD'ku ds fy, ikmMj 1 xzke izfr iSd 38.10 1330(अ) 25.03.2021 163 lQs ksVsDlkbe batSD'ku ds fy, ikmMj 250 fexzk- izfr iSd 17.32 1330(अ) 25.03.20216 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 164 lQs ksVsDlkbe batSD'ku ds fy, ikmMj 500 fexzk- izfr iSd 22.78 1330(अ) 25.03.2021 165 lQs VkftMkbe batSD'ku ds fy, ikmMj 1 xzke izfr iSd 232.39 1330(अ) 25.03.2021 166 lQs VkftMkbe batSD'ku ds fy, ikmMj 250 fexzk- izfr iSd 72.27 1330(अ) 25.03.2021 167 lQs Vªh;kDlkus batSD'ku ds fy, ikmMj 1 xzke izfr iSd 59.86 1330(अ) 25.03.2021 168 lQs Vªh;kDlkus batSD'ku ds fy, ikmMj 2 xzke izfr iSd 142.29 1330(अ) 25.03.2021 169 lQs Vªh;kDlkus batSD'ku ds fy, ikmMj 250 fexzk- izfr iSd 27.40 1330(अ) 25.03.2021 170 lQs Vªh;kDlkus batSD'ku ds fy, ikmMj 500 fexzk- izfr iSd 50.06 1330(अ) 25.03.2021 171 lfsVªftu dSIlyw 10 fexzk- 1 dSIlyw 2.64 1330(अ) 25.03.2021 172 lfsVªftu vksjy fyD;wbZM 5 fexzk-@5 fefy- 1 fefy- 0.65 1330(अ) 25.03.2021 173 lfsVªftu xkys h 10 fexzk- 1 xkys h 1.84 1330(अ) 25.03.2021 174 lfsVªekbM lkys 'q ku 20% ¼da'kuVªsV QkWj 1 fefy- 0.35 1330(अ) 25.03.2021 fMy'q ku½ 175 Dyksjkecqfly xkys h 2 fexzk- 1 xkys h 40.98 1330(अ) 25.03.2021 176 Dyksjkecqfly xkys h 5 fexzk- 1 xkys h 92.09 1330(अ) 25.03.2021 177 DyksjgsDlkMhu lkys 'q ku 5% ¼da'kuVªsV QkWj fMy'q ku½ 1 fefy- 0.17 1330(अ) 25.03.2021 178 DyksjksDohu vksjy fyD;wbZM 50 fexzk-@5 fefy- 1 fefy- 0.33 1330(अ) 25.03.2021 179 DyksjksDohu xkys h 150 fexzk- 1 xkys h 1.32 1330(अ) 25.03.2021 180 DyksjQsuhjkekbu xkys h 4 fexzk- 1 xkys h 0.10 1330(अ) 25.03.2021 181 dkWyds sfYlQsjkys dSIlyw 1000 vkbZ;w 1 dSIlyw 5.31 1330(अ) 25.03.2021 182 dkWyds sfYlQsjkys dSIlyw 60000 vkbZ;w 1 dSIlyw 32.79 1330(अ) 25.03.2021 183 dkWyds sfYlQsjkys vksjy fyD;wbZM 400 vkbZ;w@fefy- 1 fefy- 2.60 1330(अ) 25.03.2021 184 dkWyds sfYlQsjkys xkys h 1000 vkbZ;w 1 xkys h 4.16 1330(अ) 25.03.2021 185 dkWyds sfYlQsjkys xkys h 60000 vkbZ;w 1 xkys h 26.93 1330(अ) 25.03.2021 186 flizks¶yksDlkflu vksbaVesVa 0-3% 1 xzke 1.26 1330(अ) 25.03.2021 187 flizks¶yksDlkflu MªksIl 0-30% 1 fefy- 1.69 1330(अ) 25.03.2021 188 flizks¶yksDlkflu batSD'ku 200 fexzk-@100 fefy- 1 fefy- 0.19 1330(अ) 25.03.2021 189 flizks¶yksDlkflu vksjy fyD;wbZM 250 fexzk-@5 fefy- 1 fefy- 0.70 1330(अ) 25.03.2021 190 flizks¶yksDlkflu xkys h 250 fexzk- 1 xkys h 2.30 1330(अ) 25.03.2021 191 flizks¶yksDlkflu xkys h 500 fexzk- 1 xkys h 4.05 1330(अ) 25.03.2021 192 fllIysfVu batSD'ku 1 fexzk-@fefy- 1 fefy- 7.65 1330(अ) 25.03.2021 193 Dyjs hFkzkes kblhu vksjy fyD;wbZM 125 fexzk-@5 fefy- 1 fefy- 4.79 1330(अ) 25.03.2021 194 Dyjs hFkzkes kblhu xkys h 250 fexzk- 1 xkys h 31.09 1330(अ) 25.03.2021 195 Dyjs hFkzkes kblhu xkys h 500 fexzk- 1 xkys h 54.80 1330(अ) 25.03.2021 196 DyhuMkekblhu dSIlyw 150 fexzk- 1 dSIlwy 16.07 1330(अ) 25.03.2021 197 DyhuMkekblhu dSIlyw 300 fexzk- 1 dSIlyw 26.24 1330(अ) 25.03.2021 198 DyhuMkekblhu xkys h 300 fexzk- 1 xkys h 16.93 1330(अ) 25.03.2021 199 Dykscktse xkys h 10 fexzk- 1 xkys h 10.04 1330(अ) 25.03.2021 200 Dykscktse xkys h 5 fexzk- 1 xkys h 5.70 1330(अ) 25.03.2021 201 DyksQkftekbu dSIlyw 100 fexzk- 1 dSIlyw 4.12 1330(अ) 25.03.2021 202 DyksQkftekbu dSIlyw 50 fexzk- 1 dSIlyw 2.41 1330(अ) 25.03.2021 203 DyksfeQsu dSIlyw 100 fexzk- 1 dSIlyw 61.81 1330(अ) 25.03.2021 204 DyksfeQsu dSIlyw 50 fexzk- 1 dSIlyw 33.99 1330(अ) 25.03.2021 205 DyksfeQsu xkys h 100 fexzk- 1 xkys h 13.57 1330(अ) 25.03.2021[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 7 206 DyksfeQsu xkys h 50 fexzk- 1 xkys h 9.24 1330(अ) 25.03.2021 207 Dyksehizkekbu xkys h 10 fexzk- 1 xkys h 2.79 1330(अ) 25.03.2021 208 Dyksehizkekbu xkys h 25 fexzk- 1 xkys h 6.16 1330(अ) 25.03.2021 209 Dyksehizkekbu xkys h 75 fexzk- 1 xkys h 15.93 1330(अ) 25.03.2021 210 Dyksuktsike xkys h 0-25 fexzk- 1 xkys h 2.03 1330(अ) 25.03.2021 211 Dyksuktsike xkys h 0-5 fexzk- 1 xkys h 3.46 1330(अ) 25.03.2021 212 Dyksuktsike xkys h 1 fexzk- 1 xkys h 4.70 1330(अ) 25.03.2021 213 DyksfiMkxs zsy xkys h 75 fexzk- 1 xkys h 7.72 1330(अ) 25.03.2021 214 DyksfVªektksy Øhe 1% 1 xzke 3.23 1330(अ) 25.03.2021 215 DyksfVªektksy MªksIl 1% 1 fefy- 3.37 1330(अ) 25.03.2021 216 DyksfVªektksy yks'ku 1% 1 fefy- 3.98 1330(अ) 25.03.2021 217 DyksfVªektksy isljh 100 fexzk- 1 isljh 9.65 1330(अ) 25.03.2021 218 DyksDlkflfyu dSIlyw 250 fexzk- 1 dSIlyw 1.26 1330(अ) 25.03.2021 219 DyksDlkflfyu dSIlyw 500 fexzk- 1 dSIlyw 2.12 1330(अ) 25.03.2021 220 DyksDlkflfyu xkys h 250 fexzk- 1 xkys h 1.92 1330(अ) 25.03.2021 221 DyksDlkflfyu batSD'ku ds fy, ikmMj 250 fexzk- izfr iSd 4.93 1330(अ) 25.03.2021 222 Dykstkikbu xkys h 100 fexzk- 1 xkys h 8.60 1330(अ) 25.03.2021 223 Dykstkikbu xkys h 25 fexzk- 1 xkys h 2.79 1330(अ) 25.03.2021 224 Dykstkikbu xkys h 50 fexzk- 1 xkys h 5.34 1330(अ) 25.03.2021 225 dkxs qy's ku QSDVj IX batSD'ku ds fy, ikmMj 600 vkbZ;w izfr iSd 13680.58 1330(अ) 25.03.2021 226 dkssxqy's ku QSDVj VIII batSD'ku ds fy, ikmMj 250 vkbZ;w izfr iSd 4147.18 1330(अ) 25.03.2021 227 dkxs qy's ku QSDVj VIII batSD'ku ds fy, ikmMj 500 vkbZ;w izfr iSd 10176.88 1330(अ) 25.03.2021 228 dkys phflu xkys h 0-5 fexzk- 1 xkys h 3.46 1330(अ) 25.03.2021 229 dk&s Vªk;eksDlktkys vksjy fyD;wbZM 200 fexzzk-¼,½ $ 40 1 fefy- 0.37 1330(अ) 25.03.2021 [lYQkesFkkWDlklsy fexzk- ¼ch½@5 fefy- ¼,½$VªhesFkkis zhe ¼ch½]] 230 dk&s Vªk;eksDlktkys xkys h 400 fexzk- ¼,½ $ 80 fexzk- ¼ch½ 1 xkys h 0.86 1330(अ) 25.03.2021 [lYQkesFkkWDlklsy ¼,½$VªhesFkkis zhe ¼ch½]] 231 dk&s Vªk;eksDlktkys xkys h 800 fexzk- ¼,½ $ 160 fexzk- ¼ch½ 1 xkys h 2.25 1330(अ) 25.03.2021 [lYQkesFkkWDlklsy ¼,½$VªhesFkkis zhe ¼ch½]] 232 lkbDyksQkslQkekbM xkys h 50 fexzk- 1 xkys h 4.50 1330(अ) 25.03.2021 233 lkbDyksQkslQkekbM batSD'ku ds fy, ikmMj 500 fexzk- izfr iSd 88.62 1330(अ) 25.03.2021 234 lkbDykslsfju dSIlyw 250 fexzk- 1 dSIlyw 60.28 1330(अ) 25.03.2021 235 lkbDykslsfju xkys h 250 fexzk- 1 xkys h 51.83 1330(अ) 25.03.2021 236 lkbDyksLikfsju dSIlyw 100 fexzk- 1 dSIlyw 113.81 1330(अ) 25.03.2021 237 lkbDyksLikfsju dSIlyw 25 fexzk- 1 dSIlyw 30.55 1330(अ) 25.03.2021 238 lkbDyksLikfsju dSIlyw 50 fexzk- 1 dSIlyw 58.45 1330(अ) 25.03.2021 239 lkbDyksLikfsju batSD'ku 50 fexzk-@fefy- 1 fefy- 299.48 1330(अ) 25.03.2021 240 lkbDyksLikfsju vksjy fyD;wbZM 100 fexzk-@fefy- 1 fefy- 104.95 1330(अ) 25.03.2021 241 lkbVksflu vfcZukslkbM batSD'ku 100 fexzk-@fefy- izfr iSd 220.59 1330(अ) 25.03.2021 242 lkbVksflu vfcZukslkbM batSD'ku ds fy, ikmMj 1000 fexzk- izfr iSd 1189.78 1330(अ) 25.03.2021 243 lkbVksflu vfcZukslkbM batSD'ku ds fy, ikmMj 500 fexzk- izfr iSd 568.66 1330(अ) 25.03.2021 244 MkdkckfZtu batSD'ku ds fy, ikmMj 200 fexzk- izfr iSd 487.79 1330(अ) 25.03.20218 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 245 MkdkckfZtu batSD'ku ds fy, ikmMj 500 fexzk- izfr iSd 1100.41 1330(अ) 25.03.2021 246 Msilkus xkys h 100 fexzk- 1 xkys h 0.40 1330(अ) 25.03.2021 247 Mk:ukohj xkys h 600 fexzk- 1 xkys h 185.33 1330(अ) 25.03.2021 248 MkuS k:fclhu I.V. batSD'ku ds fy, ikmMj 20 izfr iSd 270.01 1330(अ) 25.03.2021 fexzk- ¼5 fexzk-@fefy-½ 249 MslQsjhvkDs lkekbu batSD'ku ds fy, ikmMj 500 fexzk- izfr iSd 178.55 1330(अ) 25.03.2021 250 MsDlkesFkklksu xkys h 0-5 fexzk- 1 xkys h 0.21 1330(अ) 25.03.2021 251 MsDlkesFkklksu batSD'ku 4 fexzk-@fefy- izfr iSd 15.29 1330(अ) 25.03.2021 ¼10 fefy-½ 252 MsDlkesFkklksu batSD'ku 4 fexzk-@fefy- izfr iSd 10.35 1330(अ) 25.03.2021 ¼2 fefy-½ 253 MsDlkesFkklksu batSD'ku 4 fexzk-@fefy- izfr iSd 29.31 1330(अ) 25.03.2021 ¼20 fefy-½ 254 MsDlkesFkklksu batSD'ku 4 fexzk-@fefy- izfr iSd 39.17 1330(अ) 25.03.2021 ¼30 fefy-½ 255 MsDlkVªku&40 batSD'ku 10% 1 fefy- 0.94 1330(अ) 25.03.2021 256 Mk;tsike batSD'ku 5 fexzk-@fefy- 1 fefy- 6.72 1330(अ) 25.03.2021 257 Mk;tsike vksjy fyD;wbZM 2 fexzk-@5 fefy- 1 fefy- 3.03 1330(अ) 25.03.2021 258 Mk;tsike lIqiksftVªh 5 fexzk- 1 lIqikfstVªh 6.63 1330(अ) 25.03.2021 259 Mk;tsike xkys h 2 fexzk- 1 xkys h 1.67 1330(अ) 25.03.2021 260 Mk;tsike xkys h 5 fexzk- 1 xkys h 1.58 1330(अ) 25.03.2021 261 fMDyksQus d dSIlyw 50 fexzk- 1 dSIlyw 0.68 1330(अ) 25.03.2021 262 fMDyksQus d batSD'ku 25 fexzk-@fefy- 1 fefy- 1.63 1330(अ) 25.03.2021 263 fMDyksQus d xkys h 50 fexzk- 1 xkys h 2.13 1330(अ) 25.03.2021 264 fMlkbDyksekbu batSD'ku 10 fexzk-@fefy-¼10 fefy- 1 fefy- 2.28 1330(अ) 25.03.2021 ,aM 30 fefy- iSd½ 265 fMlkbDyksekbu batSD'ku 10 fexzk-@fefy-¼1fefy- ,aM 1 fefy- 3.54 1330(अ) 25.03.2021 2 fefy- iSd½ 266 fMlkbDyksekbu vksjy lksy'q ku 10 fexzk-@5 fefy- 1 fefy- 0.18 1330(अ) 25.03.2021 267 fMlkbDyksekbu xkys h 10 fexzk- 1 xkys h 0.12 1330(अ) 25.03.2021 268 MkbZbFkk;ydkckeZ stkbu vksjy fyD;wbZM 120 fexzk-@5 fefy- 1 fefy- 0.54 1330(अ) 25.03.2021 269 MkbZbFkk;ydkckeZ stkbu xkys h 100 fexzk- 1 xkys h 1.57 1330(अ) 25.03.2021 270 MkbZbFkk;ydkckeZ stkbu xkys h 50 fexzk- 1 xkys h 0.62 1330(अ) 25.03.2021 271 MkbxkfsDlu batSD'ku 0-25 fexzk-@fefy- 1 fefy- 3.70 1330(अ) 25.03.2021 272 MkbxkfsDlu vksjy fyD;wbZM 0-05 fexzk-@ fefy- 1 fefy- 1.41 1330(अ) 25.03.2021 273 MkbxkfsDlu xkys h 0-25 fexzk- 1 xkys h 1.33 1330(अ) 25.03.2021 274 MkbyksDlkukbM Qwjk,s V xkys h 500 fexzk- 1 xkys h 1.17 1330(अ) 25.03.2021 275 MkbyfV;ktse dSIlyw 90 fexzk- 1 dSIlyw 10.67 1330(अ) 25.03.2021 276 MkbyfV;ktse batSD'ku 5 fexzk-@fefy- 1 fefy- 3.51 1330(अ) 25.03.2021 277 MkbyfV;ktse ,lvkj xksyh 90 fexzk- 1 xkys h 10.36 1330(अ) 25.03.2021 278 MkbyfV;ktse xkys h 30 fexzk- 1 xkys h 2.66 1330(अ) 25.03.2021 279 MkbyfV;ktse xkys h 60 fexzk- 1 xkys h 5.43 1330(अ) 25.03.2021 280 fMesjdkizkys batSD'ku 50 fexzk-@fefy- 1 fefy- 222.22 1330(अ) 25.03.2021 281 MkbuksizkLs Vkus tSy 0-5 fexzk- 1 xzke 90.01 1330(अ) 25.03.2021 282 MkbuksizkLs Vkus xkys h 0-5 fexzk- 1 xkys h 55.57 1330(अ) 25.03.2021 283 MkbQFkfsj;k ,VhaVksDlhu 10000 vkbZ;w izfr iSd 1455.21 1330(अ) 25.03.2021 284 Mkcs qVkekbu batSD'ku 50 fexzk-@fefy- izfr iSd 41.64 1330(अ) 25.03.2021[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 9 285 Mkls Vs kDlys batSD'ku ds fy, ikmMj 20 fexzk- izfr iSd 3323.65 1330(अ) 25.03.2021 286 Mkls Vs kDlys batSD'ku ds fy, ikmMj 80 fexzk- izfr iSd 12636.74 1330(अ) 25.03.2021 287 Mkes isfjMkus vksjy fyD;wbZM 1 fexzk-@fefy- 1 fefy- 1.20 1330(अ) 25.03.2021 288 Mkes isfjMkus xkys h 10 fexzk- 1 xkys h 2.68 1330(अ) 25.03.2021 289 Mkus sistkby xkys h 10 fexzk- 1 xkys h 17.82 1330(अ) 25.03.2021 290 Mkus sistkby xkys h 5 fexzk- 1 xkys h 12.48 1330(अ) 25.03.2021 291 Mkis kekbu batSD'ku 40 fexzk-@fefy- 1 fefy- 6.27 1330(अ) 25.03.2021 292 MkDs lk:s fclhu batSD'ku 2 fexzk-@fefy- 1 fefy- 39.86 1330(अ) 25.03.2021 293 MkDs lhlkblyhu dSIlyw 100 fexzk- 1 dSIlyw 2.78 1330(अ) 25.03.2021 294 MkDs lhlkblyhu xkys h 100 fexzk- 1 xkys h 1.09 1330(अ) 25.03.2021 295 MhihVh$fgc$gsi ch oSDlhu izfr 0-1 fefy- 89.18 1330(अ) 25.03.2021 296 MhihVh oSDlhu izfr 0-5 fefy- 15.73 1330(अ) 25.03.2021 297 bQkohjsat dSIlyw 200 fexzk- 1 dSIlyw 26.73 1330(अ) 25.03.2021 298 bQkohjsat dSIlyw 600 fexzk- 1 dSIlyw 69.65 1330(अ) 25.03.2021 299 bQkohjsat xkys h 200 fexzk- 1 xkys h 25.18 1330(अ) 25.03.2021 300 bQkohjsat xkys h 600 fexzk- 1 xkys h 78.85 1330(अ) 25.03.2021 301 bukykizhy xkys h 2-5 fexzk- 1 xkys h 2.15 1330(अ) 25.03.2021 302 bukykizhy xkys h 5 fexzk- 1 xkys h 3.57 1330(अ) 25.03.2021 303 buksDlkikfju batSD'ku 40 fexzk-@0-4 fefy- 0-1 fefy- 112.86 1330(अ) 25.03.2021 304 buksDlkikfju batSD'ku 60 fexzk-@0-6 fefy- 0-1 fefy- 112.86 1330(अ) 25.03.2021 305 buVsdkohj xkys h 0-5 fexzk- 1 xkys h 88.59 1330(अ) 25.03.2021 306 buVsdkohj xkys h 1 fexzk- 1 xkys h 140.76 1330(अ) 25.03.2021 307 ,fjFkkzsiksbVhu batSD'ku 10000 vkbZ;w@fefy- izfr iSd 2888.54 1330(अ) 25.03.2021 308 ,fjFkkzsiksbVhu batSD'ku 2000 vkbZ;w@fefy- izfr iSd 684.16 1330(अ) 25.03.2021 309 blhVkyksizke xkys h 10 fexzk- 1 xkys h 8.99 1330(अ) 25.03.2021 310 blhVkyksizke xkys h 20 fexzk- 1 xkys h 14.21 1330(अ) 25.03.2021 311 blhVkyksizke xkys h 5 fexzk- 1 xkys h 5.06 1330(अ) 25.03.2021 312 blekys kys batSD'ku 10 fexzk-@fefy- 1 fefy- 24.06 1330(अ) 25.03.2021 313 bFkkecqVksy xkys h 200 fexzk- 1 xkys h 1.17 1330(अ) 25.03.2021 314 bFkkecqVksy xkys h 400 fexzk- 1 xkys h 2.66 1330(अ) 25.03.2021 315 bFkkecqVksy xkys h 600 fexzk- 1 xkys h 3.93 1330(अ) 25.03.2021 316 bFkkecqVksy xkys h 800 fexzk- 1 xkys h 4.70 1330(अ) 25.03.2021 317 bFkhuyLs VkMhvkys xkys h 0-01 fexzk- 1 xkys h 2.60 1330(अ) 25.03.2021 318 bFkhuyLs VkMhvkys xkys h 0-05 fexzk- 1 xkys h 4.16 1330(अ) 25.03.2021 319 bFkhuyLs VkMhvkys xkys h 0-03 fexzk- ¼,½ $ 0-15 fexzk ¼ch½ 1 xkys h 3.83 1330(अ) 25.03.2021 ¼,½$ysokus ksxsLZ Vªsy ¼ch½ 320 bFkhukekbM xkys h 250 fexzk- 1 xkys h 17.52 1330(अ) 25.03.2021 321 bFkkbZy ,Ydkgs y ¼MhuspjM½ lkYs ;q”ku 70 izfr”kr 1 fefy- 0.47 1330(अ) 25.03.2021 322 bVksikls kbM dSIlyw 50 fexzk- 1 dSIlyw 60.37 1330(अ) 25.03.2021 323 bVksikls kbM batSD'ku 20 fexzk-@fefy- 1 fefy- 39.81 1330(अ) 25.03.2021 324 QsuVkukby batSD'ku 50 ,elhth@fefy- 1 fefy- 25.21 1330(अ) 25.03.2021 325 Qsjl lkYV ¼,½ $ Qksfyd Xkksyh 100 fexzk- byhesuVy vk;ju 1 xkys h 0.25 1330(अ) 25.03.2021 ,flM ¼ch½ ¼,½ $ 500 ,elhth ¼ch½ 326 fQyxzkLVhe batSD'ku 300 ,elhth izfr iSd 1523.73 1330(अ) 25.03.202110 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 327 ¶ydw kus ktksy dSIlyw 100 fexzk- 1 dSIlyw 28.06 1330(अ) 25.03.2021 328 ¶ydw kus ktksy dSIlyw 150 fexzk- 1 dSIlyw 20.59 1330(अ) 25.03.2021 329 ¶ydw kus ktksy dSIlyw 200 fexzk- 1 dSIlyw 40.54 1330(अ) 25.03.2021 330 ¶ydw kus ktksy vksjy fyD;wbZM 50 fexzk-@5 fefy- 1 fefy- 2.90 1330(अ) 25.03.2021 331 ¶ydw kus ktksy xkys h 100 fexzk- 1 xkys h 8.86 1330(अ) 25.03.2021 332 ¶ydw kus ktksy xkys h 150 fexzk- 1 xkys h 13.15 1330(अ) 25.03.2021 333 ¶ydw kus ktksy xkys h 200 fexzk- 1 xkys h 20.86 1330(अ) 25.03.2021 334 ¶ydw kus ktksy xkys h 400 fexzk- 1 xkys h 34.69 1330(अ) 25.03.2021 335 ¶ydw kus ktksy batSD'ku 200 fexzk-@100 fefy- izfr iSd 118.17 1330(अ) 25.03.2021 336 ¶yuw kfjtkbu xkys h 10 fexzk- 1 xkys h 5.26 1330(अ) 25.03.2021 337 ¶yuw kfjtkbu xkys h 5 fexzk- 1 xkys h 3.06 1330(अ) 25.03.2021 338 ¶yDw lsVkbu dSIlyw 10 fexzk- 1 dSIlyw 3.30 1330(अ) 25.03.2021 339 ¶yDw lsVkbu dSIlyw 20 fexzk- 1 dSIlyw 4.05 1330(अ) 25.03.2021 340 ¶yDw lsVkbu dSIlyw 40 fexzk- 1 dSIlyw 6.15 1330(अ) 25.03.2021 341 ¶yDw lsVkbu dSIlyw 60 fexzk- 1 dSIlyw 10.87 1330(अ) 25.03.2021 342 ¶yDw lsVkbu xkys h 10 fexzk- 1 xkys h 2.77 1330(अ) 25.03.2021 343 ¶yDw lsVkbu xkys h 20 fexzk- 1 xkys h 4.40 1330(अ) 25.03.2021 344 ¶yDw lsVkbu xkys h 40 fexzk- 1 xkys h 5.93 1330(अ) 25.03.2021 345 ¶yDw lsVkbu xkys h 60 fexzk- 1 xkys h 8.22 1330(अ) 25.03.2021 346 ¶yQw suktkbu fMikVs batSD'ku 25 fexzk-@fefy- 1 fefy- 55.55 1330(अ) 25.03.2021 347 Qksfyd ,flM dSIlyw 5 fexzk- 1 dSIlyw 6.26 1330(अ) 25.03.2021 348 Qksfyd ,flM xkys h 5 fexzk- 1 xkys h 1.55 1330(अ) 25.03.2021 349 Qqjksles kbM vksjy fyD;wbZM 10 fexzk-@fefy- 1 fefy- 3.07 1330(अ) 25.03.2021 350 Qqjksles kbM xkys h 40 fexzk- 1 xkys h 0.83 1330(अ) 25.03.2021 351 Qqjksles kbM batSD'ku 10 fexzk-@fefy- 1 fefy- 2.76 1330(अ) 25.03.2021 352 QqflfMd ,flM Øhe 2% 1 xzke 10.14 1330(अ) 25.03.2021 353 xkMkcs suVs batSD'ku 529 fexzk-@fefy- 1 fefy- 121.01 1330(अ) 25.03.2021 354 xkulhDyksohj dSIlyw 250 fexzk- 1 dSIlyw 133.48 1330(अ) 25.03.2021 355 xkulhDyksohj batSD'ku ds fy, ikmMj 500 fexzk- izfr iSd 1873.81 1330(अ) 25.03.2021 356 tsfQfVfuc xkys h 250 fexzk- 1 xkys h 475.90 1330(अ) 25.03.2021 357 tseflVkckbu batSD'ku ds fy, ikmMj 1 xzke izfr iSd 5890.65 1330(अ) 25.03.2021 358 tseflVkckbu batSD'ku ds fy, ikmMj 200 fexzk- izfr iSd 1300.95 1330(अ) 25.03.2021 359 tsVa kekbflu MªksIl 0-3% 1 fefy- 1.01 1330(अ) 25.03.2021 360 tsVa kekbflu batSD'ku 10 fexzk-@fefy- 1 fefy- 3.53 1330(अ) 25.03.2021 361 tsVa kekbflu batSD'ku 40 fexzk-@fefy- izfr iSd 19.95 1330(अ) 25.03.2021 ¼10 fefy-½ 362 tsVa kekbflu batSD'ku 40 fexzk-@fefy- izfr iSd 9.35 1330(अ) 25.03.2021 ¼2 fefy-½ 363 tsVa kekbflu batSD'ku 40 fexzk-@fefy- izfr iSd 30.24 1330(अ) 25.03.2021 ¼20 fefy-½ 364 tsVa kekbflu batSD'ku 40 fexzk-@fefy- izfr iSd 33.10 1330(अ) 25.03.2021 ¼30 fefy-½ 365 XyhehfijkbM xkys h 1 fexzk- 1 xkys h 3.99 1330(अ) 25.03.2021 366 XyhehfijkbM xkys h 2 fexzk- 1 xkys h 6.34 1330(अ) 25.03.2021[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 11 367 Xydw kts batSD'ku 25% 1 fefy- 0.19 1330(अ) 25.03.2021 368 Xydw kts batSD'ku 50% 1 fefy- 0.54 1330(अ) 25.03.2021 369 Xydw kts batSD'ku 5% 1000 fefy- Xykl 71.31 1330(अ) 25.03.2021 370 Xydw kts batSD'ku 5% 1000 fefy- ukWu 57.57 1330(अ) 25.03.2021 Xykl 371 Xydw kts batSD'ku 5% 100 fefy- Xykl 20.02 1330(अ) 25.03.2021 372 Xydw kts batSD'ku 5% 100 fefy- ukWu 18.12 1330(अ) 25.03.2021 Xykl 373 Xydw kts batSD'ku 5% 250 fefy- Xykl 27.66 1330(अ) 25.03.2021 374 Xydw kts batSD'ku 5% 250 fefy- ukWu 24.99 1330(अ) 25.03.2021 Xykl 375 Xydw kts batSD'ku 5% 500 fefy- Xykl 39.26 1330(अ) 25.03.2021 376 Xydw kts batSD'ku 5% 500 fefy- ukWu 33.87 1330(अ) 25.03.2021 Xykl 377 Xydw kts batSD'ku 10% izfr iSd ¼1000 28.68 1330(अ) 25.03.2021 fefy-½ 378 Xydw kts batSD'ku 10% izfr iSd ¼500 31.19 1330(अ) 25.03.2021 fefy-½ 379 Xydw kts ¼,½ $ lkfsM;e batSD'ku 5% ¼,½ $ 0-9% ¼ch½ 1000 fefy- Xykl 71.78 1330(अ) 25.03.2021 DyksjkbM ¼ch½ 380 Xydw kts ¼,½ $ lkfsM;e batSD'ku 5% ¼,½ $ 0-9% ¼ch½ 1000 fefy- ukWu 58.00 1330(अ) 25.03.2021 DyksjkbM ¼ch½ Xykl 381 Xydw kts ¼,½ $ lkfsM;e batSD'ku 5% ¼,½ $ 0-9% ¼ch½ 100 fefy- Xykl 20.07 1330(अ) 25.03.2021 DyksjkbM ¼ch½ 382 Xydw kts ¼,½ $ lkfsM;e batSD'ku 5% ¼,½ $ 0-9% ¼ch½ 100 fefy- ukWu 18.14 1330(अ) 25.03.2021 DyksjkbM ¼ch½ Xykl 383 Xydw kts ¼,½ $ lkfsM;e batSD'ku 5% ¼,½ $ 0-9% ¼ch½ 250 fefy- Xykl 27.77 1330(अ) 25.03.2021 DyksjkbM ¼ch½ 384 Xydw kts ¼,½ $ lkfsM;e batSD'ku 5% ¼,½ $ 0-9%¼ch½ 250 fefy- ukWu 25.08 1330(अ) 25.03.2021 DyksjkbM ¼ch½ Xykl 385 Xydw kts ¼,½ $ lkfsM;e batSD'ku 5% ¼,½ $ 0-9% ¼ch½ 500 fefy- Xykl 39.45 1330(अ) 25.03.2021 DyksjkbM ¼ch½ 386 Xydw kts ¼,½ $ lkfsM;e batSD'ku 5% ¼,½ $ 0-9% ¼ch½ 500 fefy- ukWu 34.08 1330(अ) 25.03.2021 DyksjkbM ¼ch½ Xykl 387 XyVw kjkyMsgkbM lkys 'q ku 2% 1 fefy- 0.07 1330(अ) 25.03.2021 388 fXyljhu vksjy fyD;wbZM 1 fefy- 0.17 1330(अ) 25.03.2021 389 fXyljkby VªkbZfuVªsV batSD'ku 5 fexzk-@fefy- 1 fefy- 7.29 1330(अ) 25.03.2021 390 fXyljkby VªkbZfuVªsV lcfyaxq,y xkys h 0-5 fexzk- 1 xkys h 2.00 1330(अ) 25.03.2021 391 Xykbdkis kbjksyVs batSD'ku 0-2 fexzk-@fefy- 1 fefy- 13.65 1330(अ) 25.03.2021 392 xzhlksQqyfou xkys h 125 fexzk- 1 xkys h 0.91 1330(अ) 25.03.2021 393 xzhlksQqyfou xkys h 250 fexzk- 1 xkys h 1.77 1330(अ) 25.03.2021 394 xzhlksQqyfou xkys h 375 fexzk- 1 xkys h 4.77 1330(अ) 25.03.2021 395 ges kMs k;ylhl ¶yMw ykblasl ds vuqlkj 1 fefy- 0.04 1330(अ) 25.03.2021 396 gys ksisfjMkys batSD'ku 5 fexzk-@fefy- 1 fefy- 6.47 1330(अ) 25.03.2021 397 gys ksisfjMkys vksjy fyD;wbZM 2 fexzk-@5 fefy- 1 fefy- 2.28 1330(अ) 25.03.2021 398 gys ksisfjMkys xkys h 1-5 fexzk- 1 xkys h 1.84 1330(अ) 25.03.2021 399 gys ksisfjMkys xkys h 10 fexzk- 1 xkys h 4.90 1330(अ) 25.03.2021 400 gys ksisfjMkys xkys h 20 fexzk- 1 xkys h 5.47 1330(अ) 25.03.2021 401 gys ksisfjMkys xkys h 5 fexzk- 1 xkys h 3.82 1330(अ) 25.03.2021 402 gys ksFkus bugsy's ku 1 fefy- 6.50 1330(अ) 25.03.202112 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 403 gis kfju batSD'ku 1000 vkbZ;w@fefy- 1 fefy- 18.11 1330(अ) 25.03.2021 404 gis kfju batSD'ku 5000 vkbZ;w@fefy- 1 fefy- 44.95 1330(अ) 25.03.2021 405 gis kVkbfVl ch bEequksXykscqfyu izfr iSd 6116.13 1330(अ) 25.03.2021 406 giS kVkbfVl ch oSDlhu 1 fefy- 86.95 1330(अ) 25.03.2021 407 gksekVªksikbu MªksIl 2% 1 fefy- 6.89 1330(अ) 25.03.2021 408 gkekZus fjfyftax vkbZ;wMh blesa 52 fexzk- ysokus ksxsLZ Vsªy 'kkfey gS 1 vkbZ;wMh 4295.01 1330(अ) 25.03.2021 409 g;~ qeu dksfjvksfud batSD'ku 1000 vkbZ;w izfr iSd 235.98 1330(अ) 25.03.2021 xkus kMkVs ªksfiu 410 g;~ qeu dksfjvksfud batSD'ku 5000 vkbZ;w izfr iSd 463.41 1330(अ) 25.03.2021 xksukMkVs ªksfiu 411 g;~ qeu ukWeZy bEequksXykscqfyu lkys ”q ku QkWj buQ~;wtu 5 izfr”kr 1 fefy- 171.30 1330(अ) 25.03.2021 412 g;~ qeu ukWeZy bEequksXykscqfyu lkys ”q ku QkWj buQ~;wtu 10 izfr”kr 1 fefy- 231.92 1330(अ) 25.03.2021 413 g;~ qeu ukWeZy bEequksXykscqfyu lkys ”q ku QkWj buQ~;wtu 16.5 1 fefy- 441.03 1428(अ) 31.03.2021 izfr”kr 414 gkbMªksDyksjksFkkbtkbM xkys h 12-5 fexzk- 1 xkys h 1.10 1330(अ) 25.03.2021 415 gkbMªksDyksjksFkkbtkbM xkys h 25 fexzk- 1 xksyh 1.87 1330(अ) 25.03.2021 416 gkbMªksDyksjksFkkbtkbM xkys h 50 fexzk- 1 xkys h 0.09 1330(अ) 25.03.2021 417 gkbMªksdkVs hZlkus xkys h 10 fexzk- 1 xkys h 6.54 1330(अ) 25.03.2021 418 gkbMªksdkVs hZlkus xkys h 5 fexzk- 1 xkys h 3.37 1330(अ) 25.03.2021 419 gkbMªksdkVs hZlkus batSD'ku 100 fexzk- izfr iSd 43.21 1330(अ) 25.03.2021 420 gkbMªksdkVs hZlkus batSD'ku 200 fexzk- izfr iSd 66.61 1330(अ) 25.03.2021 421 gkbMªksdkVs hZlkus batSD'ku ds fy, ikmMj 100 fexzk- izfr iSd 43.21 1330(अ) 25.03.2021 422 gkbMªkstu isjksDlkbM lkys 'q ku 6% 1 fefy- 0.04 1330(अ) 25.03.2021 423 हाइड्रोक्सोकोबालाजमन इंजेक्िन 1 जमलीग्राम/एमएल 1 जम.ली. 10.98 4885(अ) 26.11.2021 424 gkbMªksDlhDyksjksDohu xkys h 200 fexzk- 1 xkys h 6.58 1330(अ) 25.03.2021 425 gkbMªksDlhDyksjksDohu xkys h 400 fexzk- 1 xkys h 13.26 1330(अ) 25.03.2021 426 gkbMªksDlhizksikby batSD'ku 2% 1 fefy- 41.64 1330(अ) 25.03.2021 esFkkbylsyqykst 427 gkbMªksDlh;wfj;k dSIlyw 500 fexzk- 1 dSIlyw 14.23 1330(अ) 25.03.2021 428 gk;kslhu cqVhyczkes kbM batSD'ku 20 fexzk-@fefy- 1 fefy- 11.59 1330(अ) 25.03.2021 429 gk;kslhu cqVhyczkes kbM xkys h 10 fexzk- 1 xkys h 3.30 1330(अ) 25.03.2021 430 vkbZcqizkQs qu dSIlyw 400 fexzk- 1 dSIlyw 1.17 1330(अ) 25.03.2021 431 vkbZcqizkQs qu dSIlyw 200 fexzk- 1 lkWQ~V 2.97 1330(अ) 25.03.2021 tsysVkbu dSIlyw 432 vkbZcqizkQs qu xkys h 200 fexzk- 1 xkys h 0.65 2654(अ) 01.07.2021 433 vkbZcqizkQs qu xkys h 400 fexzk- 1 xkys h 1.15 2654(अ) 01.07.2021 434 vkbZcqizkQs qu vksjy fyD;wbZM 100 fexzk-@5 fefy- 1 fefy- 0.21 1330(अ) 25.03.2021 435 vkbZQksLQkekbM batSD'ku ds fy, ikmMj 1 xzke izfr iSd 401.77 1330(अ) 25.03.2021 436 vkbZQksLQkekbM batSD'ku ds fy, ikmMj 2 xzke izfr iSd 1054.59 1330(अ) 25.03.2021 437 besfVuhc dSIlyw 100 fexzk- 1 dSIlyw 86.20 1330(अ) 25.03.2021 438 besfVuhc dSIlyw 400 fexzk- 1 dSIlyw 283.61 1330(अ) 25.03.2021 439 besfVuhc xkys h 100 fexzk- 1 xkys h 88.18 1330(अ) 25.03.2021 440 besfVuhc xkys h 400 fexzk- 1 xkys h 255.28 1330(अ) 25.03.2021 441 balqfyu ¼lkys qcy½ batSD'ku 40 vkbZ;w@fefy- 1 fefy- 16.71 1330(अ) 25.03.2021 442 baVjesfM,V ,fDVax ¼,uih,p½ batSD'ku 40 vkbZ;w@fefy- 1 fefy- 16.71 1330(अ) 25.03.2021 balqfyu[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 13 443 bvksgsDlkys batSD'ku 300 fexzk- vk;ksfMu@fefy- 1 fefy- 18.46 1330(अ) 25.03.2021 444 vkbZizkVªkfsi;e bugsy's ku ¼,eMhvkbZ@MhihvkbZ½ 20 1 Mkts 0.68 1330(अ) 25.03.2021 ,elhth@Mkts 445 vkbZizkVªksfi;e jslfijsVkWjh lkys 'q ku QkWj ;wt bu 1 fefy- 2.81 1330(अ) 25.03.2021 uscqykbtj 250 ,elhth@fefy- 446 vk;ju lØq kts batSD'ku 20 fexzk-@fefy- 1 fefy- 59.68 1330(अ) 25.03.2021 447 vkbZlks¶yqjsu bugsy's ku 1 fefy- 11.61 1330(अ) 25.03.2021 448 vkbZlksfuftM xkys h 100 fexzk- 1 xkys h 0.75 1330(अ) 25.03.2021 449 vkbZlksfuftM xkys h 300 fexzk- 1 xkys h 1.33 1330(अ) 25.03.2021 450 vkbZlkslkfscZM 5 ekus ksuhVªsV xkys h 20 fexzk- 1 xkys h 3.64 1330(अ) 25.03.2021 451 vkbZlkslkfscZM fMfuVªsV xkys h 10 fexzk- 1 xkys h 0.81 1330(अ) 25.03.2021 452 vkbZlkslkfscZM fMfuVªsV xkys h 5 fexzk- 1 xkys h 0.83 1330(अ) 25.03.2021 453 vkbZlkslkfscZM 5 & ekus ksuhVªsV ,lvkj dSIlyw 30 fexzk- 1 dSIlyw 3.89 1330(अ) 25.03.2021 454 vkbZlkslkfscZM 5 & ekus ksuhVªsV ,lvkj dSIlyw 60 fexzk- 1 dSIlyw 3.87 1330(अ) 25.03.2021 455 vkbZlkslkfscZM 5 & ekus ksuhVªsV ,lvkj xksyh 30 fexzk- 1 xkys h 5.44 1330(अ) 25.03.2021 456 vkbZlkslkfscZM 5 & ekus ksuhVªsV ,lvkj xksyh 60 fexzk- 1 xkys h 7.09 1330(अ) 25.03.2021 457 vkbZlkslkfscZM 5 & ekus ksuhVªsV xkys h 10 fexzk- 1 xkys h 2.18 1330(अ) 25.03.2021 458 bLik?kqyk xzsU;wyl@gLd@ikmMj 1 xzke 0.85 1330(अ) 25.03.2021 459 vkbZ;wMh daVasfuxa dkWij ykblasl ds :i esa 1 vkbZ;wMh 319.22 1330(अ) 25.03.2021 460 tkiuht bulsQkfyfVl 4 ,elhth ls 6 ,elhth izfr iSd 774.52 1330(अ) 25.03.2021 oSDlhu 461 tkiuht bulsQkfyfVl 3 ,elhth rd izfr iSd 590.07 1330(अ) 25.03.2021 oSDlhu 462 dSukekblhu batSD'ku ds fy, ikmMj 1 xzke izfr iSd 43.42 1330(अ) 25.03.2021 463 dSukekblhu batSD'ku ds fy, ikmMj 500 fexzk- izfr iSd 23.68 1330(अ) 25.03.2021 464 dSukekblhu batSD'ku ds fy, ikmMj 750 fexzk- izfr iSd 40.46 1330(अ) 25.03.2021 465 dSVkekbu batSD'ku 10 fexzk-@fefy- 1 fefy- 11.76 1330(अ) 25.03.2021 466 dSVkekbu batSD'ku 50 fexzk-@fefy- 1 fefy- 11.61 1330(अ) 25.03.2021 467 ycs sVkyksy batSD'ku 5 fexzk-@fefy- 1 fefy- 56.28 1330(अ) 25.03.2021 468 yDS Vksykst vksjy fyD;wbZM 10 xzke@15 fefy- 1 fefy- 1.22 1330(अ) 25.03.2021 469 yfseoqMkbu ¼,½ $usfojkikbu xkys h 150 fexzk- ¼,½ $ 200 fexzk-¼ch½ 1 xkys h 17.32 1330(अ) 25.03.2021 ¼ch½ $LVkoqMkbu ¼lh½ $ 30 fexzk- ¼lh½ 470 yfseoqMkbu ¼,½ $ ftMkcs qMkbu xkys h 150 fexzk- ¼,½ $ 300 fexzk-¼ch½ 1 xkys h 22.28 1330(अ) 25.03.2021 ¼ch½ 471 yfseoqMkbu ¼,½ $usfojkikbu fMLiszflcy xksyh 30 fexzk- ¼,½ $ 50 1 xkys h 5.49 1330(अ) 25.03.2021 ¼ch½ $LVkoqMkbu ¼lh½ fexzk-¼ch½ $ 6 fexzk- ¼lh½ 472 ,y&,Lisjtkbul batSD'ku ds fy, ikmMj 10000 ds;w izfr iSd 1782.47 1330(अ) 25.03.2021 473 ,y&,Lisjtkbul batSD'ku ds fy, ikmMj 5000 ds;w izfr iSd 1150.56 1330(अ) 25.03.2021 474 y¶s yuq ksekbM xkys h 10 fexzk- 1 xkys h 11.11 1330(अ) 25.03.2021 475 y¶s yuq ksekbM xkys h 20 fexzk- 1 xkys h 21.69 1330(अ) 25.03.2021 476 yVs ªkstkys xkys h 2-5 fexzk- 1 xkys h 45.27 1330(अ) 25.03.2021 477 yos sfVjklsVe batSD'ku 100 fexzk-@fefy- 1 fefy- 24.22 1330(अ) 25.03.2021 478 yos sfVjklsVe bZvkj xkys h 750 fexzk- 1 xksyh 19.31 1330(अ) 25.03.2021 479 yos sfVjklsVe xkys h 250 fexzk- 1 xkys h 6.49 1330(अ) 25.03.2021 480 yos sfVjklsVe xkys h 500 fexzk- 1 xkys h 13.13 1330(अ) 25.03.2021 481 yos sfVjklsVe xkys h 750 fexzk- 1 xkys h 20.19 1330(अ) 25.03.2021 482 yos sfVjklsVe vksjy fyD;wbZM 100 fexzk-@fefy- 1 fefy- 4.05 1330(अ) 25.03.202114 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 483 yos kMs kis k ¼,½ $dkfcZMkis k ¼ch½ lhvkj xksyh 100 fexzk-¼,½ $ 25 fexzk- 1 xkys h 3.70 1330(अ) 25.03.2021 ¼ch½ 484 yos kMs kis k ¼,½ $dkfcZMkis k ¼ch½ xkys h 100 fexzk- ¼,½ $ 10 fexzk- ¼ch½ 1 xkys h 1.73 1330(अ) 25.03.2021 485 yos kMs kis k ¼,½ $dkfcZMkis k ¼ch½ xkys h 100 fexzk- ¼,½ $ 25 fexzk- ¼ch½ 1 xkys h 2.50 1330(अ) 25.03.2021 486 yos kMs kis k ¼,½ $dkfcZMkis k ¼ch½ xkys h 250 fexzk- ¼,½ $ 25 fexzk- ¼ch½ 1 xkys h 4.15 1330(अ) 25.03.2021 487 yos kMs kis k ¼,½ $dkfcZMkis k ¼ch½ lhvkj xksyh 200 fexzk-¼,½ $ 50 fexzk- 1 xkys h 4.56 1330(अ) 25.03.2021 ¼ch½ 488 yos ks¶yksDlklhu xkys h 250 fexzk- 1 xkys h 4.90 1330(अ) 25.03.2021 489 yos ks¶yksDlklhu xkys h 750 fexzk- 1 xkys h 12.14 1330(अ) 25.03.2021 490 yos ks¶yksDlklhu xkys h 500 fexzk- 1 xkys h 8.95 1330(अ) 25.03.2021 491 yos kus ksxsLZ Vªsy xkys h 0-75 fexzk- 1 xkys h 25.55 1330(अ) 25.03.2021 492 yos kFskkbjksDlhu xkys h 37.50 ,elhth 1 xkys h 1.31 1725(अ) 30.04.2021 493 yos kFskkbjksDlhu xkys h 100 ,elhth 1 xkys h 1.33 1330(अ) 25.03.2021 494 yos kFskkbjksDlhu xkys h 112 ,elhth 1 xkys h 1.60 1330(अ) 25.03.2021 495 yos kFskkbjksDlhu xkys h 12-5 ,elhth 1 xkys h 1.50 1330(अ) 25.03.2021 496 yos kFskkbjksDlhu xkys h 125 ,elhth 1 xkys h 1.71 1330(अ) 25.03.2021 497 yos kFskkbjksDlhu xkys h 150 ,elhth 1 xkys h 1.72 1330(अ) 25.03.2021 498 yos kFskkbjksDlhu xkys h 25 ,elhth 1 xkys h 1.45 1330(अ) 25.03.2021 499 yos kFskkbjksDlhu xkys h 50 ,elhth 1 xkys h 1.10 1330(अ) 25.03.2021 500 yos kFskkbjksDlhu xkys h 62-5 ,elhth 1 xkys h 1.56 1330(अ) 25.03.2021 501 ysokFskkbjksDlhu xkys h 75 ,elhth 1 xkys h 1.44 1330(अ) 25.03.2021 502 yos kFskkbjksDlhu xkys h 88 ,elhth 1 xkys h 1.71 1330(अ) 25.03.2021 503 fyXuksdsu batSD'ku 2% 1 fefy- 1.10 1330(अ) 25.03.2021 504 fyXuksdsu batSD'ku 2% ¼izstjosfVo Qzh QkWj IV 1 fefy- 1.09 1330(अ) 25.03.2021 ;wt 505 fyXuksdsu batSD'ku 1% izfr iSd 8.82 1330(अ) 25.03.2021 506 fyXuksdsu VkWfidy QkWeZ 2&5% 1 xzke vkSj 1.20 1330(अ) 25.03.2021 1 fefy- 507 fyXuksdsu batSD'ku 5% Xydw kts 7-5% ds 1 fefy- 4.09 1330(अ) 25.03.2021 lkFk 508 fyXuksdsu ¼,½ $ ,Mªsukykbu batSD'ku 1%¼,½ $ 1%200000¼5 1 fefy- 0.50 1330(अ) 25.03.2021 ¼ch½ ,elhth@fefy-½ ¼ch½ 509 fyXuksdsu ¼,½ $ ,Mªsukykbu batSD'ku 2% ¼,½ $ 1%200000 ¼5 1 fefy- 1.02 1330(अ) 25.03.2021 ¼ch½ ,elhth@fefy-½ ¼ch½ 510 ykbutkfsyM xkys h 600 fexzk- 1 xkys h 36.69 1330(अ) 25.03.2021 511 fyfFk;e xkys h 300 fexzk- 1 xkys h 1.63 1330(अ) 25.03.2021 512 yis sjkekbM dSIlyw 2 fexzk- 1 dSIlyw 3.98 1330(अ) 25.03.2021 513 yis sjkekbM xkys h 2 fexzk- 1 xkys h 2.19 1330(अ) 25.03.2021 514 yksfiukohj ¼,½ $fjVkus kohj xkys h 100 fexzk- ¼,½ $ 25 fexzk- ¼ch½ 1 xkys h 26.11 1330(अ) 25.03.2021 ¼ch½ 515 yksfiukohj ¼,½ $fjVkus kohj xkys h 200 fexzk- ¼,½ $ 50 fexzk- ¼ch½ 1 xkys h 50.59 1330(अ) 25.03.2021 ¼ch½ 516 yksjktsike batSD'ku 2 fexzk-@fefy- 1 fefy- 8.63 1330(अ) 25.03.2021 517 yksjktsike xkys h 1 fexzk- 1 xkys h 2.29 1330(अ) 25.03.2021 518 yksjktsike xkys h 2 fexzk- 1 xkys h 2.79 1330(अ) 25.03.2021 519 eSaxfuf'k;e lYQsV batSD'ku 500 fexzk-@fefy- 1 fefy- 5.31 1330(अ) 25.03.2021 520 esfuVksy batSD'ku 10% 1 fefy- 0.18 1330(अ) 25.03.2021 521 esfuVksy batSD'ku 20% 1 fefy- 0.33 1330(अ) 25.03.2021[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 15 522 fetyl :csyk oSDlhu izfr iSd 98.16 1330(अ) 25.03.2021 ¼0-5 fefy-½ 523 fetyl oSDlhu oSDlhu izfr iSd 56.61 1330(अ) 25.03.2021 ¼0-5 fefy-½ 524 esosuMktksy vksjy fyD;wbZM 100 fexzk-@5 fefy- 1 fefy- 0.85 1330(अ) 25.03.2021 525 esosuMktksy xkys h 100 fexzk- 1 xkys h 3.26 1330(अ) 25.03.2021 526 esMªksDlh izksxsLVsjkus ,lVs sV xkys h 10 fexzk- 1 xkys h 5.98 1330(अ) 25.03.2021 527 esQus kfed ,flM vksjy fyD;wbZM 100 fexzk-@5 fefy- 1 fefy- 0.58 1330(अ) 25.03.2021 528 esQus sfed ,flM xkys h 250 fexzk- 1 xkys h 2.15 1330(अ) 25.03.2021 529 esQus sfed ,flM xkys h 500 fexzk- 1 xkys h 2.72 1330(अ) 25.03.2021 530 es¶yksDohu xkys h 250 fexzk- 1 xkys h 56.60 1330(अ) 25.03.2021 531 esXyeq kbu MkbVªhtk,s V batSD'ku 60% MCY;w@oh 1 fefy- 9.17 1330(अ) 25.03.2021 532 esXyeq kbu MkbVªhtk,s V batSD'ku 76% MCY;w@oh 1 fefy- 10.60 1330(अ) 25.03.2021 533 esyQkyku xkys h 2 fexzk- 1 xkys h 108.93 1330(अ) 25.03.2021 534 esyQkyku xkys h 5 fexzk- 1 xkys h 186.83 1330(अ) 25.03.2021 535 esluk batSD'ku 100 fexzk-@fefy- 1 fefy- 18.62 1330(अ) 25.03.2021 536 esVQkWfeZu bEesMsV fjfyt xkys h 500 fexzk- 1 xkys h 1.67 1330(अ) 25.03.2021 537 esVQkWfeZu daVªkys M fjfyt xksyh 1000 fexzk- 1 xkys h 4.05 1330(अ) 25.03.2021 538 esVQkWfeZu daVªkys M fjfyt xksyh 500 fexzk- 1 xkys h 2.13 1330(अ) 25.03.2021 539 esVQkWfeZu daVªkys M fjfyt xksyh 750 fexzk- 1 xkys h 2.66 1330(अ) 25.03.2021 540 esVQkWfeZu bEesMsV fjfyt xkys h 1000 fexzk- 1 xkys h 4.00 1330(अ) 25.03.2021 541 esVQkWfeZu bEesMsV fjfyt xkys h 750 fexzk- 1 xkys h 3.38 1330(अ) 25.03.2021 542 esFkksVªsDlVs batSD'ku 25 fexzk-@fefy- 1 fefy- 53.41 1330(अ) 25.03.2021 543 esFkksVªsDlVs batSD'ku 50 fexzk-@fefy- 1 fefy- 44.47 1330(अ) 25.03.2021 544 esFkksVªsDlVs xkys h 10 fexzk- 1 xkys h 13.48 1330(अ) 25.03.2021 545 esFkksVªsDlVs xkys h 2-5 fexzk- 1 xkys h 5.32 1330(अ) 25.03.2021 546 esFkksVªsDlVs xkys h 7-5 fexzk- 1 xkys h 12.86 1330(अ) 25.03.2021 547 esFkksVªsDlVs xkys h 5 fexzk- 1 xkys h 9.29 1330(अ) 25.03.2021 548 eSfFkyMkis k xkys h 250 fexzk- 1 xkys h 2.71 1330(अ) 25.03.2021 549 eSfFkyMkis k xkys h 500 fexzk- 1 xkys h 5.21 1330(अ) 25.03.2021 550 eSfFkyxs ksZesVªhu batSD'ku 0-2 fexzk-@fefy- 1 fefy- 15.85 1330(अ) 25.03.2021 551 eSfFkyxs ksZesVªhu xkys h 0-125 fexzk- 1 xkys h 8.79 1330(अ) 25.03.2021 552 eSfFkyizsMuhlkys ksu xkys h 16 fexzk- 1 xkys h 9.90 1330(अ) 25.03.2021 553 eSfFkyizsMuhlksykus xkys h 8 fexzk- 1 xkys h 5.66 1330(अ) 25.03.2021 554 eSfFkyizsMuhlksykus batSD'ku 40 fexzk-@fefy- 1 fefy- 59.92 1330(अ) 25.03.2021 555 जमथाईलरोसाजनजलजनयम पैंन्ट 1% 1 fefy- 0.09 1330(अ) 25.03.2021 क्लोरईड (जेंजसया वाइलेट) 556 जमथाइलजथओजनजनयम इंजेक्िन 10 जमलीग्राम/जम.ली. 1 जम.ली. 24.20 4885(अ) 26.11.2021 क्लोराइड (मेजथलीन ब्लू ) 557 esVksDyksizkekbM batSD'ku 5 fexzk-@fefy- ¼10 fefy- 1 fefy- 1.58 1330(अ) 25.03.2021 iSd½ 558 esVksDyksizkekbM batSD'ku 5 fexzk-@fefy- ¼2 fefy- iSd½ 1 fefy- 2.59 1330(अ) 25.03.2021 559 esVksDyksizkekbM vksjy fyD;wbZM 5 fexzk-@5 fefy- 1 fefy- 0.49 1330(अ) 25.03.2021 560 esVksDyksizkekbM xkys h 10 fexzk- 1 xkys h 1.30 1330(अ) 25.03.2021 561 esVksizksyksy dSIlyw 25 fexzk- 1 dSIlyw 4.70 1330(अ) 25.03.202116 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 562 esVksizkys ksy dSIlyw 50 fexzk- 1 dSIlyw 7.16 1330(अ) 25.03.2021 563 esVksizkys ksy ,lvkj xksyh 25 fexzk- 1 xkys h 4.47 1330(अ) 25.03.2021 564 esVksizkys ksy ,lvkj xksyh 50 fexzk- 1 xkys h 6.41 1330(अ) 25.03.2021 565 esVksizkys ksy xkys h 25 fexzk- 1 xkys h 3.46 1330(अ) 25.03.2021 566 esVksizkys ksy xkys h 50 fexzk- 1 xkys h 5.24 1330(अ) 25.03.2021 567 esVªkfsuMktksy batSD'ku 500 fexzk-@100 fefy- 1 fefy- 0.22 1330(अ) 25.03.2021 568 esVªkfsuMktksy vksjy fyD;wbZM 200 fexzk-@5 fefy- 1 fefy- 0.50 1330(अ) 25.03.2021 569 esVªkfsuMktksy xkys h 200 fexzk- 1 xkys h 0.76 1330(अ) 25.03.2021 570 esVªkfsuMktksy xkys h 400 fexzk- 1 xkys h 1.42 1330(अ) 25.03.2021 571 feMktksye batSD'ku 1 fexzk-@fefy- 1 fefy- 6.56 1330(अ) 25.03.2021 572 feMktksye batSD'ku 5 fexzk-@fefy- 1 fefy- 16.12 1330(अ) 25.03.2021 573 feMktksye xkys h 7-5 fexzk- 1 xkys h 24.92 1330(अ) 25.03.2021 574 feQsizhLVksu xkys h 200 fexzk- 1 xkys h 357.21 1330(अ) 25.03.2021 575 felkis zkLs Vkys xkys h 100 ,elhth 1 xkys h 9.67 1330(अ) 25.03.2021 576 felkis zkLs Vkys xkys h 200 ,elhth 1 xkys h 18.54 1330(अ) 25.03.2021 577 ekQs hZu batSD'ku 10 fexzk-@fefy- 1 fefy- 26.37 1330(अ) 25.03.2021 578 ekQs hZu batSD'ku 15 fexzk-@fefy- 1 fefy- 32.91 1330(अ) 25.03.2021 579 ekQs huZ ,lvkj xksyh 30 fexzk- 1 xkys h 6.05 1330(अ) 25.03.2021 580 ekQs hZu xkys h 10 fexzk- 1 xkys h 5.91 1330(अ) 25.03.2021 581 ekDs lh¶yksDlklhu xkys h 400 fexzk- 1 xkys h 28.13 1330(अ) 25.03.2021 582 ekbZdkQs suksysV ekQs sfVy xkys h 250 fexzk- 1 xkys h 46.10 1330(अ) 25.03.2021 583 ekbZdkQs suksysV ekQs sfVy xkys h 500 fexzk- 1 xkys h 91.19 1330(अ) 25.03.2021 584 ,u&,flVkbyflLVsu batSD'ku 200 fexzk-@fefy- 1 fefy- 24.88 1330(अ) 25.03.2021 585 ,u&,flVkbyflLVsu lpsV 200 fexzk- 1 xzke 9.99 1330(अ) 25.03.2021 586 ukyksDlksu batSD'ku 0-4 fexzk-@fefy- 1 fefy- 96.32 1330(अ) 25.03.2021 587 ukVkekblhu MªksIl 5% 1 fefy- 25.32 1330(अ) 25.03.2021 588 fuvkLs Vhtekbu batSD'ku 0-5 fexzk-@fefy- 1 fefy- 4.83 1330(अ) 25.03.2021 589 fuvkLs Vhtekbu xkys h 15 fexzk- 1 xkys h 5.18 1330(अ) 25.03.2021 590 usohjkikbu vksjy fyD;wbZM 50 fexzk-@5 fefy- 1 fefy- 0.93 1330(अ) 25.03.2021 591 usohjkikbu xkys h 200 fexzk- 1 xkys h 15.89 1330(अ) 25.03.2021 592 fuQsfMikbu dSIlyw 10 fexzk- 1 dSIlyw 0.95 1330(अ) 25.03.2021 593 fuQsfMikbu xkys h 10 fexzk- 1 xkys h 1.37 1330(अ) 25.03.2021 594 जनVªksQqjuटोइन vksjy fyD;wbZM 25 fexzk-@5 fefy- 1 fefy- 0.91 1330(अ) 25.03.2021 595 जनVªksQqjuटोइन xkys h 100 fexzk- 1 xkys h 8.03 1330(अ) 25.03.2021 596 fuVªksQqjuटोइन dSIlyw 100 fexzk- 1 dSIlyw 8.72 1330(अ) 25.03.2021 597 ukbZVªl vkWDlkbM ?ku ehVj 259.43 1330(अ) 25.03.2021 598 uksjkMªsukykbu batSD'ku 2 fexzk-@fefy- 1 fefy- 28.61 1330(अ) 25.03.2021 599 uksjsfFkLVsjksu xkys h 5 fexzk- 1 xkys h 5.67 1330(अ) 25.03.2021 600 vksesizktksy dSIlyw 10 fexzk- 1 dSIlyw 2.35 1330(अ) 25.03.2021 601 vksesizktksy dSIlyw 20 fexzk- 1 dSIlyw 2.77 1330(अ) 25.03.2021 602 vksesizktksy dSIlyw 40 fexzk- 1 dSIlyw 5.48 1330(अ) 25.03.2021 603 vksesizktksy vksjy fyD;wbZM ds fy, ikmMj 20 1 xzke 1.36 1330(अ) 25.03.2021 fexzk- 604 vksesizktksy xkys h 10 fexzk- 1 xkys h 4.92 1330(अ) 25.03.2021[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 17 605 vksesizktksy xkys h 20 fexzk- 1 xkys h 5.47 1330(अ) 25.03.2021 606 vksesizktksy xkys h 40 fexzk- 1 xkys h 9.25 1330(अ) 25.03.2021 607 vksuMulsVªksu batSD'ku 2 fexzk-@fefy- 1 fefy- 6.49 1330(अ) 25.03.2021 608 vksuMulsVªksu vksjy fyD;wbZM 2 fexzk-@5 fefy- 1 fefy- 1.26 1330(अ) 25.03.2021 609 vksuMulsVªksu xkys h 4 fexzk- 1 xkys h 5.23 1330(अ) 25.03.2021 610 vksuMulsVªksu xkys h 8 fexzk- 1 xkys h 10.83 1330(अ) 25.03.2021 611 ओरल पोजलओमाईजलटटस 1 fefy- 113.86 1330(अ) 25.03.2021 वेक्सीन 612 vksjy fjgkbMªs'ku lkYVl ykblasl ds :i esa 1 xzke 0.99 1330(अ) 25.03.2021 613 vksjy fjgkbMªs'ku lkYVl ykblasl ds :i esa 1 fefy- 0.16 1330(अ) 25.03.2021 614 vksDlkyhIykVhu batSD'ku 100 fexzk-¼ykblsal ds :i es½a izfr iSd 4962.10 1330(अ) 25.03.2021 615 vksDlkyhIykVhu batSD'ku 50 fexzk-¼ykblasl ds :i es½a izfr iSd 2885.84 1330(अ) 25.03.2021 616 vkWDlhVkslhu batSD'ku 10 vkbZ;w@fefy- 1 fefy- 43.74 1330(अ) 25.03.2021 617 vkWDlhVkslhu batSD'ku 5 vkbZ;w@fefy- 1 fefy- 19.59 1330(अ) 25.03.2021 618 isdyhVsDlsy batSD'ku 100 fexzk-@16-7 fefy- 1 fefy- 228.33 1330(अ) 25.03.2021 619 isdyhVsDlsy batSD'ku 30 fexzk-@5 fefy- 1 fefy- 228.33 1330(अ) 25.03.2021 620 isuVkis zktksy batSD'ku 40 fexzk- izfr iSd 49.43 1330(अ) 25.03.2021 621 ikjk&,feukslkfyflfyd ,flM xzsU;wyl ¼ykblasl ds :i es½a 1 xzke 3.16 1330(अ) 25.03.2021 622 isjkflVkeksy vksjy fyD;wbZM 100 fexzk-@5 fefy- 1 fefy- 0.56 1330(अ) 25.03.2021 623 isjkflVkeksy vksjy fyD;wbZM 120 fexzk-@5 fefy- 1 fefy- 0.59 1330(अ) 25.03.2021 624 isjkflVkeksy vksjy fyD;wbZM 125 fexzk-@5 fefy- 1 fefy- 0.38 1330(अ) 25.03.2021 625 isjkflVkeksy vksjy fyD;wbZM 150 fexzk-@5 fefy- 1 fefy- 0.64 1330(अ) 25.03.2021 626 isjkflVkeksy vksjy fyD;wbZM 250 fexzk-@5 fefy- 1 fefy- 0.66 1330(अ) 25.03.2021 627 isjkflVkeksy vksjy fyD;wbZM 500 fexzk-@5 fefy- 1 fefy- 0.71 1330(अ) 25.03.2021 628 isjkflVkeksy vksjy fyD;wbZM 650 fexzk-@5 fefy- 1 fefy- 0.58 1330(अ) 25.03.2021 629 isjkflVkeksy xkys h 500 fexzk- 1 xkys h 1.01 1330(अ) 25.03.2021 630 isjkflVkeksy xkys h 650 fexzk- 1 xkys h 2.04 1330(अ) 25.03.2021 631 isjkflVkeksy batSD'ku 150 fexzk-@fefy- izfr iSd 3.41 1330(अ) 25.03.2021 ¼0-5 fefy-½ 632 isjkflVkeksy batSD'ku 150 fexzk-@fefy- izfr iSd 4.66 1330(अ) 25.03.2021 ¼1 fefy-½ 633 isjkflVkeksy batSD'ku 150 fexzk-@fefy- izfr iSd 7.16 1330(अ) 25.03.2021 ¼2 fefy-½ 634 isjkflVkeksy batSD'ku 150 fexzk-@fefy- izfr iSd 9.67 1330(अ) 25.03.2021 ¼3 fefy-½ 635 isjkflVkeksy batSD'ku 150 fexzk-@fefy- izfr iSd 12.17 1330(अ) 25.03.2021 ¼4 fefy-½ 636 isjkflVkeksy batSD'ku 150 fexzk-@fefy- izfr iSd 14.68 1330(अ) 25.03.2021 ¼5 fefy-½ 637 isjkflVkeksy batSD'ku 150 fexzk-@fefy- izfr iSd 19.68 1330(अ) 25.03.2021 ¼7 fefy-½ 638 isjkflVkeksy lIqiksftVªh 170 fexzk- izfr lqIiksftVªh 8.54 1330(अ) 25.03.2021 639 isjkflVkeksy lIqiksftVªh 80 fexzk- izfr lqIiksftVªh 7.22 1330(अ) 25.03.2021 640 iSjkflVkekys vksjy fyD;wbZM 100 fexzk-@fefy- ¼isMªkfVd½ 1 fefy- 1.79 1330(अ) 25.03.2021 641 iSXyVs sM baVjQsjkWu ,YQk 2 , batSD'ku 180 ,elhth izfr iSd 8786.05 1330(अ) 25.03.2021 642 iSXyVs sM baVjQsjkWu ,YQk 2 ch batSD'ku 100 ,elhth izfr iSd 17371.08 1330(अ) 25.03.2021 643 iSXyVs sM baVjQsjkWu ,YQk 2 ch batSD'ku 120 ,elhth izfr iSd 16177.38 1330(अ) 25.03.202118 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 644 iSXyVs sM baVjQsjkWu ,YQk 2 ch batSD'ku 80 ,elhth izfr iSd 13887.68 1330(अ) 25.03.2021 645 isfuflykekbu dSIlyw 250 fexzk- 1 dSIlyw 16.50 1330(अ) 25.03.2021 646 iesZFkzhu Øhe 1% 1 xzke 1.78 1330(अ) 25.03.2021 647 iesZFkzhu Øhe 5% 1 xzke 1.93 1330(अ) 25.03.2021 648 iesZFkzhu tSy 5% 1 xzke 1.63 1330(अ) 25.03.2021 649 iesZFkzhu yks'ku 1% 1 xzke 1.01 1330(अ) 25.03.2021 650 iesZFkzhu yks'ku 5% 1 fefy- 1.09 1330(अ) 25.03.2021 651 Qsuhjkekbu batSD'ku 22-75 fexzk-@fefy-¼2 fefy-½ 1 fefy- 2.54 1330(अ) 25.03.2021 652 Qsuhjkekbu batSD'ku 22-75 fexzk-@fefy-¼10 fefy-½ 1 fefy- 1.89 1330(अ) 25.03.2021 653 Qsukcs kjfcVksu batSD'ku 200 fexzk-@fefy- 1 fefy- 21.28 1330(अ) 25.03.2021 654 Qsukcs kjfcVksu xkys h 30 fexzk- 1 xkys h 1.36 1330(अ) 25.03.2021 655 Qsukcs kjfcVksu xkys h 60 fexzk- 1 xkys h 1.96 1330(अ) 25.03.2021 656 Qsukcs kjfcVksu vksjy fyD;wbZM 20 fexzk-@5 fefy- 1 fefy- 0.49 1330(अ) 25.03.2021 657 QsuhysQjhu MªksIl 10% 1 fefy- 8.97 1330(अ) 25.03.2021 658 QsuhysQjhu MªksIl 5% 1 fefy- 4.14 1330(अ) 25.03.2021 659 QsuhVkbs u dSIlyw 100 fexzk- 1 dSIlyw 1.69 1330(अ) 25.03.2021 660 QsuhVkbs u dSIlyw 300 fexzk- 1 dSIlyw 4.23 1330(अ) 25.03.2021 661 QsuhVkbs u bZvkj dSIlyw 300 fexzk- 1 dSIlyw 4.23 1330(अ) 25.03.2021 662 QsuhVkbs u batSD'ku 25 fexzk-@fefy- 1 fefy- 2.79 1330(अ) 25.03.2021 663 QsuhVkbs u batSD'ku 50 fexzk-@fefy- 1 fefy- 5.97 1330(अ) 25.03.2021 664 QsuhVkbs u vksjy fyD;wbZM 125 fexzk-@5 fefy- 1 fefy- 1.00 1330(अ) 25.03.2021 665 QsuhVkbs u vksjy fyD;wbZM 30 fexzk-@5 fefy- 1 fefy- 0.34 1330(अ) 25.03.2021 666 QsuhVkbs u bZvkj xkys h 300 fexzk- 1 xkys h 6.45 1330(अ) 25.03.2021 667 QsuhVkbs u xkys h 100 fexzk- 1 xkys h 1.73 1330(अ) 25.03.2021 668 QsuhVkbs u xkys h 300 fexzk- 1 xkys h 5.27 1330(अ) 25.03.2021 669 QsuhVkbs u xkys h 50 fexzk- 1 xkys h 0.82 1330(अ) 25.03.2021 670 QkbVksesukMhvkus ¼foVkfeu batSD'ku 10 fexzk-@fefy- 1 fefy- 53.17 1330(अ) 25.03.2021 ds1½ 671 QkbVksesukMhvkus ¼foVkfeu xkys h 10 fexzk- 1 xkys h 16.13 1330(अ) 25.03.2021 ds1½ 672 fiyksdkjfiu MªksIl 2% 1 fefy- 11.22 1330(अ) 25.03.2021 673 fiyksdkjfiu MªksIl 4% 1 fefy- 12.97 1330(अ) 25.03.2021 674 fiisjkflfyu ¼,½ $VstkscsDVe batSD'ku ds fy, ikmMj 1 xzke ¼,½ $ izfr iSd 98.15 1330(अ) 25.03.2021 ¼ch½ 125 fexzk- ¼ch½ 675 fiisjkflfyu ¼,½ $VstkscsDVe batSD'ku ds fy, ikmMj 2 xzke ¼,½ $ izfr iSd 232.20 1330(अ) 25.03.2021 ¼ch½ 250 fexzk- ¼ch½ 676 fiisjkflfyu ¼,½ $VstkscsDVe batSD'ku ds fy, ikmMj 4 xzke ¼,½ $ izfr iSd 487.76 1330(अ) 25.03.2021 ¼ch½ 500 fexzk- ¼ch½ 677 ikVs sf'k;e DyksjkbM batSD'ku 150 fexzk-@fefy- 1 fefy- 2.69 1330(अ) 25.03.2021 678 ikVs sf'k;e DyksjkbM vksjy fyD;wbZM 500 fexzk-@5 fefy- 1 fefy- 0.32 1330(अ) 25.03.2021 679 ikVs sf'k;e ijesxa usV fØLVy QkWj VkWfidy lkys 'q ku 1 xzke 0.49 1330(अ) 25.03.2021 680 ikWfoMu vk;ksMhu स्ट्रब 7-5% 1 fefy- 1.78 1428(अ) 31.03.2021 681 ikWfoMu vk;ksMhu vksbuVesaV 10% 1 xzke 5.78 1330(अ) 25.03.2021 682 ikWfoMu vk;ksMhu lkys 'q ku 4% 1 fefy- 1.93 1330(अ) 25.03.2021 683 ikWfoMu vk;ksMhu lkys 'q ku 7-5% 1 fefy- 0.85 1330(अ) 25.03.2021 684 ikWfoMu vk;ksMhu lkys 'q ku 10% 1 fefy- 1.03 1330(अ) 25.03.2021[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 19 685 ikWfoMu vk;ksMhu lkys 'q ku 5% 1 fefy- 0.43 1330(अ) 25.03.2021 686 izkfyMksDlhe DyksjkbM batSD'ku 25 fexzk-@fefy- 1 fefy- 4.14 1330(अ) 25.03.2021 ¼2&ih,,e½ 687 izkftD;wuVsy xkys h 600 fexzk 1 xkys h 38.57 1330(अ) 25.03.2021 688 izsMfulksyksu MªksIl 1% 1 fefy- 5.58 1330(अ) 25.03.2021 689 izsMfulksyksu batSD'ku 20 fexzk-@2 fefy- 1 fefy- 3.98 1330(अ) 25.03.2021 690 izsMfulksyksu vksjy fyD;wbZM 15 fexzk-@5 fefy- 1 fefy- 0.83 1330(अ) 25.03.2021 691 izsMfulksyksu vksjy fyD;wbZM 5 fexzk-@5 fefy- 1 fefy- 0.48 1330(अ) 25.03.2021 692 izsMfulksyksu xkys h 10 fexzk- 1 xkys h 1.09 1330(अ) 25.03.2021 693 izsMfulksyksu xkys h 20 fexzk- 1 xkys h 2.17 1330(अ) 25.03.2021 694 izsMfulksyksu xkys h 40 fexzk- 1 xkys h 3.12 1330(अ) 25.03.2021 695 izsMfulksyksu xkys h 5 fexzk- 1 xkys h 0.62 1330(अ) 25.03.2021 696 izsfeDl balqfyu 30%70 batSD'ku batSD'ku 40 vkbZ;w@fefy- 1 fefy- 16.71 1330(अ) 25.03.2021 ¼jsxqyj%,uih,p½ 697 izhykds su ¼,½ $ fyXuksdsu ¼ch½ Øhe 2-5% ¼,½ $ 2-5% ¼ch½ 1 xzke 22.71 1330(अ) 25.03.2021 698 izhekDohu xkys h 15 fexzk- 1 xkys h 5.07 1330(अ) 25.03.2021 699 izhekDohu xkys h 2-5 fexzk- 1 xkys h 1.73 1330(अ) 25.03.2021 700 izhekDohu xkys h 7-5 fexzk- 1 xkys h 2.35 1330(अ) 25.03.2021 701 izkds kckfZtu dSIlyw 50 fexzk- 1 dSIlyw 38.38 1330(अ) 25.03.2021 702 izkds kckfZtu xkys h 50 fexzk- 1 xkys h 52.30 1330(अ) 25.03.2021 703 izkis kjkdsu MªksIl 0-5% 1 fefy- 11.07 1330(अ) 25.03.2021 704 izkis kQs ksy batSD'ku 10 fexzk-@fefy- 1 fefy- 8.02 1330(अ) 25.03.2021 705 izkis zkukys kys dSIlyw 40 fexzk- 1 dSIlyw 4.22 1330(अ) 25.03.2021 706 izkis zkukys kys dSIlyw 80 fexzk- 1 dSIlyw 6.41 1330(अ) 25.03.2021 707 izkis zkukys kys xkys h 10 fexzk- 1 xkys h 1.30 1330(अ) 25.03.2021 708 izkis zkukys kys xkys h 40 fexzk- 1 xkys h 3.06 1330(अ) 25.03.2021 709 izkis zkukys kys xkys h 80 fexzk- 1 xkys h 5.55 1330(अ) 25.03.2021 710 izkVs kekbu batSD'ku 10 fexzk-@fefy- 1 fefy- 10.27 1330(अ) 25.03.2021 711 ikbjkftukekbM vksjy fyD;wbZM 250 fexzk-@5 fefy- 1 fefy- 0.68 1330(अ) 25.03.2021 712 ikbjkftukekbM xkys h 1000 fexzk- 1 xkys h 10.47 1330(अ) 25.03.2021 713 ikbjkftukekbM xkys h 1500 fexzk- 1 xkys h 11.60 1330(अ) 25.03.2021 714 ikbjkftukekbM xkys h 500 fexzk- 1 xkys h 4.70 1330(अ) 25.03.2021 715 ikbjkftukekbM xkys h 750 fexzk- 1 xkys h 7.14 1330(अ) 25.03.2021 716 ikbfjMkDs lhu xkys h 100 fexzk- 1 xkys h 6.20 1330(अ) 25.03.2021 717 ikbfjMkDs lhu xkys h 10 fexzk- 1 xkys h 0.12 1330(अ) 25.03.2021 718 कुनेन batSD'ku 300 fexzk-@fefy- 1 fefy- 11.29 1330(अ) 25.03.2021 719 कुनेन xkys h 300 fexzk- 1 xkys h 6.36 1330(अ) 25.03.2021 720 jsfct oSDlhu izfr iSd 379.43 1330(अ) 25.03.2021 721 jkyVxs zkohj xkys h 400 fexzk- 1 xkys h 173.77 1330(अ) 25.03.2021 722 jkfeizhy dSIlyw 2-5 fexzk- 1 dSIlyw 5.26 1330(अ) 25.03.2021 723 jkfeizhy dSIlyw 5 fexzk- 1 dSIlyw 8.21 1330(अ) 25.03.2021 724 jkfeizhy xkys h 2-5 fexzk- 1 xkys h 5.53 1330(अ) 25.03.2021 725 jkfeizhy xkys h 5 fexzk- 1 xkys h 8.70 1330(अ) 25.03.2021 726 jkfufVfMu vksjy fyD;wbZM 75 fexzk-@5 fefy- 1 fefy- 1.20 2654(अ) 01.07.202120 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 727 jkfufVfMu xkys h 150 fexzk- 1 xkys h 1.22 2654(अ) 01.07.2021 728 jkfufVfMu batSD'ku 25 fexzk-@fefy- 1 fefy- 2.69 2654(अ) 01.07.2021 729 fjckfofju dSIlyw 200 fexzk- 1 dSIlyw 92.88 1330(अ) 25.03.2021 730 fjQkcqVhu dSIlyw 150 fexzk- 1 dSIlyw 44.04 1330(अ) 25.03.2021 731 fjQkcqVhu xkys h 150 fexzk- 1 xkys h 41.13 1330(अ) 25.03.2021 732 fjQefiflu dSIlyw 150 fexzk- 1 dSIlyw 2.23 1330(अ) 25.03.2021 733 fjQefiflu dSIlyw 300 fexzk- 1 dSIlyw 4.22 1330(अ) 25.03.2021 734 fjQefiflu dSIlyw 450 fexzk- 1 dSIlyw 5.48 1330(अ) 25.03.2021 735 fjQefiflu dSIlyw 600 fexzk- 1 dSIlyw 12.87 1330(अ) 25.03.2021 736 fjQefiflu vksjy fyD;wbZM 100 fexzk-@5 fefy- 1 fefy- 0.43 1330(अ) 25.03.2021 737 fjQefiflu xkys h 150 fexzk- 1 xkys h 1.79 1330(अ) 25.03.2021 738 fjQefiflu xkys h 300 fexzk- 1 xkys h 3.26 1330(अ) 25.03.2021 739 fjxa j ySDVsV batSD'ku 1000 fefy- izfr iSd 88.57 1330(अ) 25.03.2021 740 fjxa j ySDVsV batSD'ku 100 fefy- izfr iSd 23.19 1330(अ) 25.03.2021 741 fjxa j ySDVsV batSD'ku 250 fefy- izfr iSd 39.54 1330(अ) 25.03.2021 742 fjxa j ySDVsV batSD'ku 500 fefy- izfr iSd 50.39 1330(अ) 25.03.2021 743 fjlisfjMkus vksjy fyD;wbZM 1 fexzk-@ fefy- 1 fefy- 2.15 1330(अ) 25.03.2021 744 fjlisfjMkus xkys h 1 fexzk- 1 xkys h 3.42 1330(अ) 25.03.2021 745 fjlisfjMkus xkys h 2 fexzk- 1 xkys h 5.47 1330(अ) 25.03.2021 746 fjlisfjMkus xkys h 4 fexzk- 1 xkys h 11.10 1330(अ) 25.03.2021 747 fjVkus kohj dSIlyw 100 fexzk- 1 dSIlyw 31.34 1330(अ) 25.03.2021 748 fjVkus kohj xkys h 100 fexzk- 1 xkys h 32.23 1330(अ) 25.03.2021 749 fjVqDlheso batSD'ku 10 fexzk-@fefy- 1 fefy- 842.18 1330(अ) 25.03.2021 750 lys cqVkekys dSIlyw 4 fexzk- 1 dSIlyw 0.66 1330(अ) 25.03.2021 751 lys cqVkekys bugsy's ku ¼,eMhvkbZ@MhihvkbZ½ 100 1 Mkts 0.44 1330(अ) 25.03.2021 ,elhth@Mkts 752 lys cqVkekys vksjy fyD;wbZM 2 fexzk-@5 fefy- 1 fefy- 0.17 1330(अ) 25.03.2021 753 lys cqVkekys jslfijsVkWjh lkys 'q ku QkWj ;wt bu 1 fefy- 0.78 1330(अ) 25.03.2021 uscqykbtj 5 fexzk-@fefy- 754 lys cqVkekys xkys h 2 fexzk- 1 xkys h 0.18 1330(अ) 25.03.2021 755 lys cqVkekys xkys h 4 fexzk- 1 xkys h 0.20 1330(अ) 25.03.2021 756 lys hflfyd ,flM vksbaVesVa 6% 1 xzke 1.99 1330(अ) 25.03.2021 757 los ks¶yjw ku bugsy's ku 1 fefy- 33.21 1330(अ) 25.03.2021 758 flYoj lYQkMkbftu Øhe 1% 1 xzke 0.56 1330(अ) 25.03.2021 759 LuSd osukse ,aVhlsje batSD'ku ds fy, ikmMj 10 fefy- iSd 618.71 1330(अ) 25.03.2021 ykbvksfQykftM ikWyhosysVa 760 LuSd osukse ,aVhlsje batSD'ku izfr iSd 480.46 1330(अ) 25.03.2021 lkys cq y@fyD;wbM ikWyhosysVa ¼10 fefy-½ 761 lkfsM;e ckbdkcksZusV batSD'ku 7-5% 1 fefy- 1.56 1330(अ) 25.03.2021 762 lkfsM;e ckbdkcksZusV batSD'ku 8-4% 1 fefy- 1.43 1330(अ) 25.03.2021 763 lkfsM;e Dykjs kbM batSD'ku 0-9% 1000 fefy- Xykl 65.89 1330(अ) 25.03.2021 764 lkfsM;e Dykjs kbM batSD'ku 0-9% 1000 fefy- ukWu 51.97 1330(अ) 25.03.2021 Xykl 765 lkfsM;e Dykjs kbM batSD'ku 0-9% 100 fefy- Xykl 19.48 1330(अ) 25.03.2021 766 lkfsM;e Dykjs kbM batSD'ku 0-9% 100 fefy- ukWu 17.55 1330(अ) 25.03.2021 Xykl[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 21 767 lkfsM;e Dykjs kbM batSD'ku 0-9% 250 fefy- Xykl 26.28 1330(अ) 25.03.2021 768 lkfsM;e Dykjs kbM batSD'ku 0-9% 250 fefy- ukWu 23.59 1330(अ) 25.03.2021 Xykl 769 lkfsM;e Dykjs kbM batSD'ku 0-9% 500 fefy- Xykl 36.54 1330(अ) 25.03.2021 770 lkfsM;e Dykjs kbM batSD'ku 0-9% 500 fefy- ukWu 31.10 1330(अ) 25.03.2021 Xykl 771 lkfsM;e ukbZVªsV batSD'ku 30 fexzk-@fefy- 1 fefy- 28.85 1330(अ) 25.03.2021 772 lkfsM;e ukbVªksi:lkbM batSD'ku 10 fexzk-@fefy- 1 fefy- 28.67 1330(अ) 25.03.2021 773 lkfsM;e osyizks,V batSD'ku 100 fexzk-@fefy- 1 fefy- 6.40 1330(अ) 25.03.2021 774 lkfsM;e osyizks,V vksjy fyD;wbZM 200 fexzk-@5 fefy- 1 fefy- 0.64 1330(अ) 25.03.2021 775 lkfsM;e osyizks,V lhvkj xksyh 300 fexzk- 1 xkys h 6.99 1330(अ) 25.03.2021 776 lkfsM;e osyizks,V lhvkj xksyh 500 fexzk- 1 xkys h 10.82 1330(अ) 25.03.2021 777 lkfsM;e osyizks,V xkys h 200 fexzk- 1 xkys h 3.44 1330(अ) 25.03.2021 778 lkfsM;e osyizks,V xkys h 300 fexzk- 1 xkys h 4.41 1330(अ) 25.03.2021 779 lkfsM;e osyizks,V xkys h 500 fexzk- 1 xkys h 7.71 1330(अ) 25.03.2021 780 lkQs kscqohj xkys h 400 fexzk- 1 xkys h 741.12 1330(अ) 25.03.2021 781 lkes kVkLs VkVhu batSD'ku ds fy, ikmMj 3 fexzk- izfr iSd 1759.69 1330(अ) 25.03.2021 782 LihjksuksysDVksu xkys h 25 fexzk- 1 xkys h 2.13 1330(अ) 25.03.2021 783 LihjksuksysDVksu xkys h 50 fexzk- 1 xkys h 4.22 1330(अ) 25.03.2021 784 LVkoqfMu ¼,½ $ ykfeoqfMu xkys h 30 fexzk-¼,½ $ 150 fexzk- ¼ch½ 1 xkys h 10.60 1330(अ) 25.03.2021 ¼ch½ 785 LVªsIVksfdukl batSD'ku 1500000 vkbZ;w izfr iSd 1987.53 1330(अ) 25.03.2021 786 LVªsIVksfdukl batSD'ku 7]50]000 vkbZ;w izfr iSd 1397.88 1330(अ) 25.03.2021 787 LVªsIVksekbflu batSD'ku ds fy, ikmMj 750 fexzk- izfr iSd 9.75 1330(अ) 25.03.2021 788 LVªsIVksekbflu batSD'ku ds fy, ikmMj 1 xzke izfr iSd 11.59 1330(अ) 25.03.2021 789 lfDluhy dkfsyu batSD'ku 50 fexzk-@fefy- 1 fefy- 5.37 1330(अ) 25.03.2021 790 lØq kyQsV vksjy fyD;wbZM 1 xzke 1 fefy- 0.78 1330(अ) 25.03.2021 791 lYQklkyktkbu xkys h 500 fexzk- 1 xkys h 4.42 1330(अ) 25.03.2021 792 leq kVªhIVu xkys h 25 fexzk- 1 xkys h 36.96 1330(अ) 25.03.2021 793 leq kVªhIVu xkys h 50 fexzk- 1 xkys h 57.22 1330(अ) 25.03.2021 794 ljQsDVkaV lLis'a ku QkWj buVªkVªkpsy buLVkbys'ku izfr iSd esa izfr 74.27 1330(अ) 25.03.2021 ¼ykblasl ds :i es½a fefy- QksLQkfsyfiM~l 795 VkØksfyeql dSIlyw 0-5 fexzk- 1 dSIlyw 24.56 1330(अ) 25.03.2021 796 VkØksfyeql dSIlyw 1 fexzk- 1 dSIlyw 43.38 1330(अ) 25.03.2021 797 VkØksfyeql dSIlyw 2 fexzk- 1 dSIlyw 84.97 1330(अ) 25.03.2021 798 VkØksfyeql xkys h 0.5 fexzk- 1 xkys h 20.80 1330(अ) 25.03.2021 799 VkØksfyeql xkys h 1 fexzk- 1 xkys h 38.20 1330(अ) 25.03.2021 800 VkØksfyeql xkys h 2 fexzk- 1 xkys h 75.46 1330(अ) 25.03.2021 801 VkekDs lhQsu xkys h 10 fexzk- 1 xkys h 2.86 1330(अ) 25.03.2021 802 VkekDs lhQsu xkys h 20 fexzk- 1 xkys h 3.23 1330(अ) 25.03.2021 803 टी डी वैजक्सन प्रत्येक 0.5 जमली. डोसेस मे: प्रत्येक 0.5 20.81 1330(अ) 25.03.2021 जडप्थेटरया टोक्साइड ≤ 5 एलएफ जमली. पैक (≥ 2आईयू) टेट्नस टोक्साइड ≥ 5 एलएफ (≥ 40 आईयू)22 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 804 टी डी वैजक्सन प्रत्येक 0.5 जमली. डोसेस मे: प्रत्येक 5 जमली. 195.54 1330(अ) 25.03.2021 पैक जडप्थेटरया टोक्साइड ≤ 5 एलएफ (≥ 2 आईय)ू टेट्नस टोक्साइड ≥ 5 एलएफ (≥ 40 आईयू) 805 टी डी वैजक्सन प्रत्येक 0.5 जमली. डोसेस मे: प्रत्येक 0.5 17.84 1330(अ) 25.03.2021 जमली. पैक जडप्थेटरया टोक्साइड ≤ 25 एलएफ (≥ 30 आईयू) टेट्नस टोक्साइड ≥ 5 एलएफ (≥ 40 आईयू) 806 VsyfelkVuZ xkys h 20 fexzk- 1 xkys h 4.05 1330(अ) 25.03.2021 807 VsyfelkVuZ xkys h 40 fexzk- 1 xkys h 7.32 1330(अ) 25.03.2021 808 VsyfelkVuZ xkys h 80 fexzk- 1 xkys h 11.15 1330(अ) 25.03.2021 809 Vsekts kys ksekbM dSIlyw 100 fexzk- 1 dSIlyw 2313.54 1330(अ) 25.03.2021 810 Vsekts kys ksekbM dSIlyw 20 fexzk- 1 dSIlyw 662.24 1330(अ) 25.03.2021 811 Vsekts kys ksekbM dSIlyw 250 fexzk- 1 dSIlyw 5203.58 1330(अ) 25.03.2021 812 Vsekts kys ksekbM xkys h 100 fexzk- 1 xkys h 1717.31 1330(अ) 25.03.2021 813 Vsekts kys ksekbM xkys h 20 fexzk- 1 xkys h 416.06 1330(अ) 25.03.2021 814 Vsekts kys ksekbM xkys h 250 fexzk- 1 xkys h 4250.50 1330(अ) 25.03.2021 815 VsukQs ksohj xkys h 300 fexzk- 1 xkys h 52.39 1330(अ) 25.03.2021 816 VsukQs ksohj ¼,½ $ ykfeoqMkbu xkys h 300 fexzk- ¼,½ $ 300 fexzk- ¼ch½ 1 xkys h 49.84 1330(अ) 25.03.2021 ¼ch½ 817 VsukQs ksohj ¼,½ $ ykfeoqMkbu xkys h 300 fexzk- ¼,½ $ 300 fexzk- ¼ch½ 1 xkys h 114.44 1330(अ) 25.03.2021 ¼ch½ $bQkohjsat ¼lh½ $ 600 fexzk- ¼lh½ 818 VsVul VkWDlkbM batSD'ku izfr iSd 12.04 1330(अ) 25.03.2021 ¼0-5 fefy-½ 819 VsVul VkWDlkbM batSD'ku izfr iSd 26.03 1330(अ) 25.03.2021 ¼5 fefy-½ 820 FkkyhMkes kbM dSIlyw 100 fexzk- 1 dSIlyw 67.84 1330(अ) 25.03.2021 821 FkkyhMkes kbM dSIlyw 50 fexzk- 1 dSIlyw 39.19 1330(अ) 25.03.2021 822 Fkh;kekbu batSD'ku 100 fexzk-@fefy- 1 fefy- 27.54 1330(अ) 25.03.2021 823 Fkh;kekbu xkys h 100 fexzk- 1 xkys h 4.16 1330(अ) 25.03.2021 824 Fkhvkis suVkWu batSD'ku ds fy, ikmMj 0-5 xzke izfr iSd 45.23 1330(अ) 25.03.2021 825 Fkhvkis suVkWu batSD'ku ds fy, ikmMj 1 xzke izfr iSd 54.87 1330(अ) 25.03.2021 826 fVekys ksy MªksIl 0-25% 1 fefy- 5.74 1330(अ) 25.03.2021 827 fVekys ksy MªksIl 0-5% 1 fefy- 13.24 1330(अ) 25.03.2021 828 fVvkVs ªksfi;e bugsy's ku ¼MhihvkbZ½ 9 1 Mkts 2.67 1330(अ) 25.03.2021 ,elhth@Mkts 829 fVvkVs ªksfi;e bugsy's ku ¼,eMhvkbZ½ 18 1 Mkts 10.31 1330(अ) 25.03.2021 ,elhth@Mkts 830 VªkekMkys dSIlyw 50 fexzk- 1 dSIlyw 5.01 1330(अ) 25.03.2021 831 VªkekMkys batSD'ku 50 fexzk-@fefy- ¼20 fefy- 1 fefy- 1.38 1330(अ) 25.03.2021 iSd½ 832 VªkekMkys batSD'ku 50 fexzk-@fefy- ¼2 fefy- 1 fefy- 11.63 1330(अ) 25.03.2021 iSd rd½ 833 VªkekMkys xkys h 100 fexzk- 1 xkys h 21.84 1330(अ) 25.03.2021 834 VªkekMkys xkys h 50 fexzk- 1 xkys h 8.95 1330(अ) 25.03.2021[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 23 835 VªkekMkys dSIlyw 100 fexzk- 1 dSIlyw 10.66 1330(अ) 25.03.2021 836 VªkusDlkfed ,flM batSD'ku 100 fexzk-@fefy- 1 fefy- 16.59 1330(अ) 25.03.2021 837 VªkusDlkfed ,flM xkys h 500 fexzk- 1 xkys h 19.28 1330(अ) 25.03.2021 838 VªkLVqtqec batSD'ku 440 fexzk-@50 fefy- izfr iSd 66790.46 1330(अ) 25.03.2021 839 VªhgDs lhQus hMhy xkys h 2 fexzk- 1 xkys h 1.35 1330(अ) 25.03.2021 840 VªksfidkekbM vkbZ Mªksi 1% 1 fefy- 11.17 1330(अ) 25.03.2021 841 osudksekblhu batSD'ku ds fy, ikmMj 1 xzke izfr iSd 528.43 1330(अ) 25.03.2021 842 osudksekblhu batSD'ku ds fy, ikmMj 250 fexzk- izfr iSd 246.21 1330(अ) 25.03.2021 843 osudksekblhu batSD'ku ds fy, ikmMj 500 fexzk- izfr iSd 317.83 1330(अ) 25.03.2021 844 osdqjksfu;e batSD'ku ds fy, ikmMj 10 fexzk- izfr iSd 209.93 1330(अ) 25.03.2021 845 osdqjksfu;e batSD'ku ds fy, ikmMj 4 fexzk- izfr iSd 101.32 1330(अ) 25.03.2021 846 osjkikfey batSD'ku 2-5 fexzk-@fefy- 1 fefy- 1.30 1330(अ) 25.03.2021 847 osjkikfey xkys h 40 fexzk- 1 xkys h 0.82 1330(अ) 25.03.2021 848 osjkikfey xkys h 80 fexzk- 1 xkys h 1.55 1330(अ) 25.03.2021 849 fouOykLVhu batSD'ku 1 fexzk-@fefy- 1 fefy- 22.78 1330(अ) 25.03.2021 850 fouØhLVhu batSD'ku 1 fexzk-@fefy- 1 fefy- 57.86 1330(अ) 25.03.2021 851 foVkfeu , dSIlyw 50000 vkbZ;w 1 dSIlyw 0.61 1330(अ) 25.03.2021 852 foVkfeu , batSD'ku 50000 vkbZ;w@fefy- 1 fefy- 2.13 1330(अ) 25.03.2021 853 foVkfeu , xkys h 50000 vkbZ;w 1 xkys h 0.78 1330(अ) 25.03.2021 854 okjQfju xkys h 1 fexzk- 1 xkys h 2.68 1330(अ) 25.03.2021 855 okjQfju xkys h 2 fexzk- 1 xkys h 2.96 1330(अ) 25.03.2021 856 okjQfju xkys h 3 fexzk- 1 xkys h 3.47 1330(अ) 25.03.2021 857 okjQfju xkys h 5 fexzk- 1 xkys h 2.61 1330(अ) 25.03.2021 858 okVj QkWj batSD'ku batSD'ku izfr iSd 2.58 1330(अ) 25.03.2021 ¼10 fefy-½ 859 okVj QkWj batSD'ku batSD'ku izfr iSd 2.49 1330(अ) 25.03.2021 ¼5 fefy-½ 860 okVj QkWj batSD'ku batSD'ku izfr iSd 51.19 5425(अ) 28.12.2021 ¼500 fefy-½ 861 okVj QkWj batSD'ku batSD'ku izfr iSd 89.84 5425(अ) 28.12.2021 ¼1000 fefy-½ 862 okbV iSVªksfy;e tsyh 100% 1 xzke 0.10 1330(अ) 25.03.2021 863 ,DlhyksesVktksykbu usty MªksIl 0-05% 1 fefy- 4.36 1330(अ) 25.03.2021 864 ,DlhyksesVktksykbu usty MªksIl 0-1% 1 fefy- 5.78 1330(अ) 25.03.2021 865 ftMkos qMkbu dSIlyw 300 fexzk- 1 dSIlyw 2.29 1330(अ) 25.03.2021 866 ftMkos qMkbu xkys h 300 fexzk- 1 xkys h 15.83 1330(अ) 25.03.2021 867 ftMkos qMkbu ¼,½ $ xkys h 300 fexzk- ¼,½ $ 150 fexzk- ¼ch½ 1 xkys h 22.37 1330(अ) 25.03.2021 ykfeoqMkbu ¼ch½ $ usfojkikbu $ 200 fexzk- ¼lh½ ¼lh½ 868 ftad lYQsV fMLiszflcy xksyh 20 fexzk- 1 xkys h 3.49 1330(अ) 25.03.2021 869 tkys Ms ªksfud ,flM batSD'ku ds fy, ikmMj 4 fexzk- izfr iSd 4664.74 1330(अ) 25.03.2021 870 tkys fiMse dSIlyw 5 fexzk- 1 dSIlyw 8.16 1330(अ) 25.03.2021 871 tkys fiMse xkys h 10 fexzk- 1 xkys h 9.38 1330(अ) 25.03.2021 872 tkys fiMse xkys h 5 fexzk- 1 xkys h 5.98 1330(अ) 25.03.202124 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] - ( 10.76607% ) 11(3) (5) 13(2) . (5) V (4) u II I II III II IV ड जब तक 2151 ददनांक 30.06.2020 लाग ू है तब तक हपे टरन इंजेक्िन आईय/ू एमएल और हपे टरन इंजेक्िन आईय ू / एमएल की जो उपयुचक्त ताजलका म े रम संख्या और के कॉलम ( ) म ेंजनर्ददष्ट है लागू नहीं होगा [ II][भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 25 MINISTRY OF CHEMICALS AND FERTILIZERS (Department of Pharmaceuticals) (NATIONAL PHARMACEUTICAL PRICING AUTHORITY) ORDER New Delhi, the 30th March, 2022 S.O. 1499(E).—In exercise of the powers, conferred by paragraph 4, 6, 10, 11, 14, 16, 17 and 18 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order(s) of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) S.O. Number and date specified in column no. 6(a) & 6(b) mentioned in the table below, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table herein below as ceiling prices exclusive of Goods and Services Tax applicable, if any in respect of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the dosage form & strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof: TABLE Price Revision as per Annual Wholesale Price Index (WPI) @ 10.76607% increase. Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) 1 5-aminosalicylic Acid Suppository 500 1 18.77 1330(E) 25.03.2021 mg Retention Suppository Enema 2 5-aminosalicylic Acid Tablet 400 mg 1 Tablet 8.30 1330(E) 25.03.2021 3 5-Fluorouracil Injection 250 mg/5 1 ml 2.59 1330(E) 25.03.2021 ml 4 6-Mercaptopurine Tablet 50mg 1 Tablet 7.17 1330(E) 25.03.2021 5 Abacavir Tablet 300 mg 1 Tablet 52.36 1330(E) 25.03.2021 6 Abacavir (A) + Lamivudine Tablet 60 mg(A) + 1 Tablet 22.30 1330(E) 25.03.2021 (B) 30 mg(B) 7 Abacavir (A) + Lamivudine Tablet 600 mg(A)+ 1 Tablet 101.18 1330(E) 25.03.2021 (B) 300 mg(B) 8 Acetazolamide Capsule 250 mg 1 Capsule 5.02 1330(E) 25.03.2021 9 Acetazolamide Tablet 250 mg 1 Tablet 4.07 1330(E) 25.03.2021 10 Acetylsalicylic acid Effervescent/ 1 Tablet 0.20 1330(E) 25.03.2021 Dispersible/ Enteric coated Tablet 100 mg26 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) 11 Acetylsalicylic acid Effervescent/ 1 Tablet 1.34 1330(E) 25.03.2021 Dispersible/ Enteric coated Tablet 150 mg 12 Acetylsalicylic acid Effervescent/ 1 Tablet 1.36 1330(E) 25.03.2021 Dispersible/ Enteric coated Tablet 75 mg 13 Acetylsalicylic acid Tablet 100 mg 1 Tablet 0.19 1330(E) 25.03.2021 14 Acetylsalicylic acid Tablet 150 mg 1 Tablet 0.45 1330(E) 25.03.2021 15 Acetylsalicylic acid Tablet 325mg 1 Tablet 0.61 1330(E) 25.03.2021 16 Acetylsalicylic acid Tablet 350mg 1 Tablet 0.34 1330(E) 25.03.2021 17 Acetylsalicylic acid Tablet 75 mg 1 Tablet 0.34 1330(E) 25.03.2021 18 Actinomycin D Powder for Each Pack 352.13 1330(E) 25.03.2021 Injection 0.5mg 19 Acyclovir Ointment 3% 1 gm 11.56 1330(E) 25.03.2021 20 Acyclovir Oral Liquid 400 1 ml 1.41 1330(E) 25.03.2021 mg/5ml 21 Acyclovir Tablet 200 mg 1 Tablet 7.52 1330(E) 25.03.2021 22 Acyclovir Tablet 400 mg 1 Tablet 13.67 1330(E) 25.03.2021 23 Acyclovir Powder for Each Pack 394.52 1330(E) 25.03.2021 Injection 250 mg 24 Acyclovir Powder for Each Pack 509.56 1330(E) 25.03.2021 Injection 500 mg 25 Adenosine Injection 3mg/ml 1 ml 109.33 1330(E) 25.03.2021 26 Adrenaline Injection 1 mg/ml 1 ml 17.38 1330(E) 25.03.2021 27 Albendazole Oral Liquid 200 1 ml 1.77 1330(E) 25.03.2021 mg/5ml 28 Albendazole Tablet 400 mg 1 Tablet 8.55 1330(E) 25.03.2021 29 Allopurinol Tablet 100 mg 1 Tablet 2.12 1330(E) 25.03.2021 30 Allopurinol Tablet 300 mg 1 Tablet 8.31 1330(E) 25.03.2021 31 All-trans Retinoic Acid Capsule 10 mg 1 Capsule 90.83 1330(E) 25.03.2021 32 Alprostadil Injection 0.5 mg/ml 1 ml 6288.11 1330(E) 25.03.2021 33 Alteplase Powder for Each Pack 21089.89 1330(E) 25.03.2021 Injection 20 mg 34 Alteplase Powder for Each Pack 44033.63 1330(E) 25.03.2021[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 27 Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) Injection 50 mg 35 Amiodarone Injection 50 mg/ml 1 ml 24.77 1330(E) 25.03.2021 36 Amiodarone Tablet 100 mg 1 Tablet 6.35 1330(E) 25.03.2021 37 Amiodarone Tablet 200 mg 1 Tablet 12.57 1330(E) 25.03.2021 38 Amitriptyline Tablet 10 mg 1 Tablet 2.54 1330(E) 25.03.2021 39 Amitriptyline Tablet 25 mg 1 Tablet 2.50 1330(E) 25.03.2021 40 Amitriptyline Tablet 50 mg 1 Tablet 6.45 1330(E) 25.03.2021 41 Amitriptyline Tablet 75 mg 1 Tablet 6.23 1330(E) 25.03.2021 42 Amlodipine Tablet 10 mg 1 Tablet 5.63 1330(E) 25.03.2021 43 Amlodipine Tablet 2.5 mg 1 Tablet 1.84 1330(E) 25.03.2021 44 Amlodipine Tablet 5mg 1 Tablet 2.89 1330(E) 25.03.2021 45 Amoxicillin Capsule 250 mg 1 Capsule 2.45 1330(E) 25.03.2021 46 Amoxicillin Oral Liquid 250 1 ml 1.50 1330(E) 25.03.2021 mg/5ml 47 Amoxicillin Capsule 500mg 1 Capsule 7.17 1330(E) 25.03.2021 48 Amoxicillin (A) + Clavulanic Dry Syrup 125 1 ml 2.40 1330(E) 25.03.2021 acid (B) mg(A) + 31.25 (B)/5 ml 49 Amoxicillin (A) + Clavulanic Oral Liquid 200 1 ml 2.00 1330(E) 25.03.2021 acid (B) mg(A) + 28.5 mg(B)/5ml 50 Amoxicillin (A) + Clavulanic Powder for Each Pack 99.96 1330(E) 25.03.2021 acid (B) Injection 500 mg(A) + 100 mg(B) 51 Amoxicillin (A) +Clavulanic Tablet 500mg(A) 1 Tablet 19.95 1330(E) 25.03.2021 acid (B) +125mg(B) 52 Amoxicillin (A) +Clavulanic Powder for Each Pack 139.44 1330(E) 25.03.2021 acid (B) Injection 1g (A) +200mg(B) 53 Amphotericin B (Lipid) Powder for 3558.99 1330(E) 25.03.2021 Injection 50 mg Each Pack 54 Amphotericin B (Liposomal) Powder for 8290.00 1330(E) 25.03.2021 Injection 50 mg Each Pack 55 Amphotericin B – Powder for Each Pack 343.91 1330(E) 25.03.2021 Conventional Injection 50 mg 56 Ampicillin Powder for Each Pack 23.69 1330(E) 25.03.202128 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) Injection 1 gm 57 Ampicillin Powder for Each Pack 14.60 1330(E) 25.03.2021 Injection 500 mg 58 Anti-D immunoglobulin Injection 300mcg Each Pack 2370.03 1330(E) 25.03.2021 59 Anti-D Immunoglobulin Injection 150mcg Each Vial 1847.36 1330(E) 25.03.2021 60 Anti-rabies immunoglobulin Injection 150 IU/ml 1 ml 3080.46 1330(E) 25.03.2021 61 Anti-rabies immunoglobulin Injection 300 IU/ml 1 ml 108.60 1330(E) 25.03.2021 62 Anti-tetanus immunoglobulin 250IU Each Pack 1233.92 1330(E) 25.03.2021 63 Arsenic Trioxide Injection 1mg/ml 1 ml 60.29 1330(E) 25.03.2021 64 Artemether (A) + Oral Liquid 80 1 ml 4.47 1330(E) 25.03.2021 Lumefantrine (B) mg(A) +480 mg(B) /5ml 65 Artemether (A) + Tablet 20 mg(A) + 1 Tablet 13.90 1330(E) 25.03.2021 Lumefantrine (B) 120 mg(B) 66 Artemether (A) + Tablet 40 mg(A) + 1 Tablet 17.92 1330(E) 25.03.2021 Lumefantrine (B) 240 mg(B) 67 Artemether (A) + Tablet 80 mg(A) + 1 Tablet 25.72 1330(E) 25.03.2021 Lumefantrine (B) 480 mg(B) 68 Artesunate Powder for Each Pack 462.04 1330(E) 25.03.2021 Injection 120 mg 69 Artesunate Powder for Each Pack 242.69 1330(E) 25.03.2021 Injection 60 mg 70 Artesunate (A) + Tablet 100 mg(A) Combi pack 32.75 1330(E) 25.03.2021 Sulphadoxine - + 1 Tablet (750 Pyrimethamine (B) mg+ 37.5 mg) (B) 71 Artesunate (A) + Tablet 150 mg(A) Combi pack 44.46 1330(E) 25.03.2021 Sulphadoxine - + 2 Tablet (500 Pyrimethamine (B) mg+ 25 mg) (B) 72 Artesunate (A) + Tablet 200 mg(A) Combi pack 40.54 1330(E) 25.03.2021 Sulphadoxine - + 2 Tablet (750 Pyrimethamine (B) mg+ 37.5 mg) (B) 73 Artesunate (A) + Tablet 25 mg(A) + Combi pack 21.83 1330(E) 25.03.2021 Sulphadoxine - 1 Tablet (250 mg+ Pyrimethamine (B) 12.5 mg) (B) 74 Artesunate (A) + 1 Tablet 50 mg(A) Combi Pack 23.56 1330(E) 25.03.2021 Sulphadoxine - + 1 Tablet (500 Pyrimethamine (B) mg+ 25 mg) (B)[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 29 Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) 75 Ascorbic Acid (Vitamin C) Tablet 100mg 1 Tablet 0.21 1330(E) 25.03.2021 76 Ascorbic Acid (Vitamin C) Tablet 500 mg 1 Tablet 1.53 1330(E) 25.03.2021 77 Atazanavir (A) + Ritonavir Tablet 300 mg(A) 1 Tablet 109.61 1330(E) 25.03.2021 (B) + 100 mg(B) 78 Atenolol Tablet 100 mg 1 Tablet 3.87 1330(E) 25.03.2021 79 Atenolol Tablet 50 mg 1 Tablet 1.98 1330(E) 25.03.2021 80 Atorvastatin Tablet 10 mg 1 Tablet 6.09 1330(E) 25.03.2021 81 Atorvastatin Tablet 20 mg 1 Tablet 14.75 1330(E) 25.03.2021 82 Atorvastatin Tablet 40 mg 1 Tablet 21.42 1330(E) 25.03.2021 83 Atracurium Injection 10 mg/ml Each Pack 58.21 1330(E) 25.03.2021 84 Atropine Ointment 1% 1 gm 4.20 1330(E) 25.03.2021 85 Atropine Injection 0.6 mg/ml 1 ml 4.65 1330(E) 25.03.2021 86 Atropine Drops 1% 1 ml 3.81 1330(E) 25.03.2021 87 Azathioprine Tablet 50 mg 1 Tablet 11.26 1330(E) 25.03.2021 88 Azithromycin Capsule 250 mg 1 Capsule 11.66 1330(E) 25.03.2021 89 Azithromycin Capsule 500 mg 1 Capsule 18.41 1330(E) 25.03.2021 90 Azithromycin Oral Liquid 200 1 ml 3.42 1330(E) 25.03.2021 mg/5ml 91 Azithromycin Tablet 250mg 1 Tablet 11.72 1330(E) 25.03.2021 92 Azithromycin Tablet 500mg 1 Tablet 23.64 1330(E) 25.03.2021 93 Azithromycin Powder for Each Pack 213.48 1330(E) 25.03.2021 Injection 500mg 94 Baclofen Tablet 10 mg 1 Tablet 11.94 1330(E) 25.03.2021 95 Baclofen Tablet 20 mg 1 Tablet 16.43 1330(E) 25.03.2021 96 Baclofen Tablet 5 mg 1 Tablet 6.15 1330(E) 25.03.2021 97 BCG vaccine Each Dose 9.92 1330(E) 25.03.2021 98 Benzathine benzylpenicillin Powder for Each Pack 20.25 1330(E) 25.03.2021 Injection 12 lac units 99 Benzathine benzylpenicillin Powder for Each Pack 13.39 1330(E) 25.03.2021 Injection 6 lac units 100 Benzoyl Peroxide Cream 2.5% 1 gm 2.59 1330(E) 25.03.2021 101 Benzoyl Peroxide Gel 2.5% 1 gm 4.16 1330(E) 25.03.2021 102 Benzyl penicillin Powder for Each Pack 8.66 1330(E) 25.03.2021 Injection 10 Lac30 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) Units 103 Betamethasone Cream 0.05% 1 gm 0.64 1330(E) 25.03.2021 104 Betamethasone Cream 0.1% 1 gm 0.93 1330(E) 25.03.2021 105 Betamethasone Gel 0.05% 1 gm 0.59 1330(E) 25.03.2021 106 Betamethasone Lotion 0.1% 1 ml 0.91 1330(E) 25.03.2021 107 Betamethasone Lotion 0.5% 1 ml 0.59 1330(E) 25.03.2021 108 Betamethasone Injection 4 mg/ml 1 ml 4.66 1330(E) 25.03.2021 109 Bicalutamide Tablet 50 mg 1 Tablet 76.18 1330(E) 25.03.2021 110 Bisacodyl Suppository 5 mg 1 9.37 1330(E) 25.03.2021 Suppository 111 Bisacodyl Tablet 5 mg 1 Tablet 1.12 1330(E) 25.03.2021 112 Bleomycin Powder for Each Pack 689.25 1330(E) 25.03.2021 Injection 15 Units 113 Bortezomib Powder for Each Pack 13656.22 1330(E) 25.03.2021 Injection 2 mg 114 Budesonide Nasal Spray 100 1 Dose 1.01 1330(E) 25.03.2021 mcg/dose 115 Budesonide Nasal Spray 50 1 Dose 1.13 1330(E) 25.03.2021 mcg/dose 116 Budesonide Respiratory 1 ml 11.90 1330(E) 25.03.2021 Solution for use in Nebulizer 0.5 mg/ml 117 Budesonide Respiratory 1 ml 14.34 1330(E) 25.03.2021 Solution for use in Nebulizer 1 mg/ml 118 Budesonide Inhalation (MDI) Per Metered 1.41 1330(E) 25.03.2021 100 mcg/dose Dose 119 Budesonide Inhalation (MDI) Per metered 1.96 1330(E) 25.03.2021 200 mcg/dose Dose 120 Budesonide Inhalation (DPI) Per Dose 2.22 1330(E) 25.03.2021 100 mcg/dose 121 Budesonide Inhalation (DPI) Per Dose 3.21 1330(E) 25.03.2021 200 mcg/dose 122 Budesonide (A)+ Inhalation (MDI) Per Metered 2.09 1330(E) 25.03.2021 Formoterol (B) 100 mcg (A) + 6 Dose[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 31 Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) mcg (B) 123 Budesonide (A)+ Inhalation (MDI) Per Metered 2.97 1330(E) 25.03.2021 Formoterol (B) 200 mcg (A) + 6 Dose mcg (B) 124 Budesonide (A)+ Inhalation (MDI) Per Metered 3.39 1330(E) 25.03.2021 Formoterol (B) 400 mcg (A) + 6 Dose mcg (B) 125 Budesonide (A)+ Inhalation (DPI) Per Dose 4.21 1330(E) 25.03.2021 Formoterol (B) 100 mcg (A) + 6 mcg (B) 126 Budesonide (A)+ Inhalation (DPI) Per Dose 5.59 1330(E) 25.03.2021 Formoterol (B) 200 mcg (A) + 6 mcg (B) 127 Budesonide (A)+ Inhalation (DPI) Per Dose 7.14 1330(E) 25.03.2021 Formoterol (B) 400 mcg (A) + 6 mcg (B) 128 Bupivacaine Injection 0.25% 1 ml 2.72 1330(E) 25.03.2021 129 Bupivacaine Injection 0.5% with 1 ml 6.89 1330(E) 25.03.2021 7.5% glucose 130 Bupivacaine Injection 0.50% 1 ml 4.35 1330(E) 25.03.2021 131 Caffeine Injection 20 mg/ml 1 ml 278.70 1330(E) 25.03.2021 132 Caffeine Oral Liquid 20 1 ml 236.71 1330(E) 25.03.2021 mg/ml 133 Calamine Lotion (As per IP) 1 ml 0.94 1330(E) 25.03.2021 134 Calcium Carbonate Tablet 500mg 1 Tablet 1.92 1330(E) 25.03.2021 135 Calcium folinate Tablet 15 mg 1 Tablet 45.29 1330(E) 25.03.2021 136 Calcium gluconate Injection 100 mg/ml 1 ml 0.61 1330(E) 25.03.2021 137 Capecitabine Tablet 500 mg 1 Tablet 140.33 1330(E) 25.03.2021 138 Capreomycin Powder for Each Pack 384.60 1330(E) 25.03.2021 Injection 1 gm 139 Carbamazepine Oral Liquid 100 1 ml 0.32 2654(E) 01.07.2021 mg/5ml 140 Carbamazepine CR Tablet 200 mg 1 Tablet 2.59 2654(E) 01.07.2021 141 Carbamazepine CR Tablet 400 mg 1 Tablet 5.11 2654(E) 01.07.2021 142 Carbamazepine Tablet 100 mg 1 Tablet 1.13 2654(E) 01.07.2021 143 Carbamazepine Tablet 200 mg 1 Tablet 1.55 1330(E) 25.03.202132 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) 144 Carbamazepine Tablet 400 mg 1 Tablet 3.67 1330(E) 25.03.2021 145 Carbimazole Tablet 10 mg 1 Tablet 4.11 1330(E) 25.03.2021 146 Carbimazole Tablet 5 mg 1 Tablet 2.12 1330(E) 25.03.2021 147 Carboplatin Injection 10 mg/ml 1 ml 59.08 1330(E) 25.03.2021 148 Carboxymethylcellulose Drops 0.5% 1 ml 14.19 1330(E) 25.03.2021 149 Carboxymethylcellulose Drops 1% 1 ml 19.66 1330(E) 25.03.2021 150 Cefadroxil Capsule 500 mg 1 Capsule 7.94 1330(E) 25.03.2021 151 Cefadroxil Oral Liquid 125 1 ml 0.70 1330(E) 25.03.2021 mg/5ml 152 Cefadroxil Tablet 1 gm 1 Tablet 6.98 1330(E) 25.03.2021 153 Cefadroxil Tablet 500 mg 1 Tablet 4.47 1330(E) 25.03.2021 154 Cefazolin Powder for Each Pack 27.26 1330(E) 25.03.2021 Injection 1 gm 155 Cefazolin Powder for Each Pack 17.28 1330(E) 25.03.2021 Injection 500 mg 156 Cefixime Capsule 200 mg 1 Capsule 16.03 1330(E) 25.03.2021 157 Cefixime Capsule 400 mg 1 Capsule 32.47 1330(E) 25.03.2021 158 Cefixime Oral Liquid 100 1 ml 2.39 1330(E) 25.03.2021 mg/5ml 159 Cefixime Oral Liquid 50 1 ml 1.62 1330(E) 25.03.2021 mg/5ml 160 Cefixime Tablet 400 mg 1 Tablet 24.50 1330(E) 25.03.2021 161 Cefixime Tablet 200mg 1 Tablet 10.66 1330(E) 25.03.2021 162 Cefotaxime Powder for Each Pack 38.10 1330(E) 25.03.2021 Injection 1 gm 163 Cefotaxime Powder for Each Pack 17.32 1330(E) 25.03.2021 Injection 250 mg 164 Cefotaxime Powder for Each Pack 22.78 1330(E) 25.03.2021 Injection 500 mg 165 Ceftazidime Powder for Each Pack 232.39 1330(E) 25.03.2021 Injection 1 gm 166 Ceftazidime Powder for Each Pack 72.27 1330(E) 25.03.2021 Injection 250 mg 167 Ceftriaxone Powder for Each Pack 59.86 1330(E) 25.03.2021 Injection 1gm 168 Ceftriaxone Powder for Each Pack 142.29 1330(E) 25.03.2021[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 33 Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) Injection 2 gm 169 Ceftriaxone Powder for Each Pack 27.40 1330(E) 25.03.2021 Injection 250 mg 170 Ceftriaxone Powder for Each Pack 50.06 1330(E) 25.03.2021 Injection 500 mg 171 Cetirizine Capsule 10 mg 1 Capsule 2.64 1330(E) 25.03.2021 172 Cetirizine Oral Liquid 5 1 ml 0.65 1330(E) 25.03.2021 mg/5ml 173 Cetirizine Tablet 10 mg 1 Tablet 1.84 1330(E) 25.03.2021 174 Cetrimide Solution 20% 1 ml 0.35 1330(E) 25.03.2021 (concentrate for dilution) 175 Chlorambucil Tablet 2 mg 1 Tablet 40.98 1330(E) 25.03.2021 176 Chlorambucil Tablet 5 mg 1 Tablet 92.09 1330(E) 25.03.2021 177 Chlorhexidine Solution 5% 1 ml 0.17 1330(E) 25.03.2021 (Concentrate for dilution) 178 Chloroquine Oral Liquid 50 1 ml 0.33 1330(E) 25.03.2021 mg/5ml 179 Chloroquine Tablet 150mg 1 Tablet 1.32 1330(E) 25.03.2021 180 Chlorpheniramine Tablet 4 mg 1 Tablet 0.10 1330(E) 25.03.2021 181 Cholecalciferol Capsule 1000 IU 1 Capsule 5.31 1330(E) 25.03.2021 182 Cholecalciferol Capsule 60000 IU 1 Capsule 32.79 1330(E) 25.03.2021 183 Cholecalciferol Oral Liquid 400 1 ml 2.60 1330(E) 25.03.2021 IU/ml 184 Cholecalciferol Tablet 1000 IU 1 Tablet 4.16 1330(E) 25.03.2021 185 Cholecalciferol Tablet 60000 IU 1 Tablet 26.93 1330(E) 25.03.2021 186 Ciprofloxacin Ointment 0.3% 1 gm 1.26 1330(E) 25.03.2021 187 Ciprofloxacin Drops 0.30% 1 ml 1.69 1330(E) 25.03.2021 188 Ciprofloxacin Injection 200 1 ml 0.19 1330(E) 25.03.2021 mg/100ml 189 Ciprofloxacin Oral Liquid 250 1 ml 0.70 1330(E) 25.03.2021 mg/5ml 190 Ciprofloxacin Tablet 250mg 1 Tablet 2.30 1330(E) 25.03.2021 191 Ciprofloxacin Tablet 500mg 1 Tablet 4.05 1330(E) 25.03.2021 192 Cisplatin Injection 1 mg/ml 1 ml 7.65 1330(E) 25.03.202134 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) 193 Clarithromycin Oral Liquid 125 1 ml 4.79 1330(E) 25.03.2021 mg/5ml 194 Clarithromycin Tablet 250 mg 1 Tablet 31.09 1330(E) 25.03.2021 195 Clarithromycin Tablet 500 mg 1 Tablet 54.80 1330(E) 25.03.2021 196 Clindamycin Capsule 150 mg 1 Capsule 16.07 1330(E) 25.03.2021 197 Clindamycin Capsule 300 mg 1 Capsule 26.24 1330(E) 25.03.2021 198 Clindamycin Tablet 300 mg 1 Tablet 16.93 1330(E) 25.03.2021 199 Clobazam Tablet 10 mg 1 Tablet 10.04 1330(E) 25.03.2021 200 Clobazam Tablet 5 mg 1 Tablet 5.70 1330(E) 25.03.2021 201 Clofazimine Capsule 100 mg 1 Capsule 4.12 1330(E) 25.03.2021 202 Clofazimine Capsule 50 mg 1 Capsule 2.41 1330(E) 25.03.2021 203 Clomiphene Capsule 100 mg 1 Capsule 61.81 1330(E) 25.03.2021 204 Clomiphene Capsule 50 mg 1 Capsule 33.99 1330(E) 25.03.2021 205 Clomiphene Tablet 100mg 1 Tablet 13.57 1330(E) 25.03.2021 206 Clomiphene Tablet 50mg 1 Tablet 9.24 1330(E) 25.03.2021 207 Clomipramine Tablet 10 mg 1 Tablet 2.79 1330(E) 25.03.2021 208 Clomipramine Tablet 25 mg 1 Tablet 6.16 1330(E) 25.03.2021 209 Clomipramine Tablet 75 mg 1 Tablet 15.93 1330(E) 25.03.2021 210 Clonazepam Tablet 0.25 mg 1 Tablet 2.03 1330(E) 25.03.2021 211 Clonazepam Tablet 0.5 mg 1 Tablet 3.46 1330(E) 25.03.2021 212 Clonazepam Tablet 1 mg 1 Tablet 4.70 1330(E) 25.03.2021 213 Clopidogrel Tablet 75 mg 1 Tablet 7.72 1330(E) 25.03.2021 214 Clotrimazole Cream 1% 1 gm 3.23 1330(E) 25.03.2021 215 Clotrimazole Drops 1% 1 ml 3.37 1330(E) 25.03.2021 216 Clotrimazole Lotion 1% 1 ml 3.98 1330(E) 25.03.2021 217 Clotrimazole Pessary 100 mg 1 Pessary 9.65 1330(E) 25.03.2021 218 Cloxacillin Capsule 250mg 1 Capsule 1.26 1330(E) 25.03.2021 219 Cloxacillin Capsule 500mg 1 Capsule 2.12 1330(E) 25.03.2021 220 Cloxacillin Tablet 250mg 1 Tablet 1.92 1330(E) 25.03.2021 221 Cloxacillin Powder for Each Pack 4.93 1330(E) 25.03.2021 Injection250mg 222 Clozapine Tablet 100 mg 1 Tablet 8.60 1330(E) 25.03.2021 223 Clozapine Tablet 25 mg 1 Tablet 2.79 1330(E) 25.03.2021 224 Clozapine Tablet 50 mg 1 Tablet 5.34 1330(E) 25.03.2021[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 35 Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) 225 Coagulation factor IX Powder for Each Pack 13680.58 1330(E) 25.03.2021 Injection 600 IU 226 Coagulation factor VIII Powder for Each pack 4147.18 1330(E) 25.03.2021 Injection 250 IU 227 Coagulation factor VIII Powder for Each Pack 10176.88 1330(E) 25.03.2021 Injection 500 IU 228 Colchicine Tablet 0.5 mg 1 Tablet 3.46 1330(E) 25.03.2021 229 Co-trimoxazole Oral Liquid 200 1 ml 0.37 1330(E) 25.03.2021 (Sulphamethoxazole mg(A)+40 (A)+Trimethoprim (B)] mg(B)/5ml 230 Co-trimoxazole Tablet 400 1 Tablet 0.86 1330(E) 25.03.2021 (Sulphamethoxazole mg(A)+80 mg(B) (A)+Trimethoprim (B)] 231 Co-trimoxazole Tablet 800 1 Tablet 2.25 1330(E) 25.03.2021 (Sulphamethoxazole mg(A)+160 mg(B) (A)+Trimethoprim (B)] 232 Cyclophosphamide Tablet 50 mg 1 Tablet 4.50 1330(E) 25.03.2021 233 Cyclophosphamide Powder for Each Pack 88.62 1330(E) 25.03.2021 Injection 500 mg 234 Cycloserine Capsule 250 mg 1 Capsule 60.28 1330(E) 25.03.2021 235 Cycloserine Tablet 250 mg 1 Tablet 51.83 1330(E) 25.03.2021 236 Cyclosporine Capsule 100 mg 1 Capsule 113.81 1330(E) 25.03.2021 237 Cyclosporine Capsule 25 mg 1 Capsule 30.55 1330(E) 25.03.2021 238 Cyclosporine Capsule 50 mg 1 Capsule 58.45 1330(E) 25.03.2021 239 Cyclosporine Injection 50 mg/ml 1 ml 299.48 1330(E) 25.03.2021 240 Cyclosporine Oral Liquid 100 1 ml 104.95 1330(E) 25.03.2021 mg/ml 241 Cytosine arabinoside Injection 100 mg/ml Each Pack 220.59 1330(E) 25.03.2021 242 Cytosine arabinoside Powder for Each Pack 1189.78 1330(E) 25.03.2021 Injection 1000 mg 243 Cytosine arabinoside Powder for Each Pack 568.66 1330(E) 25.03.2021 Injection 500 mg 244 Dacarbazine Powder for Each Pack 487.79 1330(E) 25.03.2021 Injection 200 mg 245 Dacarbazine Powder for Each Pack 1100.41 1330(E) 25.03.2021 Injection 500 mg36 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) 246 Dapsone Tablet 100 mg 1 Tablet 0.40 1330(E) 25.03.2021 247 Darunavir Tablet 600 mg 1 Tablet 185.33 1330(E) 25.03.2021 248 Daunarubicin Powder for I.V. Each pack 270.01 1330(E) 25.03.2021 Injection 20 mg (5 mg/ml) 249 Desferrioxamine Powder for Each pack 178.55 1330(E) 25.03.2021 Injection 500mg 250 Dexamethasone Tablet 0.5 mg 1 Tablet 0.21 1330(E) 25.03.2021 251 Dexamethasone Injection 4 mg/ml Each Pack 15.29 1330(E) 25.03.2021 (10 ml) 252 Dexamethasone Injection 4 mg/ml Each Pack 10.35 1330(E) 25.03.2021 (2 ml) 253 Dexamethasone Injection 4 mg/ml Each Pack 29.31 1330(E) 25.03.2021 (20 ml) 254 Dexamethasone Injection 4 mg/ml Each Pack 39.17 1330(E) 25.03.2021 (30 ml) 255 Dextran-40 Injection 10% 1 ml 0.94 1330(E) 25.03.2021 256 Diazepam Injection 5 mg/ml 1 ml 6.72 1330(E) 25.03.2021 257 Diazepam Oral Liquid 2 1 ml 3.03 1330(E) 25.03.2021 mg/5ml 258 Diazepam Suppository 5 mg 1 6.63 1330(E) 25.03.2021 Suppository 259 Diazepam Tablet 2 mg 1 Tablet 1.67 1330(E) 25.03.2021 260 Diazepam Tablet 5 mg 1 Tablet 1.58 1330(E) 25.03.2021 261 Diclofenac Capsule 50 mg 1 Capsule 0.68 1330(E) 25.03.2021 262 Diclofenac Injection 25 mg/ml 1 ml 1.63 1330(E) 25.03.2021 263 Diclofenac Tablet 50 mg 1 Tablet 2.13 1330(E) 25.03.2021 264 Dicyclomine Injection 10 mg/ml 1 ml 2.28 1330(E) 25.03.2021 (10ml & 30ml Pack) 265 Dicyclomine Injection 10 mg/ml 1 ml 3.54 1330(E) 25.03.2021 (1ml & 2ml Pack) 266 Dicyclomine Oral Solution 1 ml 0.18 1330(E) 25.03.2021 10mg/5ml 267 Dicyclomine Tablet 10mg 1 Tablet 0.12 1330(E) 25.03.2021 268 Diethylcarbamazine Oral Liquid 120 1 ml 0.54 1330(E) 25.03.2021[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 37 Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) mg/5ml 269 Diethylcarbamazine Tablet 100 mg 1 Tablet 1.57 1330(E) 25.03.2021 270 Diethylcarbamazine Tablet 50 mg 1 Tablet 0.62 1330(E) 25.03.2021 271 Digoxin Injection 0.25 1 ml 3.70 1330(E) 25.03.2021 mg/ml 272 Digoxin Oral liquid 0.05 1 ml 1.41 1330(E) 25.03.2021 mg/ml 273 Digoxin Tablet 0.25 mg 1 Tablet 1.33 1330(E) 25.03.2021 274 Diloxanide furoate Tablet 500mg 1 Tablet 1.17 1330(E) 25.03.2021 275 Diltiazem Capsule 90 mg 1 Capsule 10.67 1330(E) 25.03.2021 276 Diltiazem Injection 5 mg/ml 1 ml 3.51 1330(E) 25.03.2021 277 Diltiazem SR Tablet 90 mg 1 Tablet 10.36 1330(E) 25.03.2021 278 Diltiazem Tablet 30 mg 1 Tablet 2.66 1330(E) 25.03.2021 279 Diltiazem Tablet 60 mg 1 Tablet 5.43 1330(E) 25.03.2021 280 Dimercaprol Injection 50 mg/ml 1 ml 222.22 1330(E) 25.03.2021 281 Dinoprostone Gel 0.5 mg 1 gm 90.01 1330(E) 25.03.2021 282 Dinoprostone Tablet 0.5mg 1 Tablet 55.57 1330(E) 25.03.2021 283 Diphtheria antitoxin 10000 IU Each Pack 1455.21 1330(E) 25.03.2021 284 Dobutamine Injection 50 mg/ml Each Pack 41.64 1330(E) 25.03.2021 285 Docetaxel Powder for Each Pack 3323.65 1330(E) 25.03.2021 Injection 20 mg 286 Docetaxel Powder for Each Pack 12636.74 1330(E) 25.03.2021 Injection 80 mg 287 Domperidone Oral Liquid 1 1 ml 1.20 1330(E) 25.03.2021 mg/ml 288 Domperidone Tablet 10 mg 1 Tablet 2.68 1330(E) 25.03.2021 289 Donepezil Tablet 10 mg 1 Tablet 17.82 1330(E) 25.03.2021 290 Donepezil Tablet 5 mg 1 Tablet 12.48 1330(E) 25.03.2021 291 Dopamine Injection 40 mg/ml 1 ml 6.27 1330(E) 25.03.2021 292 Doxorubicin Injection 2 mg/ml 1 ml 39.86 1330(E) 25.03.2021 293 Doxycycline Capsule 100 mg 1 Capsule 2.78 1330(E) 25.03.2021 294 Doxycycline Tablet 100 mg 1 Tablet 1.09 1330(E) 25.03.2021 295 DPT + Hib + Hep B Per 0.1 ml 89.18 1330(E) 25.03.2021 vaccine 296 DPT vaccine Per 0.5 ml 15.73 1330(E) 25.03.202138 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) 297 Efavirenz Capsule 200 mg 1 Capsule 26.73 1330(E) 25.03.2021 298 Efavirenz Capsule 600 mg 1 Capsule 69.65 1330(E) 25.03.2021 299 Efavirenz Tablet 200 mg 1 Tablet 25.18 1330(E) 25.03.2021 300 Efavirenz Tablet 600 mg 1 Tablet 78.85 1330(E) 25.03.2021 301 Enalapril Tablet 2.5 mg 1 Tablet 2.15 1330(E) 25.03.2021 302 Enalapril Tablet 5 mg 1 Tablet 3.57 1330(E) 25.03.2021 303 Enoxaparin Injection 40 0.1 ml 112.86 1330(E) 25.03.2021 mg/0.4ml 304 Enoxaparin Injection 60 0.1 ml 112.86 1330(E) 25.03.2021 mg/0.6ml 305 Entecavir Tablet 0.5 mg 1 Tablet 88.59 1330(E) 25.03.2021 306 Entecavir Tablet 1 mg 1 Tablet 140.76 1330(E) 25.03.2021 307 Erythropoietin Injection 10000 Each pack 2888.54 1330(E) 25.03.2021 IU/ml 308 Erythropoietin Injection 2000 Each pack 684.16 1330(E) 25.03.2021 IU/ml 309 Escitalopram Tablet 10 mg 1 Tablet 8.99 1330(E) 25.03.2021 310 Escitalopram Tablet 20 mg 1 Tablet 14.21 1330(E) 25.03.2021 311 Escitalopram Tablet 5 mg 1 Tablet 5.06 1330(E) 25.03.2021 312 Esmolol Injection 10mg/ml 1 ml 24.06 1330(E) 25.03.2021 313 Ethambutol Tablet 200 mg 1 Tablet 1.17 1330(E) 25.03.2021 314 Ethambutol Tablet 400 mg 1 Tablet 2.66 1330(E) 25.03.2021 315 Ethambutol Tablet 600 mg 1 Tablet 3.93 1330(E) 25.03.2021 316 Ethambutol Tablet 800 mg 1 Tablet 4.70 1330(E) 25.03.2021 317 Ethinylestradiol Tablet 0.01 mg 1 Tablet 2.60 1330(E) 25.03.2021 318 Ethinylestradiol Tablet 0.05 mg 1 Tablet 4.16 1330(E) 25.03.2021 319 Ethinylestradiol (A) + Tablet 0.03 mg(A) 1 Tablet 3.83 1330(E) 25.03.2021 Levonorgestrel (B) + 0.15 mg(B) 320 Ethionamide Tablet 250 mg 1 Tablet 17.52 1330(E) 25.03.2021 321 Ethyl Alcohol (Denatured) Solution 70% 1 ml 0.47 1330(E) 25.03.2021 322 Etoposide Capsule 50 mg 1 Capsule 60.37 1330(E) 25.03.2021 323 Etoposide Injection 20 mg/ml 1 ml 39.81 1330(E) 25.03.2021 324 Fentanyl Injection 50mcg/ml 1 ml 25.21 1330(E) 25.03.2021 325 Ferrous Salt (A) + Folic Tablet 100mg 1 Tablet 0.25 1330(E) 25.03.2021 Acid (B) elemental iron (A)[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 39 Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) + 500mcg (B) 326 Filgrastim Injection 300 mcg Each pack 1523.73 1330(E) 25.03.2021 327 Fluconazole Capsule 100 mg 1 Capsule 28.06 1330(E) 25.03.2021 328 Fluconazole Capsule 150 mg 1 Capsule 20.59 1330(E) 25.03.2021 329 Fluconazole Capsule 200 mg 1 Capsule 40.54 1330(E) 25.03.2021 330 Fluconazole Oral Liquid 1 ml 2.90 1330(E) 25.03.2021 50mg/5ml 331 Fluconazole Tablet 100 mg 1 Tablet 8.86 1330(E) 25.03.2021 332 Fluconazole Tablet 150 mg 1 Tablet 13.15 1330(E) 25.03.2021 333 Fluconazole Tablet 200 mg 1 Tablet 20.86 1330(E) 25.03.2021 334 Fluconazole Tablet 400 mg 1 Tablet 34.69 1330(E) 25.03.2021 335 Fluconazole Injection 200 Each Pack 118.17 1330(E) 25.03.2021 mg/100 ml 336 Flunarizine Tablet 10 mg 1 Tablet 5.26 1330(E) 25.03.2021 337 Flunarizine Tablet 5 mg 1 Tablet 3.06 1330(E) 25.03.2021 338 Fluoxetine Capsule 10 mg 1 Capsule 3.30 1330(E) 25.03.2021 339 Fluoxetine Capsule 20 mg 1 Capsule 4.05 1330(E) 25.03.2021 340 Fluoxetine Capsule 40 mg 1 Capsule 6.15 1330(E) 25.03.2021 341 Fluoxetine Capsule 60 mg 1 Capsule 10.87 1330(E) 25.03.2021 342 Fluoxetine Tablet 10 mg 1 Tablet 2.77 1330(E) 25.03.2021 343 Fluoxetine Tablet 20 mg 1 Tablet 4.40 1330(E) 25.03.2021 344 Fluoxetine Tablet 40 mg 1 Tablet 5.93 1330(E) 25.03.2021 345 Fluoxetine Tablet 60 mg 1 Tablet 8.22 1330(E) 25.03.2021 346 Fluphenazine Depot Injection 25 1 ml 55.55 1330(E) 25.03.2021 mg/ml 347 Folic Acid Capsule 5 mg 1 Capsule 6.26 1330(E) 25.03.2021 348 Folic Acid Tablet 5 mg 1 Tablet 1.55 1330(E) 25.03.2021 349 Furosemide Oral liquid 10 1 ml 3.07 1330(E) 25.03.2021 mg/ml 350 Furosemide Tablet 40 mg 1 Tablet 0.83 1330(E) 25.03.2021 351 Furosemide Injection 10mg/ml 1 ml 2.76 1330(E) 25.03.2021 352 Fusidic acid Cream 2% 1 gm 10.14 1330(E) 25.03.2021 353 Gadobenate Injection 529 mg/ml 1 ml 121.01 1330(E) 25.03.2021 354 Ganciclovir Capsule 250 mg 1 Capsule 133.48 1330(E) 25.03.2021 355 Ganciclovir Powder for Each Pack 1873.81 1330(E) 25.03.202140 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) Injection 500 mg 356 Gefitinib Tablet 250 mg 1 Tablet 475.90 1330(E) 25.03.2021 357 Gemcitabine Powder for Each Pack 5890.65 1330(E) 25.03.2021 Injection 1 gm 358 Gemcitabine Powder for Each Pack 1300.95 1330(E) 25.03.2021 Injection 200mg 359 Gentamicin Drops 0.3% 1 ml 1.01 1330(E) 25.03.2021 360 Gentamicin Injection 10 mg/ml 1 ml 3.53 1330(E) 25.03.2021 361 Gentamicin Injection 40 mg/ml Each Pack 19.95 1330(E) 25.03.2021 (10 ml) 362 Gentamicin Injection 40 mg/ml Each Pack 9.35 1330(E) 25.03.2021 (2 ml) 363 Gentamicin Injection 40 mg/ml Each Pack 30.24 1330(E) 25.03.2021 (20 ml) 364 Gentamicin Injection 40 mg/ml Each Pack 33.10 1330(E) 25.03.2021 (30 ml) 365 Glimepiride Tablet 1 mg 1 Tablet 3.99 1330(E) 25.03.2021 366 Glimepiride Tablet 2 mg 1 Tablet 6.34 1330(E) 25.03.2021 367 Glucose Injection 25% 1 ml 0.19 1330(E) 25.03.2021 368 Glucose Injection 50% 1 ml 0.54 1330(E) 25.03.2021 369 Glucose Injection 5% 1000ml 71.31 1330(E) 25.03.2021 Glass 370 Glucose Injection 5% 1000ml Non- 57.57 1330(E) 25.03.2021 Glass 371 Glucose Injection 5% 100ml Glass 20.02 1330(E) 25.03.2021 372 Glucose Injection 5% 100ml Non- 18.12 1330(E) 25.03.2021 Glass 373 Glucose Injection 5% 250ml Glass 27.66 1330(E) 25.03.2021 374 Glucose Injection 5% 250ml Non- 24.99 1330(E) 25.03.2021 Glass 375 Glucose Injection 5% 500ml Glass 39.26 1330(E) 25.03.2021 376 Glucose Injection 5% 500ml Non- 33.87 1330(E) 25.03.2021 Glass 377 Glucose Injection 10% Each Pack 28.68 1330(E) 25.03.2021 (1000 ml) 378 Glucose Injection 10% Each Pack 31.19 1330(E) 25.03.2021[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 41 Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) (500 ml) 379 Glucose (A) + Sodium Injection 5% (A) + 1000ml 71.78 1330(E) 25.03.2021 Chloride (B) 0.9% (B) Glass 380 Glucose (A) + Sodium Injection 5% (A) + 1000ml Non- 58.00 1330(E) 25.03.2021 Chloride (B) 0.9% (B) Glass 381 Glucose (A) + Sodium Injection 5% (A) + 100ml Glass 20.07 1330(E) 25.03.2021 Chloride (B) 0.9% (B) 382 Glucose (A) + Sodium Injection 5% (A) + 100ml Non- 18.14 1330(E) 25.03.2021 Chloride (B) 0.9% (B) Glass 383 Glucose (A) + Sodium Injection 5% (A) + 250ml Glass 27.77 1330(E) 25.03.2021 Chloride (B) 0.9% (B) 384 Glucose (A) + Sodium Injection 5% (A) + 250ml Non- 25.08 1330(E) 25.03.2021 Chloride (B) 0.9% (B) Glass 385 Glucose (A) + Sodium Injection 5% (A) + 500ml Glass 39.45 1330(E) 25.03.2021 Chloride (B) 0.9% (B) 386 Glucose (A) + Sodium Injection 5% (A) + 500ml Non- 34.08 1330(E) 25.03.2021 Chloride (B) 0.9% (B) Glass 387 Glutaraldehyde Solution 2% 1 ml 0.07 1330(E) 25.03.2021 388 Glycerin Oral Liquid 1 ml 0.17 1330(E) 25.03.2021 389 Glyceryl Trinitrate Injection 5 mg/ml 1 ml 7.29 1330(E) 25.03.2021 390 Glyceryl Trinitrate Sublingual Tablet 1 Tablet 2.00 1330(E) 25.03.2021 0.5 mg 391 Glycopyrrolate Injection 0.2 mg/ml 1 ml 13.65 1330(E) 25.03.2021 392 Griseofulvin Tablet 125mg 1 Tablet 0.91 1330(E) 25.03.2021 393 Griseofulvin Tablet 250 mg 1 Tablet 1.77 1330(E) 25.03.2021 394 Griseofulvin Tablet 375 mg 1 Tablet 4.77 1330(E) 25.03.2021 395 Haemodialysis fluid As license 1 ml 0.04 1330(E) 25.03.2021 396 Haloperidol Injection 5 mg/ml 1 ml 6.47 1330(E) 25.03.2021 397 Haloperidol Oral Liquid 2 mg/ 1 ml 2.28 1330(E) 25.03.2021 5ml 398 Haloperidol Tablet 1.5 mg 1 Tablet 1.84 1330(E) 25.03.2021 399 Haloperidol Tablet 10 mg 1 Tablet 4.90 1330(E) 25.03.2021 400 Haloperidol Tablet 20 mg 1 Tablet 5.47 1330(E) 25.03.2021 401 Haloperidol Tablet 5 mg 1 Tablet 3.82 1330(E) 25.03.2021 402 Halothane Inhalation 1 ml 6.50 1330(E) 25.03.2021 403 Heparin Injection 1000 1 ml 18.11 1330(E) 25.03.202142 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) IU/ml 404 Heparin Injection 5000 1 ml 44.95 1330(E) 25.03.2021 IU/ml 405 Hepatitis B immunoglobulin Each Pack 6116.13 1330(E) 25.03.2021 406 Hepatitis B vaccine 1 ml 86.95 1330(E) 25.03.2021 407 Homatropine Drops 2% 1 ml 6.89 1330(E) 25.03.2021 408 Hormone releasing IUD Contains 52 mgof 1 IUD 4295.01 1330(E) 25.03.2021 Levonorgestrel 409 Human chorionic Injection 1000 IU Each Pack 235.98 1330(E) 25.03.2021 Gonadotropin 410 Human chorionic Injection 5000 IU Each Pack 463.41 1330(E) 25.03.2021 Gonadotropin 411 Human Normal Solution for 1 ml 171.30 1330(E) 25.03.2021 Immunoglobulin infusion 5% 412 Human Normal Solution for 1 ml 231.92 1330(E) 25.03.2021 Immunoglobulin infusion 10% 413 Human Normal Solution for 1 ml 441.03 1428(E) 31.03.2021 Immunoglobulin infusion 16.5% 414 Hydrochlorothiazide Tablet 12.5 mg 1 Tablet 1.10 1330(E) 25.03.2021 415 Hydrochlorothiazide Tablet 25 mg 1 Tablet 1.87 1330(E) 25.03.2021 416 Hydrochlorothiazide Tablet 50 mg 1 Tablet 0.09 1330(E) 25.03.2021 417 Hydrocortisone Tablet 10 mg 1 Tablet 6.54 1330(E) 25.03.2021 418 Hydrocortisone Tablet 5 mg 1 Tablet 3.37 1330(E) 25.03.2021 419 Hydrocortisone Injection 100 mg Each Pack 43.21 1330(E) 25.03.2021 420 Hydrocortisone Injection 200 mg Each Pack 66.61 1330(E) 25.03.2021 421 Hydrocortisone Powder for Each Pack 43.21 1330(E) 25.03.2021 Injection 100 mg 422 Hydrogen peroxide Solution 6% 1 ml 0.04 1330(E) 25.03.2021 Hydroxocobalamin Injection 1 mg/ml 423 1 ML 10.98 4885(E) 26.11.2021 424 Hydroxychloroquine Tablet 200 mg 1 Tablet 6.58 1330(E) 25.03.2021 425 Hydroxychloroquine Tablet 400 mg 1 Tablet 13.26 1330(E) 25.03.2021 426 Hydroxypropyl Injection 2% 1 ml 41.64 1330(E) 25.03.2021 methylcellulose 427 Hydroxyurea Capsule 500 mg 1 Capsule 14.23 1330(E) 25.03.2021 428 Hyoscine butylbromide Injection 20 mg/ml 1 ml 11.59 1330(E) 25.03.2021[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 43 Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) 429 Hyoscine Butylbromide Tablet 10 mg 1 Tablet 3.30 1330(E) 25.03.2021 430 Ibuprofen Capsule 400 mg 1 Capsule 1.17 1330(E) 25.03.2021 431 Ibuprofen Capsule 200 mg 1 soft gelatin 2.97 1330(E) 25.03.2021 capsule 432 Ibuprofen Tablet 200 mg 1 Tablet 0.65 2654(E) 01.07.2021 433 Ibuprofen Tablet 400 mg 1 Tablet 1.15 2654(E) 01.07.2021 434 Ibuprofen Oral Liquid 1 ml 0.21 1330(E) 25.03.2021 100mg/5ml 435 Ifosfamide Powder for Each Pack 401.77 1330(E) 25.03.2021 Injection 1g 436 Ifosfamide Powder for Each Pack 1054.59 1330(E) 25.03.2021 Injection 2g 437 Imatinib Capsule 100 mg 1 Capsule 86.20 1330(E) 25.03.2021 438 Imatinib Capsule 400 mg 1 Capsule 283.61 1330(E) 25.03.2021 439 Imatinib Tablet 100 mg 1 Tablet 88.18 1330(E) 25.03.2021 440 Imatinib Tablet 400 mg 1 Tablet 255.28 1330(E) 25.03.2021 441 Insulin (Soluble) Injection 40 IU/ml 1 ml 16.71 1330(E) 25.03.2021 442 Intermediate Acting (NPH) Injection 40 IU/ml 1 ml 16.71 1330(E) 25.03.2021 Insulin 443 Iohexol Injection 1 ml 18.46 1330(E) 25.03.2021 300mgiodine/ml 444 Ipratropium Inhalation 1 Dose 0.68 1330(E) 25.03.2021 (MDI/DPI) 20 mcg/dose 445 Ipratropium Respirator solution 1 ml 2.81 1330(E) 25.03.2021 for use in Nebulizer 250 mcg/ml 446 Iron sucrose Injection 20 mg/ml 1 ml 59.68 1330(E) 25.03.2021 447 Isoflurane Inhalation 1 ml 11.61 1330(E) 25.03.2021 448 Isoniazid Tablet 100mg 1 Tablet 0.75 1330(E) 25.03.2021 449 Isoniazid Tablet 300mg 1 Tablet 1.33 1330(E) 25.03.2021 450 Isosorbide 5 Mononitrate Tablet 20 mg 1 Tablet 3.64 1330(E) 25.03.2021 451 Isosorbide dinitrate Tablet 10 mg 1 Tablet 0.81 1330(E) 25.03.2021 452 Isosorbide dinitrate Tablet 5 mg 1 Tablet 0.83 1330(E) 25.03.2021 453 Isosorbide-5-mononitrate SR Capsule 30 mg 1 Capsule 3.89 1330(E) 25.03.202144 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) 454 Isosorbide-5-mononitrate SR Capsule 60 mg 1 Capsule 3.87 1330(E) 25.03.2021 455 Isosorbide-5-mononitrate SR Tablet 30 mg 1 Tablet 5.44 1330(E) 25.03.2021 456 Isosorbide-5-mononitrate SR Tablet 60 mg 1 Tablet 7.09 1330(E) 25.03.2021 457 Isosorbide-5-mononitrate Tablet 10 mg 1 Tablet 2.18 1330(E) 25.03.2021 458 Ispaghula Granules/ Husk/ 1 gm 0.85 1330(E) 25.03.2021 Powder 459 IUD containing Copper As licensed 1 IUD 319.22 1330(E) 25.03.2021 460 Japanese Encephalitis 4mcg to 6mcg Each Pack 774.52 1330(E) 25.03.2021 Vaccine 461 Japanese Encephalitis up to 3mcg Each Pack 590.07 1330(E) 25.03.2021 Vaccine 462 Kanamycin Powder for Each Pack 43.42 1330(E) 25.03.2021 Injection 1 gm 463 Kanamycin Powder for Each Pack 23.68 1330(E) 25.03.2021 Injection 500 mg 464 Kanamycin Powder for Each Pack 40.46 1330(E) 25.03.2021 Injection 750 mg 465 Ketamine Injection 10 mg/ml 1 ml 11.76 1330(E) 25.03.2021 466 Ketamine Injection 50 mg/ml 1 ml 11.61 1330(E) 25.03.2021 467 Labetalol Injection 5 mg/ml 1 ml 56.28 1330(E) 25.03.2021 468 Lactulose Oral Liquid 10 g/15 1 ml 1.22 1330(E) 25.03.2021 ml 469 Lamivudine (A) + Tablet 150 mg(A) 1 Tablet 17.32 1330(E) 25.03.2021 Nevirapine (B) + Stavudine + 200 mg(B) + 30 (C) mg(C) 470 Lamivudine (A) + Tablet 150 mg(A) 1 Tablet 22.28 1330(E) 25.03.2021 Zidovudine (B) + 300 mg(B) 471 Lamivudine (A)+ Nevirapine Dispersible Tablet 1 Tablet 5.49 1330(E) 25.03.2021 (B) + Stavudine (C) 30 mg(A) + 50 mg(B) + 6 mg(C) 472 L-Asparaginase Powder for Each Pack 1782.47 1330(E) 25.03.2021 Injection 10000 KU 473 L-Asparaginase Powder for Each Pack 1150.56 1330(E) 25.03.2021 Injection 5000KU 474 Leflunomide Tablet 10 mg 1 Tablet 11.11 1330(E) 25.03.2021 475 Leflunomide Tablet 20 mg 1 Tablet 21.69 1330(E) 25.03.2021[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 45 Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) 476 Letrozole Tablet 2.5 mg 1 Tablet 45.27 1330(E) 25.03.2021 477 Levetiracetam Injection 100 mg/ml 1 ml 24.22 1330(E) 25.03.2021 478 Levetiracetam ER Tablet 750 mg 1 Tablet 19.31 1330(E) 25.03.2021 479 Levetiracetam Tablet 250 mg 1 Tablet 6.49 1330(E) 25.03.2021 480 Levetiracetam Tablet 500 mg 1 Tablet 13.13 1330(E) 25.03.2021 481 Levetiracetam Tablet 750 mg 1 Tablet 20.19 1330(E) 25.03.2021 482 Levetiracetam Oral Liquid 100 1 ml 4.05 1330(E) 25.03.2021 mg/ml 483 Levodopa (A) + Carbidopa CR Tablet 100 1 Tablet 3.70 1330(E) 25.03.2021 (B) mg(A) + 25 mg(B) 484 Levodopa (A) + Carbidopa Tablet 100 mg(A) 1 Tablet 1.73 1330(E) 25.03.2021 (B) + 10 mg(B) 485 Levodopa (A) + Carbidopa Tablet 100 mg(A) 1 Tablet 2.50 1330(E) 25.03.2021 (B) + 25 mg(B) 486 Levodopa (A) + Carbidopa Tablet 250 mg(A) 1 Tablet 4.15 1330(E) 25.03.2021 (B) + 25 mg(B) 487 Levodopa (A) + Carbidopa CR Tablet 200 1 Tablet 4.56 1330(E) 25.03.2021 (B) mg(A) + 50 mg(B) 488 Levofloxacin Tablet 250 mg 1 Tablet 4.90 1330(E) 25.03.2021 489 Levofloxacin Tablet 750 mg 1 Tablet 12.14 1330(E) 25.03.2021 490 Levofloxacin Tablet 500mg 1 Tablet 8.95 1330(E) 25.03.2021 491 Levonorgestrel Tablet 0.75 mg 1 Tablet 25.55 1330(E) 25.03.2021 492 Levothyroxine Tablet 37.50 mcg 1 Tablet 1.31 1725(E) 30.04.2021 493 Levothyroxine Tablet 100 mcg 1 Tablet 1.33 1330(E) 25.03.2021 494 Levothyroxine Tablet 112mcg 1 Tablet 1.60 1330(E) 25.03.2021 495 Levothyroxine Tablet 12.5 mcg 1 Tablet 1.50 1330(E) 25.03.2021 496 Levothyroxine Tablet 125 mcg 1 Tablet 1.71 1330(E) 25.03.2021 497 Levothyroxine Tablet 150 mcg 1 Tablet 1.72 1330(E) 25.03.2021 498 Levothyroxine Tablet 25 mcg 1 Tablet 1.45 1330(E) 25.03.2021 499 Levothyroxine Tablet 50 mcg 1 Tablet 1.10 1330(E) 25.03.2021 500 Levothyroxine Tablet 62.5mcg 1 Tablet 1.56 1330(E) 25.03.2021 501 Levothyroxine Tablet 75 mcg 1 Tablet 1.44 1330(E) 25.03.2021 502 Levothyroxine Tablet 88 mcg 1 Tablet 1.71 1330(E) 25.03.2021 503 Lignocaine Injection 2% 1 ml 1.10 1330(E) 25.03.2021 504 Lignocaine Injection 1 ml 1.09 1330(E) 25.03.202146 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) 2%(Preservative free for IV use) 505 Lignocaine Injection 1% Each Pack 8.82 1330(E) 25.03.2021 506 Lignocaine Topical Forms 2- 1 gm or 1 1.20 1330(E) 25.03.2021 5% ml 507 Lignocaine Injection 5% with 1 ml 4.09 1330(E) 25.03.2021 7.5% Glucose 508 Lignocaine (A) + Adrenaline Injection 1% (A) + 1 ml 0.50 1330(E) 25.03.2021 (B) 1:200000 (5 mcg/ml) (B) 509 Lignocaine (A) + Adrenaline Injection 2% (A) + 1 ml 1.02 1330(E) 25.03.2021 (B) 1:200000 (5mcg/ml) (B) 510 Linezolid Tablet 600 mg 1 Tablet 36.69 1330(E) 25.03.2021 511 Lithium Tablet 300 mg 1 Tablet 1.63 1330(E) 25.03.2021 512 Loperamide Capsule 2 mg 1 Capsule 3.98 1330(E) 25.03.2021 513 Loperamide Tablet 2 mg 1 Tablet 2.19 1330(E) 25.03.2021 514 Lopinavir (A) + Ritonavir Tablet 100 mg(A) 1 Tablet 26.11 1330(E) 25.03.2021 (B) + 25 mg(B) 515 Lopinavir (A) + Ritonavir Tablet 200 mg(A) 1 Tablet 50.59 1330(E) 25.03.2021 (B) + 50 mg(B) 516 Lorazepam injection 2 mg/ml 1 ml 8.63 1330(E) 25.03.2021 517 Lorazepam Tablet 1 mg 1 Tablet 2.29 1330(E) 25.03.2021 518 Lorazepam Tablet 2 mg 1 Tablet 2.79 1330(E) 25.03.2021 519 Magnesium Sulphate Injection 500 mg/ml 1 ml 5.31 1330(E) 25.03.2021 520 Mannitol Injection 10% 1 ml 0.18 1330(E) 25.03.2021 521 Mannitol Injection 20% 1 ml 0.33 1330(E) 25.03.2021 522 Measles Rubbela Vaccine Each Pack 98.16 1330(E) 25.03.2021 (0.5ml) 523 Measles vaccine Vaccine Each Pack 56.61 1330(E) 25.03.2021 (0.5ml) 524 Mebendazole Oral Liquid 100 1 ml 0.85 1330(E) 25.03.2021 mg/5ml 525 Mebendazole Tablet 100 mg 1 Tablet 3.26 1330(E) 25.03.2021 526 Medroxyprogesteroneacetate Tablet 10 mg 1 Tablet 5.98 1330(E) 25.03.2021 527 Mefenamic acid Oral Liquid 100 1 ml 0.58 1330(E) 25.03.2021[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 47 Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) mg/5ml 528 Mefenamic acid Tablet 250 mg 1 Tablet 2.15 1330(E) 25.03.2021 529 Mefenamic acid Tablet 500 mg 1 Tablet 2.72 1330(E) 25.03.2021 530 Mefloquine Tablet 250 mg 1 Tablet 56.60 1330(E) 25.03.2021 531 Meglumine Diatrizoate Injection 60%w/v 1 ml 9.17 1330(E) 25.03.2021 532 Meglumine Diatrizoate Injection 76%w/v 1 ml 10.60 1330(E) 25.03.2021 533 Melphalan Tablet 2 mg 1 Tablet 108.93 1330(E) 25.03.2021 534 Melphalan Tablet 5 mg 1 Tablet 186.83 1330(E) 25.03.2021 535 Mesna Injection 100 mg/ml 1 ml 18.62 1330(E) 25.03.2021 536 Metformin Immediate 1 Tablet 1.67 1330(E) 25.03.2021 Release Tablet 500 mg 537 Metformin Controlled Release 1 Tablet 4.05 1330(E) 25.03.2021 Tablet 1000 mg 538 Metformin Controlled Release 1 Tablet 2.13 1330(E) 25.03.2021 Tablet 500 mg 539 Metformin controlled Released 1 Tablet 2.66 1330(E) 25.03.2021 Tablet 750 mg 540 Metformin Immediate Release 1 Tablet 4.00 1330(E) 25.03.2021 Tablet 1000 mg 541 Metformin Immediate Release 1 Tablet 3.38 1330(E) 25.03.2021 Tablet 750 mg 542 Methotrexate Injection 25 mg/ml 1 ml 53.41 1330(E) 25.03.2021 543 Methotrexate Injection 50 mg/ml 1 ml 44.47 1330(E) 25.03.2021 544 Methotrexate Tablet 10 mg 1 Tablet 13.48 1330(E) 25.03.2021 545 Methotrexate Tablet 2.5 mg 1 Tablet 5.32 1330(E) 25.03.2021 546 Methotrexate Tablet 7.5 mg 1 Tablet 12.86 1330(E) 25.03.2021 547 Methotrexate Tablet 5 mg 1 Tablet 9.29 1330(E) 25.03.2021 548 Methyldopa Tablet 250 mg 1 Tablet 2.71 1330(E) 25.03.2021 549 Methyldopa Tablet 500 mg 1 Tablet 5.21 1330(E) 25.03.2021 550 Methylergometrine Injection 0.2 mg/ml 1 ml 15.85 1330(E) 25.03.2021 551 Methylergometrine Tablet 0.125 mg 1 Tablet 8.79 1330(E) 25.03.2021 552 Methylprednisolone Tablet 16 mg 1 Tablet 9.90 1330(E) 25.03.2021 553 Methylprednisolone Tablet 8 mg 1 Tablet 5.66 1330(E) 25.03.2021 554 Methylprednisolone Injection 40mg/ml 1 ml 59.92 1330(E) 25.03.202148 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) 555 Methylrosanilinium chloride Paint 1% 1 ml 0.09 1330(E) 25.03.2021 (Gentian Violet) 556 Methylthioninium chloride Injection 10mg/ml 1 ML 24.20 4885(E) 26.11.2021 (Methylene blue) 557 Metoclopramide Injection 5 mg/ml 1 ml 1.58 1330(E) 25.03.2021 (10 ml Pack) 558 Metoclopramide Injection 5 mg/ml 1 ml 2.59 1330(E) 25.03.2021 (2 ml Pack) 559 Metoclopramide Oral Liquid 5 1 ml 0.49 1330(E) 25.03.2021 mg/5ml 560 Metoclopramide Tablet 10 mg 1 Tablet 1.30 1330(E) 25.03.2021 561 Metoprolol Capsule 25 mg 1 Capsule 4.70 1330(E) 25.03.2021 562 Metoprolol Capsule 50 mg 1 Capsule 7.16 1330(E) 25.03.2021 563 Metoprolol SR Tablet 25 mg 1 Tablet 4.47 1330(E) 25.03.2021 564 Metoprolol SR Tablet 50 mg 1 Tablet 6.41 1330(E) 25.03.2021 565 Metoprolol Tablet 25 mg 1 Tablet 3.46 1330(E) 25.03.2021 566 Metoprolol Tablet 50 mg 1 Tablet 5.24 1330(E) 25.03.2021 567 Metronidazole Injection 1 ml 0.22 1330(E) 25.03.2021 500mg/100ml 568 Metronidazole Oral Liquid 200 1 ml 0.50 1330(E) 25.03.2021 mg/5ml 569 Metronidazole Tablet 200 mg 1 Tablet 0.76 1330(E) 25.03.2021 570 Metronidazole Tablet 400 mg 1 Tablet 1.42 1330(E) 25.03.2021 571 Midazolam Injection 1 mg/ml 1 ml 6.56 1330(E) 25.03.2021 572 Midazolam Injection 5 mg/ml 1 ml 16.12 1330(E) 25.03.2021 573 Midazolam Tablet 7.5mg 1 Tablet 24.92 1330(E) 25.03.2021 574 Mifepristone Tablet 200 mg 1 Tablet 357.21 1330(E) 25.03.2021 575 Misoprostol Tablet 100 mcg 1 Tablet 9.67 1330(E) 25.03.2021 576 Misoprostol Tablet 200 mcg 1 Tablet 18.54 1330(E) 25.03.2021 577 Morphine Injection 10 mg/ml 1 ml 26.37 1330(E) 25.03.2021 578 Morphine Injection 15 mg/ml 1 ml 32.91 1330(E) 25.03.2021 579 Morphine SR Tablet 30 mg 1 Tablet 6.05 1330(E) 25.03.2021 580 Morphine Tablet 10 mg 1 Tablet 5.91 1330(E) 25.03.2021 581 Moxifloxacin Tablet 400 mg 1 Tablet 28.13 1330(E) 25.03.2021 582 Mycophenolate mofetil Tablet 250 mg 1 Tablet 46.10 1330(E) 25.03.2021 583 Mycophenolate mofetil Tablet 500 mg 1 Tablet 91.19 1330(E) 25.03.2021[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 49 Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) 584 N-acetylcysteine Injection 200 mg/ml 1 ml 24.88 1330(E) 25.03.2021 585 N-acetylcysteine Sachet 200mg 1 gm 9.99 1330(E) 25.03.2021 586 Naloxone injection 0.4 mg/ml 1 ml 96.32 1330(E) 25.03.2021 587 Natamycin Drops 5% 1 ml 25.32 1330(E) 25.03.2021 588 Neostigmine injection 0.5 mg/ml 1 ml 4.83 1330(E) 25.03.2021 589 Neostigmine Tablet 15 mg 1 Tablet 5.18 1330(E) 25.03.2021 590 Nevirapine Oral Liquid 50 1 ml 0.93 1330(E) 25.03.2021 mg/5ml 591 Nevirapine Tablet 200 mg 1 Tablet 15.89 1330(E) 25.03.2021 592 Nifedipine Capsule 10 mg 1 Capsule 0.95 1330(E) 25.03.2021 593 Nifedipine Tablet 10 mg 1 Tablet 1.37 1330(E) 25.03.2021 594 Nitrofurantoin Oral Liquid 25 1 ml 0.91 1330(E) 25.03.2021 mg/5ml 595 Nitrofurantoin Tablet 100 mg 1 Tablet 8.03 1330(E) 25.03.2021 596 Nitrofurantoin Capsule 100mg 1 Capsule 8.72 1330(E) 25.03.2021 597 Nitrous Oxide Inhalation Cubic Meter 259.43 1330(E) 25.03.2021 598 Noradrenaline Injection 2 mg/ml 1 ml 28.61 1330(E) 25.03.2021 599 Norethisterone Tablet 5 mg 1 Tablet 5.67 1330(E) 25.03.2021 600 Omeprazole Capsule 10 mg 1 Capsule 2.35 1330(E) 25.03.2021 601 Omeprazole Capsule 20 mg 1 Capsule 2.77 1330(E) 25.03.2021 602 Omeprazole Capsule 40 mg 1 Capsule 5.48 1330(E) 25.03.2021 603 Omeprazole Powder for oral 1 gm 1.36 1330(E) 25.03.2021 Liquid 20 mg 604 Omeprazole Tablet 10 mg 1 Tablet 4.92 1330(E) 25.03.2021 605 Omeprazole Tablet 20 mg 1 Tablet 5.47 1330(E) 25.03.2021 606 Omeprazole Tablet 40 mg 1 Tablet 9.25 1330(E) 25.03.2021 607 Ondansetron Injection 2 mg/ml 1 ml 6.49 1330(E) 25.03.2021 608 Ondansetron Oral Liquid 2 1 ml 1.26 1330(E) 25.03.2021 mg/5ml 609 Ondansetron Tablet 4 mg 1 Tablet 5.23 1330(E) 25.03.2021 610 Ondansetron Tablet 8 mg 1 Tablet 10.83 1330(E) 25.03.2021 611 Oral poliomyelitis vaccine 1 ml 113.86 1330(E) 25.03.2021 612 Oral Rehydration Salts As Licensed 1 gm 0.99 1330(E) 25.03.2021 613 Oral Rehydration Salts As Licensed 1 ml 0.16 1330(E) 25.03.2021 614 Oxaliplatin Injection 100mg(as Each Pack 4962.10 1330(E) 25.03.202150 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) licensed) 615 Oxaliplatin Injection 50mg(as Each Pack 2885.84 1330(E) 25.03.2021 licensed) 616 Oxytocin Injection 10 IU/ml 1 ml 43.74 1330(E) 25.03.2021 617 Oxytocin Injection 5IU/ml 1 ml 19.59 1330(E) 25.03.2021 618 Paclitaxel Injection 100 1 ml 228.33 1330(E) 25.03.2021 mg/16.7 ml 619 Paclitaxel Injection 30 mg/ 1 ml 228.33 1330(E) 25.03.2021 5ml 620 Pantoprazole Injection 40 mg Each Pack 49.43 1330(E) 25.03.2021 621 Para-aminosalicylic acid Granules (As 1 gm 3.16 1330(E) 25.03.2021 licensed) 622 Paracetamol Oral Liquid 100 1 ml 0.56 1330(E) 25.03.2021 mg/5ml 623 Paracetamol Oral Liquid 120 1 ml 0.59 1330(E) 25.03.2021 mg/5ml 624 Paracetamol Oral Liquid 125 1 ml 0.38 1330(E) 25.03.2021 mg/5ml 625 Paracetamol Oral Liquid 150 1 ml 0.64 1330(E) 25.03.2021 mg/5ml 626 Paracetamol Oral Liquid 250 1 ml 0.66 1330(E) 25.03.2021 mg/5ml 627 Paracetamol Oral Liquid 500 1 ml 0.71 1330(E) 25.03.2021 mg/5ml 628 Paracetamol Oral Liquid 650 1 ml 0.58 1330(E) 25.03.2021 mg/5ml 629 Paracetamol Tablet 500 mg 1 Tablet 1.01 1330(E) 25.03.2021 630 Paracetamol Tablet 650 mg 1 Tablet 2.04 1330(E) 25.03.2021 631 Paracetamol Injection 150 mg/ml Each Pack ( 3.41 1330(E) 25.03.2021 0.5 ml) 632 Paracetamol Injection 150 mg/ml Each Pack 4.66 1330(E) 25.03.2021 (1 ml) 633 Paracetamol Injection 150 mg/ml Each Pack 7.16 1330(E) 25.03.2021 (2 ml) 634 Paracetamol Injection 150 mg/ml Each Pack 9.67 1330(E) 25.03.2021 (3 ml)[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 51 Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) 635 Paracetamol Injection 150 mg/ml Each Pack 12.17 1330(E) 25.03.2021 (4 ml) 636 Paracetamol Injection 150 mg/ml Each Pack 14.68 1330(E) 25.03.2021 (5 ml) 637 Paracetamol Injection 150 mg/ml Each Pack 19.68 1330(E) 25.03.2021 (7 ml) 638 Paracetamol Suppository 170 Each 8.54 1330(E) 25.03.2021 mg Suppository 639 Paracetamol Suppository 80 mg Each 7.22 1330(E) 25.03.2021 Suppository 640 Paracetamol Oral Liquid 100 mg/ml 1 ml 1.79 1330(E) 25.03.2021 (pediatric) 641 Pegylated interferon alfa 2a Injection 180mcg Each Pack 8786.05 1330(E) 25.03.2021 642 Pegylated interferon alfa 2b Injection 100mcg Each Pack 17371.08 1330(E) 25.03.2021 643 Pegylated interferon alfa 2b Injection 120mcg Each Pack 16177.38 1330(E) 25.03.2021 644 Pegylated interferon alfa 2b Injection 80mcg Each Pack 13887.68 1330(E) 25.03.2021 645 Penicillamine Capsule 250 mg 1 Capsule 16.50 1330(E) 25.03.2021 646 Permethrin Cream 1% 1 gm 1.78 1330(E) 25.03.2021 647 Permethrin Cream 5% 1 gm 1.93 1330(E) 25.03.2021 648 Permethrin Gel 5% 1 gm 1.63 1330(E) 25.03.2021 649 Permethrin Lotion 1% 1 gm 1.01 1330(E) 25.03.2021 650 Permethrin Lotion 5% 1 ml 1.09 1330(E) 25.03.2021 651 Pheniramine Injection 22.75 1 ml 2.54 1330(E) 25.03.2021 mg/ml (2ml) 652 Pheniramine Injection 22.75 1 ml 1.89 1330(E) 25.03.2021 mg/ml(10ml) 653 Phenobarbitone Injection 200 mg/ml 1 ml 21.28 1330(E) 25.03.2021 654 Phenobarbitone Tablet 30 mg 1 Tablet 1.36 1330(E) 25.03.2021 655 Phenobarbitone Tablet 60 mg 1 Tablet 1.96 1330(E) 25.03.2021 656 Phenobarbitone Oral liquid 20 mg/5 1 ml 0.49 1330(E) 25.03.2021 ml 657 Phenylephrine Drop 10% 1 ml 8.97 1330(E) 25.03.2021 658 Phenylephrine Drops 5% 1 ml 4.14 1330(E) 25.03.2021 659 Phenytoin Capsule 100 mg 1 Capsule 1.69 1330(E) 25.03.2021 660 Phenytoin Capsule 300 mg 1 Capsule 4.23 1330(E) 25.03.202152 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) 661 Phenytoin ERCapsule 300 mg 1 Capsule 4.23 1330(E) 25.03.2021 662 Phenytoin injection 25 mg/ml 1 ml 2.79 1330(E) 25.03.2021 663 Phenytoin Injection 50 mg/ml 1 ml 5.97 1330(E) 25.03.2021 664 Phenytoin Oral Liquid 125 1 ml 1.00 1330(E) 25.03.2021 mg/5ml 665 Phenytoin Oral Liquid 30 1 ml 0.34 1330(E) 25.03.2021 mg/5ml 666 Phenytoin ER Tablet 300 mg 1 Tablet 6.45 1330(E) 25.03.2021 667 Phenytoin Tablet 100 mg 1 Tablet 1.73 1330(E) 25.03.2021 668 Phenytoin Tablet 300 mg 1 Tablet 5.27 1330(E) 25.03.2021 669 Phenytoin Tablet 50 mg 1 Tablet 0.82 1330(E) 25.03.2021 670 Phytomenadione (Vitamin Injection 10mg/ml 1 ml 53.17 1330(E) 25.03.2021 K1) 671 Phytomenadione (Vitamin Tablet 10mg 1 Tablet 16.13 1330(E) 25.03.2021 K1) 672 Pilocarpine Drops 2% 1 ml 11.22 1330(E) 25.03.2021 673 Pilocarpine Drops 4% 1 ml 12.97 1330(E) 25.03.2021 674 Piperacillin (A) + Powder for Each Pack 98.15 1330(E) 25.03.2021 Tazobactam (B) Injection 1 g (A) + 125 mg(B) 675 Piperacillin (A) + Powder for Each Pack 232.20 1330(E) 25.03.2021 Tazobactam (B) Injection 2 g (A) + 250 mg(B) 676 Piperacillin (A) + Powder for Each Pack 487.76 1330(E) 25.03.2021 Tazobactam (B) Injection 4 g (A) + 500 mg(B) 677 Potassium chloride Injection 150 mg/ml 1 ml 2.69 1330(E) 25.03.2021 678 Potassium chloride Oral Liquid 500 1 ml 0.32 1330(E) 25.03.2021 mg/5ml 679 Potassium permanganate Crystals for topical 1 gm 0.49 1330(E) 25.03.2021 solution 680 Povidone iodine Scrub 7.5% 1 ml 1.78 1428(E) 31.03.2021 681 Povidone iodine Ointment 10% 1 gm 5.78 1330(E) 25.03.2021 682 Povidone iodine Solution 4% 1 ml 1.93 1330(E) 25.03.2021 683 Povidone Iodine Solution 7.5% 1 ml 0.85 1330(E) 25.03.2021 684 Povidone Iodine Solution 10% 1 ml 1.03 1330(E) 25.03.2021[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 53 Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) 685 Povidone Iodine Solution 5% 1 ml 0.43 1330(E) 25.03.2021 686 Pralidoxime chloride (2- Injection 25 mg/ml 1 ml 4.14 1330(E) 25.03.2021 PAM) 687 Praziquantel Tablet 600 mg 1 tablet 38.57 1330(E) 25.03.2021 688 Prednisolone Drops 1% 1 ml 5.58 1330(E) 25.03.2021 689 Prednisolone Injection 20 mg/2ml 1 ml 3.98 1330(E) 25.03.2021 690 Prednisolone Oral Liquid 15 mg/ 1 ml 0.83 1330(E) 25.03.2021 5ml 691 Prednisolone Oral Liquid 5 mg/ 1 ml 0.48 1330(E) 25.03.2021 5ml 692 Prednisolone Tablet 10 mg 1 Tablet 1.09 1330(E) 25.03.2021 693 Prednisolone Tablet 20 mg 1 Tablet 2.17 1330(E) 25.03.2021 694 Prednisolone Tablet 40 mg 1 Tablet 3.12 1330(E) 25.03.2021 695 Prednisolone Tablet 5 mg 1 Tablet 0.62 1330(E) 25.03.2021 696 Premix Insulin 30:70 Injection 40 IU /ml 1 ml 16.71 1330(E) 25.03.2021 Injection (Regular:NPH) 697 Prilocaine (A) + Lignocaine Cream 2.5% (A) + 1 gm 22.71 1330(E) 25.03.2021 (B) 2.5% (B ) 698 Primaquine Tablet 15 mg 1 Tablet 5.07 1330(E) 25.03.2021 699 Primaquine Tablet 2.5 mg 1 Tablet 1.73 1330(E) 25.03.2021 700 Primaquine Tablet 7.5 mg 1 Tablet 2.35 1330(E) 25.03.2021 701 Procarbazine Capsule 50 mg 1 Capsule 38.38 1330(E) 25.03.2021 702 Procarbazine Tablet 50 mg 1 Tablet 52.30 1330(E) 25.03.2021 703 Proparacaine Drops 0.5% 1 ml 11.07 1330(E) 25.03.2021 704 Propofol Injection 10 mg/ml 1 ml 8.02 1330(E) 25.03.2021 705 Propranolol Capsule 40 mg 1 Capsule 4.22 1330(E) 25.03.2021 706 Propranolol Capsule 80 mg 1 Capsule 6.41 1330(E) 25.03.2021 707 Propranolol Tablet 10 mg 1 Tablet 1.30 1330(E) 25.03.2021 708 Propranolol Tablet 40 mg 1 Tablet 3.06 1330(E) 25.03.2021 709 Propranolol Tablet 80 mg 1 Tablet 5.55 1330(E) 25.03.2021 710 Protamine Injection 10 mg/ml 1 ml 10.27 1330(E) 25.03.2021 711 Pyrazinamide Oral Liquid 250 1 ml 0.68 1330(E) 25.03.2021 mg/5ml 712 Pyrazinamide Tablet 1000 mg 1 Tablet 10.47 1330(E) 25.03.2021 713 Pyrazinamide Tablet 1500 mg 1 Tablet 11.60 1330(E) 25.03.202154 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) 714 Pyrazinamide Tablet 500 mg 1 Tablet 4.70 1330(E) 25.03.2021 715 Pyrazinamide Tablet 750 mg 1 Tablet 7.14 1330(E) 25.03.2021 716 Pyridoxine Tablet 100 mg 1 Tablet 6.20 1330(E) 25.03.2021 717 Pyridoxine Tablet 10mg 1 Tablet 0.12 1330(E) 25.03.2021 718 Quinine Injection 300 mg/ml 1 ml 11.29 1330(E) 25.03.2021 719 Quinine Tablet 300 mg 1 Tablet 6.36 1330(E) 25.03.2021 720 Rabies Vaccine Each Pack 379.43 1330(E) 25.03.2021 721 Raltegravir Tablet 400 mg 1 Tablet 173.77 1330(E) 25.03.2021 722 Ramipril Capsule 2.5 mg 1 Capsule 5.26 1330(E) 25.03.2021 723 Ramipril Capsule 5 mg 1 Capsule 8.21 1330(E) 25.03.2021 724 Ramipril Tablet 2.5 mg 1 Tablet 5.53 1330(E) 25.03.2021 725 Ramipril Tablet 5 mg 1 Tablet 8.70 1330(E) 25.03.2021 726 Ranitidine Oral Liquid 75 1 ml 1.20 2654(E) 01.07.2021 mg/5ml 727 Ranitidine Tablet 150 mg 1 Tablet 1.22 2654(E) 01.07.2021 728 Ranitidine Injection 25mg/ml 1 ml 2.69 2654(E) 01.07.2021 729 Ribavirin Capsule 200 mg 1 Capsule 92.88 1330(E) 25.03.2021 730 Rifabutin Capsule 150mg 1 Capsule 44.04 1330(E) 25.03.2021 731 Rifabutin Tablet 150mg 1 Tablet 41.13 1330(E) 25.03.2021 732 Rifampicin Capsule 150 mg 1 Capsule 2.23 1330(E) 25.03.2021 733 Rifampicin Capsule 300 mg 1 Capsule 4.22 1330(E) 25.03.2021 734 Rifampicin Capsule 450 mg 1 Capsule 5.48 1330(E) 25.03.2021 735 Rifampicin Capsule 600 mg 1 Capsule 12.87 1330(E) 25.03.2021 736 Rifampicin Oral Liquid 100 1 ml 0.43 1330(E) 25.03.2021 mg/5ml 737 Rifampicin Tablet 150 mg 1 Tablet 1.79 1330(E) 25.03.2021 738 Rifampicin Tablet 300 mg 1 Tablet 3.26 1330(E) 25.03.2021 739 Ringer Lactate Injection 1000ml Each Pack 88.57 1330(E) 25.03.2021 740 Ringer Lactate Injection 100ml Each Pack 23.19 1330(E) 25.03.2021 741 Ringer Lactate Injection 250ml Each Pack 39.54 1330(E) 25.03.2021 742 Ringer Lactate Injection 500ml Each Pack 50.39 1330(E) 25.03.2021 743 Risperidone Oral Liquid 1 1 ml 2.15 1330(E) 25.03.2021 mg/ml 744 Risperidone Tablet 1 mg 1 Tablet 3.42 1330(E) 25.03.2021 745 Risperidone Tablet 2 mg 1 Tablet 5.47 1330(E) 25.03.2021[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 55 Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) 746 Risperidone Tablet 4 mg 1 Tablet 11.10 1330(E) 25.03.2021 747 Ritonavir Capsule 100 mg 1 Capsule 31.34 1330(E) 25.03.2021 748 Ritonavir Tablet 100 mg 1 Tablet 32.23 1330(E) 25.03.2021 749 Rituximab Injection 10 mg/ml 1 ml 842.18 1330(E) 25.03.2021 750 Salbutamol Capsule 4 mg 1 Capsule 0.66 1330(E) 25.03.2021 751 Salbutamol Inhalation 1 Dose 0.44 1330(E) 25.03.2021 (MDI/DPI) 100 mcg/dose 752 Salbutamol Oral Liquid 2 1 ml 0.17 1330(E) 25.03.2021 mg/5ml 753 Salbutamol Respirator solution 1 ml 0.78 1330(E) 25.03.2021 for use in Nebulizer 5 mg/ml 754 Salbutamol Tablet 2 mg 1 Tablet 0.18 1330(E) 25.03.2021 755 Salbutamol Tablet 4 mg 1 Tablet 0.20 1330(E) 25.03.2021 756 Salicylic acid Ointment 6% 1 gm 1.99 1330(E) 25.03.2021 757 Sevoflurane Inhalation 1 ml 33.21 1330(E) 25.03.2021 758 Silver Sulphadiazine Cream 1% 1 gm 0.56 1330(E) 25.03.2021 759 Snake venom antiserum- Powder for 10 ml Pack 618.71 1330(E) 25.03.2021 Lyophilized polyvalent Injection 760 Snake Venom Antiserum- Injection Each Pack 480.46 1330(E) 25.03.2021 Soluble/ Liquid Polyvalent (10 ML) 761 Sodium Bicarbonate Injection 7.5% 1 ml 1.56 1330(E) 25.03.2021 762 Sodium Bicarbonate Injection 8.4% 1 ml 1.43 1330(E) 25.03.2021 763 Sodium Chloride Injection 0.9% 1000ml 65.89 1330(E) 25.03.2021 Glass 764 Sodium Chloride Injection 0.9% 1000ml Non- 51.97 1330(E) 25.03.2021 Glass 765 Sodium Chloride Injection 0.9% 100ml Glass 19.48 1330(E) 25.03.2021 766 Sodium Chloride Injection 0.9% 100ml Non- 17.55 1330(E) 25.03.2021 Glass 767 Sodium Chloride Injection 0.9% 250ml Glass 26.28 1330(E) 25.03.2021 768 Sodium Chloride Injection 0.9% 250ml Non- 23.59 1330(E) 25.03.2021 Glass 769 Sodium Chloride Injection 0.9% 500ml Glass 36.54 1330(E) 25.03.2021 770 Sodium Chloride Injection 0.9% 500ml Non- 31.10 1330(E) 25.03.202156 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) Glass 771 Sodium nitrite Injection 30 mg/ml 1 ml 28.85 1330(E) 25.03.2021 772 Sodium Nitroprusside Injection 10 mg/ml 1 ml 28.67 1330(E) 25.03.2021 773 Sodium Valproate Injection 100 mg/ml 1 ml 6.40 1330(E) 25.03.2021 774 Sodium Valproate Oral Liquid 200 1 ml 0.64 1330(E) 25.03.2021 mg/5ml 775 Sodium Valproate CR Tablets 300mg 1 Tablet 6.99 1330(E) 25.03.2021 776 Sodium Valproate CR Tablets 500mg 1 Tablet 10.82 1330(E) 25.03.2021 777 Sodium Valproate Tablet 200 mg 1 Tablet 3.44 1330(E) 25.03.2021 778 Sodium Valproate Tablet 300 mg 1 Tablet 4.41 1330(E) 25.03.2021 779 Sodium Valproate Tablet 500 mg 1 Tablet 7.71 1330(E) 25.03.2021 780 Sofosbuvir Tablet 400 mg 1 Tablet 741.12 1330(E) 25.03.2021 781 Somatostatin Powder for Each pack 1759.69 1330(E) 25.03.2021 Injection 3 mg 782 Spironolactone Tablet 25 mg 1 Tablet 2.13 1330(E) 25.03.2021 783 Spironolactone Tablet 50 mg 1 Tablet 4.22 1330(E) 25.03.2021 784 Stavudine (A) + Lamivudine Tablet 30 mg(A) 1 Tablet 10.60 1330(E) 25.03.2021 (B) +150 mg(B) 785 Streptokinase Injection 15,00,000 Each Pack 1987.53 1330(E) 25.03.2021 IU 786 Streptokinase Injection 7,50,000 Each Pack 1397.88 1330(E) 25.03.2021 IU 787 Streptomycin Powder for Each Pack 9.75 1330(E) 25.03.2021 Injection 750 mg 788 Streptomycin Powder for Each Pack 11.59 1330(E) 25.03.2021 Injection 1 gm 789 Succinyl Choline Injection 50 mg/ml 1 ml 5.37 1330(E) 25.03.2021 790 Sucralfate Oral Liquid 1 g 1 ml 0.78 1330(E) 25.03.2021 791 Sulfasalazine Tablet 500 mg 1 Tablet 4.42 1330(E) 25.03.2021 792 Sumatriptan Tablet 25mg 1 Tablet 36.96 1330(E) 25.03.2021 793 Sumatriptan Tablet 50mg 1 Tablet 57.22 1330(E) 25.03.2021 794 Surfactant Suspension for Per mg of 74.27 1330(E) 25.03.2021 intratracheal Phospholipids instillation (As in the pack liensed) 795 Tacrolimus Capsule 0.5 mg 1 Capsule 24.56 1330(E) 25.03.2021[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 57 Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) 796 Tacrolimus Capsule 1 mg 1 Capsule 43.38 1330(E) 25.03.2021 797 Tacrolimus Capsule 2 mg 1 Capsule 84.97 1330(E) 25.03.2021 798 Tacrolimus Tablet 0.5 mg 1 Tablet 20.80 1330(E) 25.03.2021 799 Tacrolimus Tablet 1 mg 1 Tablet 38.20 1330(E) 25.03.2021 800 Tacrolimus Tablet 2 mg 1 Tablet 75.46 1330(E) 25.03.2021 801 Tamoxifen Tablet 10 mg 1 Tablet 2.86 1330(E) 25.03.2021 802 Tamoxifen Tablet 20 mg 1 Tablet 3.23 1330(E) 25.03.2021 803 TD Vaccine Each dose of Each 0.5ml 20.81 1330(E) 25.03.2021 0.5ml contains: Pack Diphtheria Toxoid ≤5Lf (≥ 2IU) Tetanus Toxoid ≥ 5Lf (≥ 40IU) 804 Each dose of Each 5ml 195.54 1330(E) 25.03.2021 0.5ml contains: Pack Diphtheria Toxoid ≤5Lf (≥ 2IU) Tetanus Toxoid ≥ TD Vaccine 5Lf (≥ 40IU) 805 Each dose of Each 0.5ml 17.84 1330(E) 25.03.2021 0.5ml contains: Pack Diphtheria Toxoid ≤25Lf (≥ 30IU) Tetanus Toxoid ≥ TD Vaccine 5Lf (≥ 40IU) 806 Telmisartan Tablet 20 mg 1 Tablet 4.05 1330(E) 25.03.2021 807 Telmisartan Tablet 40 mg 1 Tablet 7.32 1330(E) 25.03.2021 808 Telmisartan Tablet 80 mg 1 Tablet 11.15 1330(E) 25.03.2021 809 Temozolomide Capsule 100 mg 1 Capsule 2313.54 1330(E) 25.03.2021 810 Temozolomide Capsule 20 mg 1 Capsule 662.24 1330(E) 25.03.2021 811 Temozolomide Capsule 250 mg 1 Capsule 5203.58 1330(E) 25.03.2021 812 Temozolomide Tablet 100 mg 1 Tablet 1717.31 1330(E) 25.03.2021 813 Temozolomide Tablet 20 mg 1 Tablet 416.06 1330(E) 25.03.2021 814 Temozolomide Tablet 250 mg 1 Tablet 4250.50 1330(E) 25.03.2021 815 Tenofovir Tablet 300 mg 1 Tablet 52.39 1330(E) 25.03.2021 816 Tenofovir (A) + Lamivudine Tablet 300 mg(A) 1 Tablet 49.84 1330(E) 25.03.202158 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) (B) + 300 mg(B) 817 Tenofovir (A) + Lamivudine Tablet 300 mg(A) 1 Tablet 114.44 1330(E) 25.03.2021 (B) + Efavirenz (C) + 300 mg(B) + 600 mg(C) 818 Tetanus Toxoid Injection Each Pack 12.04 1330(E) 25.03.2021 (0.5ml) 819 Tetanus Toxoid Injection Each Pack 26.03 1330(E) 25.03.2021 (5 ml) 820 Thalidomide Capsule 100 mg 1 Capsule 67.84 1330(E) 25.03.2021 821 Thalidomide Capsule 50 mg 1 Capsule 39.19 1330(E) 25.03.2021 822 Thiamine Injection 100 mg/ml 1 ml 27.54 1330(E) 25.03.2021 823 Thiamine Tablet 100 mg 1 Tablet 4.16 1330(E) 25.03.2021 824 Thiopentone Powder for Each Pack 45.23 1330(E) 25.03.2021 Injection 0.5 gm 825 Thiopentone Powder for Each Pack 54.87 1330(E) 25.03.2021 Injection 1 gm 826 Timolol Drops 0.25% 1 ml 5.74 1330(E) 25.03.2021 827 Timolol Drops 0.5% 1 ml 13.24 1330(E) 25.03.2021 828 Tiotropium Inhalation (MDI) 9 Per Metered 2.67 1330(E) 25.03.2021 mcg/dose Dose 829 Tiotropium Inhalation (DPI) 18 Per Dose 10.31 1330(E) 25.03.2021 mcg/dose 830 Tramadol Capsule 50 mg 1 Capsule 5.01 1330(E) 25.03.2021 831 Tramadol Injection 50 mg/ml 1 ml 1.38 1330(E) 25.03.2021 (20 ml Pack) 832 Tramadol Injection 50 mg/ml 1 ml 11.63 1330(E) 25.03.2021 (upto 2 ml Pack) 833 Tramadol Tablet 100 mg 1 Tablet 21.84 1330(E) 25.03.2021 834 Tramadol Tablet 50 mg 1 Tablet 8.95 1330(E) 25.03.2021 835 Tramadol Capsule 100 mg 1 Capsule 10.66 1330(E) 25.03.2021 836 Tranexamic acid Injection 100 mg/ml 1 ml 16.59 1330(E) 25.03.2021 837 Tranexamic acid Tablet 500 mg 1 Tablet 19.28 1330(E) 25.03.2021 838 Trastuzumab Injection 440 mg/50 Each Pack 66790.46 1330(E) 25.03.2021 ml 839 Trihexyphenidyl Tablet 2 mg 1 Tablet 1.35 1330(E) 25.03.2021 840 Tropicamide Eye Drop 1% 1 ml 11.17 1330(E) 25.03.2021[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 59 Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) 841 Vancomycin Powder for Each Pack 528.43 1330(E) 25.03.2021 Injection 1 gm 842 Vancomycin Powder for Each Pack 246.21 1330(E) 25.03.2021 Injection 250 mg 843 Vancomycin Powder for Each Pack 317.83 1330(E) 25.03.2021 Injection 500 mg 844 Vecuronium Powder for Each Pack 209.93 1330(E) 25.03.2021 Injection 10 mg 845 Vecuronium Powder for Each Pack 101.32 1330(E) 25.03.2021 Injection 4 mg 846 Verapamil Injection 2.5 1 ml 1.30 1330(E) 25.03.2021 mg/ml 847 Verapamil Tablet 40 mg 1 Tablet 0.82 1330(E) 25.03.2021 848 Verapamil Tablet 80 mg 1 Tablet 1.55 1330(E) 25.03.2021 849 Vinblastine Injection 1mg/ml 1 ml 22.78 1330(E) 25.03.2021 850 Vincristine Injection 1 mg/ml 1 ml 57.86 1330(E) 25.03.2021 851 Vitamin A Capsule 50000 IU 1 Capsule 0.61 1330(E) 25.03.2021 852 Vitamin A Injection 50000 1 ml 2.13 1330(E) 25.03.2021 IU/ml 853 Vitamin A Tablet 50000 IU 1 Tablet 0.78 1330(E) 25.03.2021 854 Warfarin Tablet 1 mg 1 Tablet 2.68 1330(E) 25.03.2021 855 Warfarin Tablet 2 mg 1 Tablet 2.96 1330(E) 25.03.2021 856 Warfarin Tablet 3 mg 1 Tablet 3.47 1330(E) 25.03.2021 857 Warfarin Tablet 5 mg 1 Tablet 2.61 1330(E) 25.03.2021 858 Water for Injection Injection Each Pack 2.58 1330(E) 25.03.2021 (10 ml) 859 Water for Injection Injection Each Pack 2.49 1330(E) 25.03.2021 (5 ml) Water for Injection Injection 860 Per 500 ml 51.19 5425(E) 28.12.2021 Pack Water for Injection Injection 861 Per 1000 ml 89.84 5425(E) 28.12.2021 Pack 862 White Petrolatum Jelly 100% 1 gm 0.10 1330(E) 25.03.2021 863 Xylometazoline Nasal Drops 0.05% 1 ml 4.36 1330(E) 25.03.2021 864 Xylometazoline Nasal Drops 0.1% 1 ml 5.78 1330(E) 25.03.2021 865 Zidovudine Capsule 300 mg 1 Capsule 2.29 1330(E) 25.03.202160 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] Sl. Medicines Dosage form and Unit Ceiling Existing S.O. No. & No. Strength price (wef Date 1.4.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) 866 Zidovudine Tablet 300 mg 1 Tablet 15.83 1330(E) 25.03.2021 867 Zidovudine (A) + Tablet 300 mg(A) 1 Tablet 22.37 1330(E) 25.03.2021 Lamivudine (B) + + 150 mg(B) + 200 Nevirapine (C) mg(C) 868 Zinc sulphate Dispersible Tablet 1 Tablet 3.49 1330(E) 25.03.2021 20mg 869 Zoledronic Acid Powder for Each Pack 4664.74 1330(E) 25.03.2021 Injection 4 mg 870 Zolpidem Capsule 5 mg 1 Capsule 8.16 1330(E) 25.03.2021 871 Zolpidem Tablet 10 mg 1 Tablet 9.38 1330(E) 25.03.2021 872 Zolpidem Tablet 5 mg 1 Tablet 5.98 1330(E) 25.03.2021 Notes: (a) The ceiling prices are applicable with effect from 01.04.2022 (ceiling prices are inclusive of Wholesale Price Index (WPI) @10.76607% for the year 2021 over 2020). (b) In respect of formulation where pack wise ceiling price is notified, for any other pack size manufactured, the manufacturer shall approach NPPA under para 11(3) of DPCO, 2013 for specific price approval for its formulations. The formulation of Sodium Valproate includes combination of Sodium Valproate and Valproic Acid both together corresponding to Sodium Valproate of the stated strength. (c) In respect of any other scheduled formulation, for which ceiling price is not mentioned above, the manufacturer shall approach NPPA for specific price approval for its formulations. (d) All manufacturers of scheduled formulations, selling branded or generic or both the versions of scheduled formulations at price higher than the ceiling price (plus Goods and Services Taxes as applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above table plus Goods and Services Taxes as applicable, if any. (e) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table (plus Goods and Services Taxes as applicable, if any), may revise the existing MRP of their formulations, on the basis of WPI @ 10.76607% for year 2021 over 2020 in accordance with paragraph 16(2) of DPCO, 2013, read with para 13(2) of DPCO, 2013.[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 61 (f) The manufacturers may add Goods and Services Taxes only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above said table. (g) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers. (h) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (i) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (j) The manufacturers of above said scheduled formulations shall furnish quarterly return to NPPA, in respect of production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to NPPA, in respect of discontinuation of production and / or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of discontinuation. (k) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955. (l) Consequent to the issue of ceiling prices of such formulations as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded. (m) The ceiling price of Heparin Injection 1000IU/ml specified in col. (5) of Sl. No. 403 of the Table above and the ceiling price of Heparin Injection 5000IU/ml specified in col. (5) of Sl. No. 404 of the Table above would not be applicable till the time, the price fixed vide SO. 2151(E) dated 30.06.2020 is in force. [P.N./228/96/2022/F/F. No. 8(96)/2022/D.P./NPPA-Div.-II] PRASENJIT DAS, Dy. Director62 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ubZ fnYyh] 30 ] 2022 ¼v½ Hkkjr ljdkj ds jlk;u vkSj moZjd e=a ky; }kjk tkjh dk-vk- 1394¼v½ rkjh[k 30 ebZ] 2013 .— vkSj dk-vk- 1192¼v½ rkjh[k 22 ekpZ] 2016 ds lkFk ifBr vkS"k/k ¼dher fu;a=.k½ vkn's k] 2013 ds iSjk 11 ds mi&iSjk ¼3½ vkSj ¼4½ vkSj iSjk 14 }kjk iznRr 'kfDr;ks a dk iz;ksx djrs gq, rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd e=a ky;] ¼jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k½ ds 'kqf)&i= vkns'k dk-vk- 1332¼v½ fnukad 25 ekpZ] 2021, dk-vk- 1726¼v½ fnukad 30.04.2021 vkSj dk-vk- 3163¼v½ fnukad 06.08.2021 vkns'k ds vf/kØe.k es a tgk¡ rd mldk lEcU/k uhps dh lkj.kh ^d* eas fofufeZr iSdks a ds fo'ks"k fo'ks”krkvks a lfgr xSj&dk¡p ds :i eas [dk-vk- 1993¼v½ fnukad 3 twu] 2016 esa xSj&ihohlh ds #i eas ;Fkk&of.kZr]] l'akks/ku fd;k] uhp s nh xbZ lkj.kh [k eas fofufnZ"V fuekZrk ds fo'ks”k mRikn ,oa iSsd vkdkj] mu ckrks a ds flok; vf/kØkUr djr s gq, ftUgs a ,sl s vf/kØe.k ds iwoZ fd;k x;k gS ;k djus dk yksi fd;k x;k gS] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] ,rn~}kjk] Fkksd eYw ; lwpdkad ¼MCY;wihvkbZ½] 2021 ij vk/kkfjr la”kks/ku djrk gS] tSlk fd uhp s dh lkj.kh ^d* ds LraHk ¼5½ eas fofufnZ"V gS] vf/kdre dher dk s mDr lkj.kh ds LraHk ¼3½ vkSj ¼4½ eas dh xbZ Øe'k% rRLFkkuh izfof"V;ks a eas fofufnZ"V [kqjkd :i ,oa izcyrk vkSj bdkbZ ¼;wfuV½@iSdsftax lfgr ml lkj.kh ds LraHk ¼2½ eas dh xbZ rRLFkkuh izfof"V es a fofufnZ"V vuqlwfpr fofufeZfr;ks a eas ls izR;sd dh oLrq ,oa lsok dj] ;fn dksbZ gS] dk s NksM+dj vf/kdre dher ds #i es a fu;r djrh gSA @ 10.76607% @ 10.76607% (1) (2) (3) (4) (5) 1 Xywdkst batsD”ku 5% 1000 fefy xSj&dk¡p fo'ks"k fo'ks’krkvks a lfgr 84.82 2 Xywdkst batsD”ku 5% 500 fefy xSj&dk¡p fo'ks"k fo'ks’krkvks a lfgr 73.38 3 Xywdkst ¼,½$lksfM;e DyksjkbM batsD”ku 5% ¼,½$0-9% 1000 fefy xSj&dk¡p fo'ks"k ¼ch½ fo'ks’krkvks a lfgr ¼ch½ 89.13 4 Xywdkst ¼,½$lksfM;e DyksjkbM batsD”ku 5% ¼,½$ 0-9% 500 fefy xSj&dk¡p fo'ks"k ¼ch½ fo'ks’krkvks a lfgr ¼ch½ 76.27 5 lksfM;e DyksjkbM batsD”ku 0-9% 100 fefy xSj&dk¡p fo'ks"k fo'ks’krkvks a lfgr 37.51 6 lksfM;e DyksjkbM batsD”ku 0-9% 250 fefy xSj&dk¡p fo'ks"k fo'ks”krkvks a lfgr 55.39 7 lksfM;e DyksjkbM batsD”ku 0-9% 500 fefy xSj&dk¡p fo'ks"k fo'ks’krkvks a lfgr 78.43 8 lksfM;e DyksjkbM batsD”ku 0-9% 1000 fefy xSj&dk¡p fo'ks"k fo'ks’krkvks a lfgr 87.85[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 63 मसै सच अक्सा पैरेंटल्स जलजमटेड यूरोहडे के साथ स्ट्टेरी जड्रप बोतल मसै सच श्री कृष्णा केिव लेबोरेटरीज जलजमटेड यूरोहडे के साथ ईजीपोटच बोतल मसै सच रुसोमा लेबोरेटरीज प्रा०जलजमटेड प् यूराड्रीप मसै सच आर. के. लेबोरेटरीज प्रा०जलजमटेड यूरोहडे बाटल मसै सच यूरोलाइफ हल्े थकेयर प्रा०जलजमटेड लाइफ पोटच मसै सच टरयलकेड लाईफसाइंस प्रा०जलजमटेड यूरोहडे बाटल मसै सच पुजनस्ट्का हल्े थकेयर प्रा०जलजमटेड (नीचे नोन पीवीसी बेग मसै स चअबैटरस हल्े थकेयर प्रा० जलजमटेड डुओ पोटच मसै स चजहग्स हल्े थकेयर (नीचे एक्वा जड्रप मसै सच रूसोमा लेबोरेटरीज प्रा०जलजमटेड यूरोहडे बोटल ब्ांड नाम ड्यूजड्रप के साथ 10.76607% के 5, 6, 7 और 8 मे दिाचई गई कीमते केवल मसै स च पुजनस्ट्का हल्े थकेयर प्रा०जलजमटेड ( के 19) पर लागू होंगी के 1, 2, 3, 4, 5, 7 और 8 मे दिाचई गई कीमते केवल मसै स चजहग्स हल्े थकेयर ( के 21) पर लाग ूहोंगी (5) 10.76607% (5) i ii iii V (4)64 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] u II I II III II IV ड [ II] ORDER New Delhi, the 30th March, 2022 S.O. 1500(E).—In exercise of powers, conferred by sub paragraph (3) and (4) of paragraph 11 and paragraph 14 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013, S.O. 1192(E) dated 22nd March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) No. S.O. 1332(E) dated 25.03.2021, S.O. 1726(E) dated 30.04.2021 and S.O. 3163(E) dated 06.08.2021, in so far as they relate to formulation packs of Non- Glass with special features (mentioned as Non-PVC in S.O. 1993(E) dated 3rd June 2016) mentioned in the Table A herein below, manufactured by the manufacturers specified in Table B for specified products and pack-sizes, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby revises the price based on Wholesale price index(WPI) of 2021 as specified in column (5) of the Table A herein below as separate ceiling price exclusive of Goods and Services Tax applicable, if any, in respect of the scheduled formulations specified in the corresponding entry in column (2) of the said Table with the dosage form and strength and unit/packaging specified respectively in the corresponding entries in columns (3) and (4) thereof: TABLE A Price Revision as per Annual Wholesale Price Index (WPI) @ 10.76607% increase. Sl. No. Medicines Dosage form and Unit Ceiling price (wef Strength 01.04.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 1 Glucose Injection 5% 1000ml Non Glass with special features 84.82 2 Glucose Injection 5% 500ml Non Glass with special features 73.38 3 Glucose (A) + Sodium Injection 5% (A) + 1000ml Non Glass with Chloride (B) 0.9% (B) special features 89.13 4 Glucose (A) + Sodium Injection 5% (A) + 500ml Non Glass with Chloride (B) 0.9% (B) special features 76.27 5 Sodium Chloride Injection 0.9% 100ml Non Glass with special features 37.51 6 Sodium Chloride Injection 0.9% 250ml Non Glass with special features 55.39[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 65 7 Sodium Chloride Injection 0.9% 500ml Non Glass with special features 78.43 8 Sodium Chloride Injection 0.9% 1000ml Non Glass with special features 87.85 TABLE ‘B’ Sl. No. Name of Manufacturer Product /Brand Name (1) (2) (3) 1 M/s B.Braun Medical (I) Pvt Ltd. Ecoflac Plus bottle with Eurohead 2 M/s Amanta Healthcare Ltd. Steriport bottle 3 M/s Aculife Healthcare Pvt Ltd. Aculife bottle with Eurohead 4 M/s Albert David Limited Albert David bottle with Eurohead 5 M/s Denis Chem Limited Aquapulse with Eurohead 6 M/s Claris Life Sciences Limited Claris bottle with Eurohead 7 M/s Fresenius Kabi India Pvt Limited Freeflex bags 8 M/s Otsuka Pharmaceutical India Private Ltd. Unibag (previously known as Claris Otsuka Private Limited) 9 M/s Aishwarya Lifesciences Lifusion Eurohead bottle 10 M/s Baxter (India) Pvt. Ltd. Viaflex bags 11 M/s Otsuka Pharmaceutical India Private Ltd. Eurohead bottle (previously known as Claris Otsuka Private Limited) 12 M/s Fresenius Kabi India Pvt Limited Eurohead bottle 13 M/s Axa Parenterals Ltd Steri Drip bottle with Eurohead 14 M/s Shree Krishna Keshav Laboratories Ltd Easyport bottle with Eurohead 15 M/s Rusoma Laboratories Pvt. Ltd. Puradrip 16 M/s R. K. Laboratories Pvt. Ltd. Eurohead bottle 17 M/s Eurolife Healthcare Pvt. Ltd. Life port 18 M/s Realcade Lifescience Pvt. Ltd. Euro head bottle 19 M/s Puniska Healthcare Pvt. Ltd [Note (b) Non –PVC bag below] 20 M/s Abaris Healthcare Pvt. Ltd Duo Port 21 M/s Higgs Healthcare [Note (c) below] Aqua Drip 22 M/s Rusoma Laboratories Pvt. Ltd. Eurohead Bottles with Brand name “Dewdrip” Note : (a) The ceiling prices are applicable with effect from 01.04.2022 (ceiling prices are inclusive of Wholesale Price Index (WPI) @10.76607 % for the year 2021 over 2020). (b) In case of M/s Puniska Healthcare Pvt. Ltd. mentioned in Sl. No. 19 of Table B, only the prices of the formulations specified in Sl. No. 5, 6, 7 & 8 of Table A are applicable. (c) In case of M/s Higgs Healthcare mentioned in Sl. No. 21 of Table B, only the prices of the formulations specified in Sl. No. 1, 2, 3, 4, 5, 7 & 8 of Table A are applicable. (d) The manufacturers of scheduled formulations, selling abovesaid products/brandname of scheduled formulations at price higher than the ceiling price (plus goods and services tax as applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any.66 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] (e) The manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table (plus goods and services tax as applicable, if any), may revise the existing M.R.P. of their formulations, on the basis of WPI @ 10.76607% for year 2021 over 2020 in accordance with paragraph 16(2) of DPCO, 2013, read with para 13(2) of DPCO, 2013. (f) The manufacturers may add goods and services tax only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above said table. (g) Any other manufacturer claiming separate ceiling price for Non-Glass with special feature shall apply to NPPA for separate ceiling price approval with details and demonstrate, that such pack has all of the features as (i) self collapsibility and self-sealability (ii) not having air-vent and (iii) there is no chance of contamination during manufacture/ infusion/ admixing levels alongwith documentation and demonstration. (h) For other special features claimed or any other pack size manufactured, the manufacturer shall approach the NPPA for specific price approval for its formulation. (i) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers. (j) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (k) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (l) The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and / or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of discontinuation. (m) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955. (n) Consequent to the issue of ceiling prices of such formulations as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded. [P.N./228/96/2022/F/F. No. 8(96)/2022/D.P./NPPA-Div.-II] PRASENJIT DAS, Dy. Director ubZ fnYyh] 30 ] 2022 .—Hkkjr ljdkj ds jlk;u vkSj moZjd e=a ky; }kjk tkjh dk-vk- 1394¼v½ rkjh[k 30 ebZ] 2013 vkSj dk-vk- 1192¼v½ rkjh[k 22 ekpZ] 2016 ds lkFk ifBr vkS"k/k ¼dher fu;a=.k½ vkn's k] 2013 ds iSjk 11 ds mi& iSjk ¼3½ vkSj ¼4½ vkSj iSjk 14 }kjk iznRr 'kfDr;ks a dk iz;ksx djr s gq, rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd e=a ky;] ¼jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k½ ds vkns'k dk- vk- 1333¼v½ fnukad 25 ekpZ] 2021, dk- vk- 1727¼v½ fnukad 30.04.2021 vkSj dk-vk- 3164¼v½ fnukad 06.08.2021, vkn's k ds vf/kØe.k es a tgk¡ rd, जिसमें अब तक यह पैक में ररिंगर लैक्टेट[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 67 इिंिेक्शन से सिंबिंजित है, जिसमें जिशेष सुजििाएँ हैं िैसे) i) स्व-सिंप्रेषणीयता और स्व-सीलजबजलटी) ii) एयर-िेंट नही िं होना और) iii) जनमााण/िलसेक/प्रिेश स्तर के दौरान सिंदूषण का कोई उपाय नही िंहै, uhp s nh xbZ lkj.kh [k es a fofufnZ"V fuekZrk ds fo'ks”k mRikn ,oa iSsd vkdkj] mu ckrks a ds flok; vf/kØkUr djrs gq, ftUgs a ,sl s vf/kØe.k ds iwoZ fd;k x;k gS ;k dju s dk yksi fd;k x;k gS] jk"Vªh; vkS"k/k eYw ; fu/kkZj.k izkf/kdj.k] ,rn~}kjk] Fkksd eYw ; lwpdkad ¼MCY;wihvkbZ½] 2021 ij vk/kkfjr la”kks/ku djrk gS] tSlk fd uhp s dh lkj.kh ^d* ds LraHk ¼5½ esa fofufnZ"V gS] vf/kdre dher dks mDr lkj.kh ds LrHa k ¼3½ vkSj ¼4½ esa dh xbZ Øe'k% rRLFkkuh izfof"V;ks a eas fofufnZ"V [kqjkd :i ,oa izcyrk vkSj bdkbZ ¼;wfuV½@iSdsftax lfgr ml lkj.kh ds LraHk ¼2½ eas dh xbZ rRLFkkuh izfof"V eas fofufnZ"V vuqlwfpr fofufeZfr;ks a eas ls izR;sd dh oLrq ,oa lsok dj] ;fn dksbZ gS] dks NksM+dj vf/kdre dher ds #i es a fu;r djrh gSA @ 10.76607% @ 10.76607% (1) (2) (3) (4) (5) 1 ररगर लैक्टेट इंजेक्िन 100 जमली प्रत्येक 100 जमलीलीटर पैक में जविेष जविषे ताएं ह ैं 26.67 2 ररगर लैक्टेट इंजेक्िन 250 जमली प्रत्येक 250 जमलीलीटर पैक में जविेष जविषे ताएं ह ैं 45.48 3 ररगर लैक्टेट इंजेक्िन 500 जमली प्रत्येक 500 जमलीलीटर पैक में जविेष जविषे ताएं ह ैं 57.94 4 ररगर लैक्टेट इंजेक्िन 1000 जमली प्रत्येक 1000 जमलीलीटर पैक में जविेष जविेषताएं ह ैं 101.85 (1) (2) 1 मैससच अल्बटच डेजवड जल. 2 मैससच एक्यूलाइफ हेल्थकेयर प्रा. जलजमटेड 3 मैससच बी। ब्ौन मेजडकल (इंजडया) प्रा. जलजमटेड 4 मैससच फ्रेसेजनयस काबी इंजडया प्रा. जलजमटेड 5 मैससच ओस्ट्तुका फामाचस्ट्यूटटकल्स इंजडया प्रा. जलजमटेड 6 मैससच डेजनस केम लेब जलजमटेड 7 मैससच अमान्ता हेल्थकेयर जलजमटेड 8 मैससच श्री कृष्णा केिव लेबोरेटरीज जलजमटेड 9 मसै सच अक्सा पैरेंटल्स जलजमटेड 10 मसै सच रुसोमा लेबोरेटरीज जलजमटेड 11 मसै सच आर. के. लेबोरेटरीज प्रा० जलजमटेड 12 मसै सच टरयलकेड लाईफसाइंस प्रा० जलजमटेड 13. मसै सच अबैटरस हल्े थकेयर प्रा० जलजमटेड (नीचे 14. मसै सच जहग्स हल्े थकेयर (नीचे 15. मसै सच रूसोमा लेबोरेटरीज प्रा. जलजमटेड [यूरोहडे बोटल ब्ांड नाम ड्यूजड्रप के साथ) (नीचे ] 10.76607% के 2, 3 और 4 मे दिाचई गई कीमते केवल मसै सच मैससच अबैटरस हल्े थकेयर प्रा० जलजमटेड ( के 13) और मसै सच रूसोमा लेबोरेटरीज प्रा०जलजमटेड ( के 15) पर लाग ूहोंगी के और 4 मे दिाचई गई कीमते केवल मसै सच जहग्स हल्े थकेयर ( के 14) पर लागू होंगी68 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] (5) 10.76607% (5) कोई अन्य जवजनमाचता जो जविेष सुजवधाओं वाले पैकेजों में ररगर लैक्टेट इंजक्े िन में जैसे( i) स्ट्व-संप्रेषणीयता और स्ट्व-सीलजबजलटी( ii) में एयर-वेंट नहीं होने और( iii) जनमाचण/जलसेक/प्रवेि के स्ट्तर के दौरान संदषू ण का कोई उपाय नहीं ह,ै के जलए अलग अजधकतम मूल्य का दावा करता ह ैतो वह अलग अजधकतम मूल्य अनुमोदन के जलए एनपीपीए को आवेदन करेगा। V (ञ) (4) u II I II III II IV ड ढ [ II] ORDER New Delhi, the 30th March, 2022 S.O. 1501(E).—In exercise of powers, conferred by sub paragraph (3) and (4) of paragraph 11 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013, S.O. 1192(E) dated 22nd March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) No. S.O. 1333(E) dated 25.03.2021, S.O. 1727(E) dated 30.04.2021, and S.O. 3164(E) dated 06.08.2021, in so far as it relates to ringer lactate injection in pack having special features like (i) self collapsibility and self-sealability (ii) not[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 69 having air-vent and (iii) there is no chance of contamination during manufacture/ infusion/ admixing levels, manufactured by the manufacturers specified in Table B for specified products and pack-sizes, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby revises the price based on Wholesale price index (WPI) of 2021 as specified in column (5) of the Table A herein below as separate ceiling price exclusive of Goods and Services Tax applicable, if any, in respect of the scheduled formulations specified in the corresponding entry in column (2) of the said Table with the dosage form and strength and unit/packaging specified respectively in the corresponding entries in columns (3) and (4) thereof: TABLE A Price Revision as per Annual Wholesale Price Index (WPI) @ 10.76607% increase. Sl. No. Medicines Dosage form and Unit Ceiling price (w.e.f. Strength 01.04.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 1 Ringer lactate Injection100 ml Each 100 ml pack having 26.67 special features 2 Ringer lactate Injection 250 ml Each 250 ml pack having 45.48 special features 3 Ringer lactate Injection 500 ml Each 500 ml pack having 57.94 special features 4 Ringer lactate Injection 1000 ml Each 1000 ml pack having 101.85 special features TABLE ‘B’ Sl. No. Name of Manufacturer (1) (2) 1 M/s Albert David Ltd. 2 M/s Aculife Healthcare Pvt. Ltd. 3 M/s B. Braun Medical (India) Pvt. Ltd. 4 M/s Fresenius Kabi India Pvt. Ltd. 5 M/s Ostuka Pharmaceuticals India Pvt. Ltd. 6 M/s Denis Chem lab Ltd. 7 M/s Amanta Healthcare Ltd. 8 M/s Shree Krishna Keshav Laboratories Ltd. 9 M/s Axa Parenterals Ltd. 10 M/s Rusoma Laboratories Pvt. Ltd. 11 M/s R. K. Laboratories Pvt. Ltd. 12 M/s Realcade Lifescience Pvt. Ltd. 13 M/s Abaris Healthcare Pvt. Ltd (Note (b) below) 14 M/s Higgs Healthcare (Note (c) below) 15 M/s Rusoma Laboratories Pvt. Ltd. (Eurohead Bottles with Brand name “Dewdrip”) [Note (b)] below] Note: (a) The ceiling prices are applicable with effect from 01.04.2021 (ceiling prices are inclusive of Wholesale Price Index (WPI) @10.76607% for the year 2021 over 2020). (b) In case of M/s Abaris Healthcare Pvt. Ltd (Sl. No. 13 of Table B) & M/s Rusoma Laboratories Pvt. Ltd. (Sl. No. 15 of Table B), only the prices of the formulations specified in Sl. No. 2, 3 & 4 of Table A are applicable. (c) In case of M/s Higgs Healthcare mentioned in Sl. No. 14 of Table B, only the prices of the formulations specified in Sl. No. 3 & 4 of Table A are applicable. (d) The manufacturers of scheduled formulations, selling abovesaid products/brandname of scheduled formulations at price higher than the ceiling price (plus goods and services tax as70 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any. (e) The manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table (plus goods and services tax as applicable, if any), may revise the existing M.R.P. of their formulations, on the basis of WPI @ 10.76607% for year 2021 over the year 2020 in accordance with paragraph 16(2) of DPCO, 2013, read with para 13(2) of DPCO, 2013. (f) The manufacturers may add goods and services tax only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above said table. (g) Any other manufacturer claiming separate ceiling price for ringer lactate injection in pack having special features like (i) self collapsibility and self-sealability (ii) not having air-vent and (iii) there is no chance of contamination during manufacture/ infusion/ admixing levels shall apply to NPPA for separate ceiling price approval. (h) For other special features claimed or any other pack size manufactured, the manufacturer shall approach the NPPA for specific price approval for its formulation. (i) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers. (j) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (k) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (l) The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and / or import of scheduled formulation in Form-IV of Schedule- II of the DPCO, 2013 at least six months prior to the intended date of discontinuation. (m) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955. (n) Consequent to the issue of ceiling prices of such formulations as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded. [P.N./228/96/2022/F /F. No. 8(96)/2022/D.P./NPPA-Div.-II] PRASENJIT DAS, Dy. Director ubZ fnYyh] 30 ekpZ] 2022 , . . . . @10.76607% , ,[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 71 I 9373.03 34128.13 13(2) @ . % (4) [ II] ORDER New Delhi, the 30th March, 2022 S.O. 1502(E).—In continuation of the notifications issued by National Pharmaceutical Pricing Authority, Department of Pharmaceuticals, Ministry of Chemical and Fertilizers vide S.O. 639(E) dated 12.02.2018, S.O. 1464(E) dated 02.04.2018, S.O. 1488(E) dated 29.03.2019, S.O. 1217(E) dated 25.03.2020 and S.O. 1334(E) dated 25.03.2021 regarding the fixation of ceiling price of the Coronary Stents as specified in column no. (2) mentioned in the table below; after considering the Wholesale Price Index (WPI) @10.76607% for the year 2021 over 2020, it has been decided to revise the ceiling prices of Coronary Stents as mentioned in column no. (4) in the table below, exclusive of Goods and Services Tax as applicable, and unit specified in column (3) with effect from 01.04.2022, as under: TABLE Sl. Coronary Stents Unit Ceiling Price No. ( Sl. No. 31 in Schedule-I of the DPCO, 2013) (in Number) (in Rs.) (1) (2) (3) (4) 1 Bare Metal Stents 1 9373.03 Drug Eluting Stents (DES) including metallic DES and 2 1 Bioresorbable Vascular Scaffold (BVS)/ Biodegradable Stents 34128.1372 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] Notes: (a) All the existing manufacturers/importers of Coronary Stents having MRP lower than the ceiling price specified in column (4) in the above table (plus Goods and Services Taxes as applicable, if any), may revise the existing MRP of Coronary Stent, on the basis of WPI @ 10.76607% for the year 2021 over 2020 in accordance with Paragraph 16(2) of DPCO, 2013, read with Para 13(2) of DPCO, 2013. (b) The manufacturers/importers of Coronary Stents may add Goods and Services Taxes only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (4) of the aforesaid table. (c) As per Para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer/importers, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (d) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955. [P.N./228/96/2022/F/F. No. 8(96)/2022/D.P./NPPA-Div.-II] PRASENJIT DAS, Dy. Director ub Z fnYyh] 30 ] 2022 .— 4, 6, 10, 11, 14, 61 ,61 ,4 18 a b @ (10.76607%) 10.76607% (1) (2) (3) (4) (5) 6(a) 6(b) 1 ,lhVkby lkfyflfyd xksyh 300 fexzk 1331 ¼v½ 25.03.2021 1 xksyh ,flM 0.25 2 dSfY'k;e dkcksZusV xksyh 250 fexzk 1 xksyh 2.17 1331 ¼v½ 25.03.2021 3 daMksel 1 daMkse 10.14 1331 ¼v½ 25.03.2021 4 Msilksu xksyh 50 fexzk 1 xksyh 0.26 1331 ¼v½ 25.03.2021 5 bVksikslkbM dSIlwy 100 fexzk- 1 dSIlwy 67.22 1331 ¼v½ 25.03.2021 6 ÝkekblsVhu lYQsV Øhe 0-50% 1 xzke 0.97 1331 ¼v½ 25.03.2021 7 vkbZlksfutkbM flji 100 fexzk-@5 1331 ¼v½ 25.03.2021 1 fefy- fefy- 0.29[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 73 8 eMs ªksDlh izksxsLVsjksu xksyh 5 fexzk 1331 ¼v½ 25.03.2021 1 xksyh ,flVsV 3.32 9 fjQefiflu xksyh 450 fexzk 1 xksyh 4.92 1331 ¼v½ 25.03.2021 ( 10.76607% ) (5) 13(2) 10.76607% घ (5) ङ V च (4) u II I ज II III II IV झ ञ [ II]74 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ORDER New Delhi, the 30 March, 2022 S.O. 1503(E).—In exercise of the powers, conferred by paragraph 4, 6, 10, 11, 14, 16, 17 and 18 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order(s) of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) S.O. Number and date specified in column No. 6(a) & 6(b) mentioned in the table below, the National Pharmaceutical Pricing Authority, hereby fixes the prices as specified in column (5) of the table herein below as ceiling prices exclusive of Goods and Services Tax applicable, if any, in respect of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the dosage form & strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof: TABLE Price Revision as per Annual Wholesale Price Index (WPI) @ 10.76607% increase. Sl. No. Medicines Dosage form Unit Ceiling price Existing S.O. No. & Date and Strength (wef 01.04.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 6(a) 6(b) 1 Acetyl Salicylic Tablet 300mg 1 Tablet 1331 (E) 25.03.2021 Acid 0.25 2 Calcium Tablet 250 mg 1 Tablet 1331 (E) 25.03.2021 carbonate 2.17 3 Condoms 1 Condom 10.14 1331 (E) 25.03.2021 4 Dapsone Tablet 50 mg 1 Tablet 0.26 1331 (E) 25.03.2021 5 Etoposide Capsules 100 1 Capsule 1331 (E) 25.03.2021 mg 67.22 6 Framycetin Cream 0.50% 1 GM 1331 (E) 25.03.2021 Sulphate 0.97 7 Isoniazid Syrup 100 1 ML 1331 (E) 25.03.2021 mg/5ml 0.29 8 Medroxy Tablet 5mg 1 Tablet 1331 (E) 25.03.2021 Progesterone Acetate 3.32 9 Rifampicin Tablet 450mg 1 Tablet 4.92 1331 (E) 25.03.2021[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 75 Notes: (a) The ceiling prices are applicable with effect from 01.04.2022 (ceiling prices are inclusive of Wholesale Price Index (WPI) @10.76607% for the year 2021 over 2020). (b) All manufacturers of scheduled formulations, selling the branded or generic or both the versions of scheduled formulations at a price higher than the ceiling price (plus goods and services taxes as applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above table plus goods and services taxes as applicable, if any. (c) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table (plus goods and services taxes as applicable, if any), may revise the existing M.R.P. of their formulations, on the basis of WPI @ 10.76607% for year 2021 over 2020 in accordance with paragraph 16(2) of DPCO, 2013, read with para 13(2) of DPCO, 2013. (d) The manufacturers may add goods and services taxes only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above said table. (e) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers. (f) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (g) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (h) The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and / or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of discontinuation.76 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] (i) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955. (j) Consequent to the issue of ceiling prices of such formulations as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded. [P.N./228/96/2022/F/F. No. 8(96)/2022/D.P./NPPA-Div.-II] PRASENJIT DAS, Dy. Director ubZ fnYyh] 30 ] 2022 Hkkjr ljdkj ds jlk;u vkSj moZjd e=a ky; }kjk tkjh dk-vk- 1394¼v½ rkjh[k 30 ebZ] 2013 vkSj dk-vk- 1192¼v½ rkjh[k 22 ekpZ] 2016 ds lkFk ifBr vkS"k/k ¼dher fu;a=.k½ vkn's k] 2013 ds iSjk 11 ds mi iSjk ¼3½ vkSj ¼4½ vkSj iSjk 14 }kjk iznRr 'kfDr;ks a dk iz;ksx djr s gq, rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd e=a ky;] ¼jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k½ ds 'kqf)&i= vkns'k dk- vk- 3937¼v½ fnukad 23.09.2021, dk-vk- vkSj dk-vk- 5426¼v½ fnukad 28.12.2021 vkn's k ds vf/kØe.k eas tgk¡ rd mldk lEcU/k uhp s dh lkj.kh ^d* es a fofufeZr गैर-ग्लास कंटेनर में पैकेज के जलए 100 जमलीलीटर पैक में मेरोजनडाजोल इंजेक्िन आईपी (0.5% w/v)/500 जमलीलीटर/100 जमलीलीटर से संबंजधत ह ै जजसमें (i) सेल्फ- कोलैजप्सजबजलटी और सेल्फ-सीलेजबजलटी (ii) एयर-वेंट नहीं होना और (iii) जनमाचण / जलसेक / जमश्रण स्ट्तरों के दौरान संदषू ण की कोई संभावना नहीं होने जैसी जविेष जविेषताएं ह।ैं uhp s nh xbZ lkj.kh [k eas fofufnZ"V fuekZrk ds fo"ks”k mRikn ,oa iSsd vkdkj] mu ckrks a ds flok; vf/kØkUr djr s gq, ftUgs a ,sl s vf/kØe.k ds iwoZ fd;k x;k gS ;k dju s dk yksi fd;k x;k gS] jk"Vªh; vkS"k/k eYw ; fu/kkZj.k izkf/kdj.k] ,rn~}kjk] Fkksd eYw ; lwpdkad ¼MCY;wihvkbZ½] 2021 ij vk/kkfjr la”kks/ku djrk gS] tSlk fd uhps dh lkj.kh ^d* ds LraHk ¼5½ es a fofufnZ"V gS] vf/kdre dher dks mDr lkj.kh ds LraHk ¼3½ vkSj ¼4½ esa dh xbZ Øe'k% rRLFkkuh izfof"V;ks a es a fofufnZ"V [kqjkd :i ,oa izcyrk vkSj bdkbZ ¼;wfuV½@iSdsftax lfgr ml lkj.kh ds LrHa k ¼2½ eas dh xbZ rRLFkkuh izfof"V es a fofufnZ"V vuqlwfpr fofufeZfr;ks a eas ls izR;sd dh oLrq ,oa lsok dj] ;fn dkbs Z gS] dk s NksM+dj vf/kdre dher ds #i eas fu;r djrh gSA @ 10.76607% @ 10.76607% (1) (2) (3) (4) (5) 1 मेरोजनडाजोल यूरो हडे के साथ प्लाजस्ट्टक बोतल में गैर-ग्लास कंटेनर में पैकेज के प्रजत 0.25 जलए 100जमली पैक में इंजेक्िन (0.5%डब्लू/वी(/ 500 जमलीग्राम/ जमली 100जमली जविेष जविेषताएं ह ैं मैससच ओत्सुका फामाचस्ट्युटटकल इंजडया प्रा. जलजमटेड मैसस चडेजनस केम लेब प्रा. जलजमटेड मैससच रूसोमा लेबोरेटरीज प्रा. जलजमटेड[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 77 10.76607% (5) 10.76607% (5) कोई अन्य जवजनमाचता जो जविेष सुजवधाओं वाले पैकेजों में मेरोजनडाजोल इंजेक्िन यूरो हेड के साथ प्लाजस्ट्टक बोतल में गैर- ग्लास कंटेनर में पैकेज के जलए 100 जमली पैक में इंजेक्िन (0.5%डब्लू/वी(/ 500 जमलीग्राम/100 जमली जविेष जविेषताएं ह ैं में जैसे (i) स्ट्व-संप्रेषणीयता और स्ट्व-सीलजबजलटी (ii) में एयर-वेंट नहीं होने और (iii) जनमाणच /जलसेक/प्रवेि के स्ट्तर के दौरान संदषू ण का कोई उपाय नहीं है, के जलए अलग अजधकतम मूल्य का दावा करता ह ै तो वह अलग अजधकतम मूल्य अनुमोदन के जलए एनपीपीए को आवेदन करेगा। V (4) u II I ञ II III II IV [ II]78 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] ORDER New Delhi, the 30th March, 2022 S.O. 1504(E).—In exercise of powers, conferred by sub paragraph (3) and (4) of paragraph 11 and paragraph 14 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013, S.O. 1192(E) dated 22nd March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) No. S.O. 3937(E) dated 23.09.2021 and S.O. 5426(E) dated 28.12.2021, in so far as they relate to Metronidazole Injection IP (0.5% w/v)/ 500mg/100ml in 100ml pack for packages in non-glass container in plastic bottle with euro head having special features like (i) self-collapsibility and self-sealeability (ii) not having air-vent and (iii) there is no chance of contamination during manufacture/ infusion/ admixing levels mentioned in the Table A herein below, manufactured by the manufacturers specified in Table B for specified products and pack-sizes, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby revises the price based on Wholesale price index(WPI) of 2021 as specified in column (5) of the Table A herein below as separate ceiling price exclusive of goods and services tax applicable, if any, in respect of the scheduled formulations specified in the corresponding entry in column (2) of the said Table with the dosage form and strength and unit/packaging specified respectively in the corresponding entries in columns (3) and (4) thereof: TABLE A Price Revision as per Annual Wholesale Price Index (WPI) @ 10.76607% increase. Sl. Medicines Dosage form and Strength Unit Ceiling price (wef No. 01.04.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 1 Metronidazole Injection (0.5%w/v) / 500mg/100ml Per ml 0.25 in 100ml pack for packages in non- glass container in plastic bottle with euro head having special features TABLE ‘B’ Sl. No. Name of Manufacturer (1) (2) 1 M/s Otsuka Pharmaceutical India Private Ltd. 2 M/s Denis Chem Lab Ltd. 3 M/s Rusoma Laboratories Pvt. Ltd. Note : (a) The ceiling prices are applicable with effect from 01.04.2022 (ceiling prices are inclusive of Wholesale Price Index (WPI) @10.76607% for the year 2021 over 2020). (b) The manufacturers of scheduled formulations, selling abovesaid products/brandname of scheduled formulations at price higher than the ceiling price (plus goods and services tax as applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any. (c) The manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table (plus goods and services tax as applicable, if any), may revise the existing M.R.P. of their formulations, on the basis of WPI @ 10.76607% for year 2021 over 2020 in accordance with paragraph 16(2) of DPCO, 2013, read with para 13(2) of DPCO, 2013. (d) The manufacturers may add Goods and Services Tax only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above said table.[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 79 (e) Any other manufacturer claiming separate ceiling price for Metronidazole Injection (0.5%w/v) / 500mg/100ml in 100ml pack for packages in non-glass container in plastic bottle with euro head having special features like (i) self collapsibility and self-sealability (ii) not having air-vent and (iii) there is no chance of contamination during manufacture/ infusion/ admixing levels shall apply to NPPA for separate ceiling price approval. (f) For other special features claimed or any other pack size manufactured, the manufacturer shall approach the NPPA for specific price approval for its formulation (g) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers. (h) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (i) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (j) The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and / or import of scheduled formulation in Form-IV of Schedule- II of the DPCO, 2013 at least six months prior to the intended date of discontinuation. (k) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955. (l) Consequent to the issue of ceiling prices of such formulations as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded. [P.N./228/96/2022/F/F. No. 8(96)/2022/D.P./NPPA-Div.-II] PRASENJIT DAS, Dy. Director ubZ fnYyh] 30 ] 2022 Hkkjr ljdkj ds jlk;u vkSj moZjd e=a ky; }kjk tkjh dk-vk- 1394¼v½ rkjh[k 30 ebZ] 2013 vkSj dk-vk- 1192¼v½ rkjh[k 22 ekpZ] 2016 ds lkFk ifBr vkS"k/k ¼dher fu;a=.k½ vkn's k] 2013 ds iSjk 11 ds mi&iSjk ¼3½ vkSj ¼4½ vkSj iSjk 14 }kjk iznRr 'kfDr;ks a dk iz;ksx djr s gq, rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd e=a ky;] ¼jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k½ ds 'kqf)&i= vkn's k dk-vk- 3938¼v½ fnukad 23.09.2021 vkSj dk-vk- 5427¼v½ fnukad 28.12.2021 vkns'k ds vf/kØe.k eas tgk¡ rd mldk lEcU/k uhp s dh lkj.kh ^d* eas fofufeZr गैर-ग्लास कंटेनर में पैकेज के जलए 100 जमलीलीटर पैक में मेंनीटोल इंजेक्िन 20% से संबंजधत ह ै जजसमें (i) सेल्फ-कोलैजप्सजबजलटी और सेल्फ-सीलेजबजलटी (ii) एयर-वेंट नहीं होना और (iii) जनमाचण / जलसेक / जमश्रण स्ट्तरों के दौरान संदषू ण की कोई संभावना नहीं होने जैसी जविेष जविेषताएं ह।ैं uhp s nh xbZ lkj.kh [k eas fofufnZ"V fuekZrk ds fo'ks"k mRikn ,oa iSsd vkdkj] mu ckrks a ds flok; vf/kØkUr djr s gq, ftUgs a ,sl s vf/kØe.k ds iwoZ fd;k x;k gS ;k dju s dk yksi fd;k x;k gS] jk"Vªh; vkS"k/k eYw ; fu/kkZj.k izkf/kdj.k] ,rn~}kjk] Fkksd eYw ; lwpdkad ¼MCY;wihvkbZ½] 2021 ij vk/kkfjr la'kks/ku djrk gS] tSlk fd uhps dh lkj.kh ^d* ds LraHk ¼5½ eas fofufnZ"V gS] vf/kdre dher dk s mDr lkj.kh ds LraHk ¼3½ vkSj ¼4½ es a dh xbZ Øe'k% rRLFkkuh izfof"V;ks a eas fofufnZ"V [kqjkd :i ,oa80 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] izcyrk vkSj bdkbZ ¼;wfuV½@iSdsftax lfgr ml lkj.kh ds LraHk ¼2½ eas dh xbZ rRLFkkuh izfof"V es a fofufnZ"V vuqlwfpr fofufeZfr;ks a eas ls izR;sd dh oLrq ,oa lsok dj] ;fn dksbZ gS] dks NksM+dj vf/kdre dher ds #i eas fu;r djrh gSA @ 10.76607% @ 10.76607% (1) (2) (3) (4) (5) 1 मेंनीटोल यूरो हडे के साथ प्लाजस्ट्टक बोतल में गैर-ग्लास कंटेनर में पैकेज के प्रजत जमली 0.382 जलए 100 जमली पैक में इंजेक्िन 20% की जविेष जविेषताएं ह ैं मैससच ओत्सुका फामाचस्ट्युटटकल इंजडया प्रा. जलजमटेड मैसस चडेजनस केम लेब प्रा०जलजमटेड मैससच रूसोमा लेबोरेटरीज प्रा०जलजमटेड 10.76607% (5) 10.76607% (5) कोई अन्य जवजनमाचता जो जविेष सुजवधाओं वाले पैकेजों में मेंनीटोल यूरो हेड के साथ प्लाजस्ट्टक बोतल में गैर-ग्लास कंटेनर में पैकेज के जलए 100जमली पैक में इंजेक्िन 20% की जविेष जविेषताएं ह ैं जैसे (i) स्ट्व-संप्रेषणीयता और स्ट्व- सीलजबजलटी (ii) में एयर-वेंट नहीं होने और (iii) जनमाचण/जलसेक/प्रवेि के स्ट्तर के दौरान संदषू ण का कोई उपाय नहीं है, के जलए अलग अजधकतम मूल्य का दावा करता ह ैतो वह अलग अजधकतम मूल्य अनुमोदन के जलए एनपीपीए को आवेदन करेगा। V[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 81 (4) u II I ञ II III II IV [ II] ORDER New Delhi, the 30th March, 2022 S.O. 1505(E).—In exercise of powers, conferred by sub paragraph (3) and (4) of paragraph 11 and paragraph 14 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013, S.O. 1192(E) dated 22nd March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) No. S.O. 3938(E) dated 23.09.2021 and S.O. 5427(E) dated 28.12.2021, in so far as they relate to Mannitol Injection 20% in 100 ml pack for packages in non-glass container in plastic bottle with euro head having special features like (i) self-collapsibility and self- sealeability (ii) not having air-vent and (iii) there is no chance of contamination during manufacture/ infusion/ admixing levels mentioned in the Table A herein below, manufactured by the manufacturers specified in Table B for specified products and pack-sizes, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby revises the price based on Wholesale price index(WPI) of 2021 as specified in column (5) of the Table A herein below as separate ceiling price exclusive of goods and services tax applicable, if any, in respect of the scheduled formulations specified in the corresponding entry in column (2) of the said Table with the dosage form and strength and unit/packaging specified respectively in the corresponding entries in columns (3) and (4) thereof: TABLE A Price Revision as per Annual Wholesale Price Index (WPI) @ 10.76607% increase. Sl. Medicines Dosage form and Strength Unit Ceiling price (wef 01.04.2022 No. with WPI @ 10.76607%) (1) (2) (3) (4) (5) 1 Mannitol Injection 20% in 100 ml pack for Per ml 0.382 packages in non-glass container in plastic bottle with euro head having special features82 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] TABLE ‘B’ Sl. No. Name of Manufacturer (1) (2) 1 M/s Otsuka Pharmaceutical India Private Ltd. 2 M/s Denis Chem Lab Ltd. 3 M/s Rusoma Laboratories Pvt. Ltd. Note : (a) The ceiling prices are applicable with effect from 01.04.2022 (ceiling prices are inclusive of Wholesale Price Index (WPI) @10.76607% for the year 2021 over 2020). (b) The manufacturers of scheduled formulations, selling abovesaid products/brandname of scheduled formulations at price higher than the ceiling price (plus goods and services tax as applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any. (c) The manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table (plus goods and services tax as applicable, if any), may revise the existing M.R.P. of their formulations, on the basis of WPI @ 10.76607% for year 2021 over 2020 in accordance with paragraph 16(2) of DPCO, 2013, read with para 13(2) of DPCO, 2013. (d) The manufacturers may add goods and services tax only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above said table. (e) Any other manufacturer claiming separate ceiling price for Mannitol Injection 20% in 100 ml pack for packages in non-glass container in plastic bottle with euro head having special features like (i) self collapsibility and self-sealability (ii) not having air-vent and (iii) there is no chance of contamination during manufacture/ infusion/ admixing levels shall apply to NPPA for separate ceiling price approval. (f) For other special features claimed or any other pack size manufactured, the manufacturer shall approach the NPPA for specific price approval for its formulation. (g) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers. (h) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (i) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (j) The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and / or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of discontinuation. (k) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955.[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 83 (l) Consequent to the issue of ceiling prices of such formulations as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded. [P.N./228/96/2022/F/F. No. 8(96)/2022/D.P./NPPA-Div.-II] PRASENJIT DAS, Dy. Director ub Z fnYyh] 30 ] 2022 Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky; }kjk tkjh dk-vk- 1394¼v½ rkjh[k 30 ebZ] 2013 vkSj dk- vk- 1192¼v½ rkjh[k 22 ekpZ] 2016 ds lkFk ifBr vkS"k/k ¼dher fu;a=.k½ vkns'k] 2013 ds iSjk 11 ds mi iSjk ¼3½ vkSj ¼4½ vkSj iSjk 14 }kjk iznRr 'kfDr;ksa dk iz;ksx djrs gq, rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=ky;] ¼jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k½ ds 'kqf)&i= vkns'k dk- vk- 3939¼v½ fnukad 23.09.2021 vkSj dk-vk- 5428¼v½ fnukad 28.12.2021 vkns'k ds vf/kØe.k es a tgk¡ rd mldk lEcU/k uhps dh lkj.kh ^d* e sa fofufeZr गैर-ग्लास कंटेनर में पैकेज के जलए 100 जमलीलीटर पैक में डेक्सरोज( ग्लूकोज( इंजेक्िन (25% डब्ल्यू/वी( से संबंजधत ह ैजजसमें (i) सेल्फ-कोलैजप्सजबजलटी और सेल्फ-सीलेजबजलटी (ii) एयर-वेंट नहीं होना और (iii) जनमाचण /जलसेक / जमश्रण स्ट्तरों के दौरान संदषू ण की कोई संभावना नहीं होन ेजैसी जविेष जविेषताएं ह।ैं] uhps nh xbZ lkj.kh [k es a fofufnZ"V fuekZrk ds fo'ks”k mRikn ,oa iSsd vkdkj] mu ckrks a ds flok; vf/kØkUr djrs gq, ftUgs a ,sl s vf/kØe.k ds iwo Z fd;k x;k gS ;k djus dk yksi fd;k x;k gS] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] ,rn~}kjk] Fkksd ewY; lpw dkad ¼MCY;wihvkbZ½] 2020 ij vk/kkfjr la”kks/ku djrk gS] tSlk fd uhps dh lkj.kh ^d* ds LraHk ¼5½ es a fofufnZ"V gS] vf/kdre dher dks mDr lkj.kh ds LraHk ¼3½ vkSj ¼4½ es a dh xb Z Øe'k% rRLFkkuh izfof"V;ksa es a fofufnZ"V [kqjkd :i ,oa izcyrk vkSj bdkbZ ¼;wfuV½@iSdsftax lfgr ml lkj.kh ds LraHk ¼2½ es a dh xbZ rRLFkkuh izfof"V es a fofufnZ"V vulq fwpr fofufeZfr;ksa e sa l s izR;sd dh oLrq ,oa lsok dj] ;fn dksb Z gS] dks NksM+dj vf/kdre dher ds #i es a fu;r djrh gSA @ 10.76607% @ 10.76607% (1) (2) (3) (4) (5) 1 डेक्सरोज )ग्लूकोज( यूरो हडे के साथ प्लाजस्ट्टक बोतल म ेंगैर-ग्लास कंटेनर प्रजत जमली 0.2165 म ेंपैकेज के जलए 100 जमली पैक म ें इंजेक्िन (25% डब्ल्य ू/ वी( की जविेष जविषे ताएं ह ैं मैससच ओत्सुका फामाचस्ट्युटटकल इंजडया प्रा. जलजमटेड मैसस चडेजनस केम लेब प्रा. जलजमटेड मैससच रूसोमा लेबोरेटरीज प्रा. जलजमटेड 10.76607% (5)84 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 10.76607% (5) कोई अन्य जवजनमाचता जो जविेष सुजवधाओं वाले पैकेजों में डेक्सरोज (ग्लूकोज( यूरो हडे के साथ प्लाजस्ट्टक बोतल में गैर-ग्लास कंटेनर में पैकेज के जलए 100जमली पैक में इंजेक्िन (25% डब्ल्यू / वी( की जविेष जविेषताएं ह ैंजैसे (i) स्ट्व-संप्रेषणीयता और स्ट्व-सीलजबजलटी (ii) में एयर-वेंट नहीं होने और (iii) जनमाचण/जलसेक/प्रवेि के स्ट्तर के दौरान संदषू ण का कोई उपाय नहीं ह,ै के जलए अलग अजधकतम मूल्य का दावा करता ह ैतो वह अलग अजधकतम मूल्य अनुमोदन के जलए एनपीपीए को आवेदन करेगा। V (4) u II I ञ II III II IV [ II] ORDER New Delhi, the 30th March, 2022 S.O. 1506(E).—In exercise of powers, conferred by sub paragraph (3) and (4) of paragraph 11 and paragraph 14 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013, S.O. 1192(E) dated 22nd March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) No. S.O. 3939(E) dated 23.09.2021 and S.O. 5428(E) dated 28.12.2021, in so far as they relate to Dextrose (Glucose) Injection (25% w/v) in 100 ml pack for packages in non-glass container in plastic bottle with euro head having special features like (i) self- collapsibility and self-sealeability (ii) not having air-vent and (iii) there is no chance of contamination during manufacture/ infusion/ admixing levels mentioned in the Table A herein below, manufactured by the manufacturers specified in Table B for specified products and pack-sizes, except in respect of things done[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 85 or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, hereby revises the price based on Wholesale price index(WPI) of 2021 as specified in column (5) of the Table A herein below as separate ceiling price exclusive of goods and services tax applicable, if any, in respect of the scheduled formulations specified in the corresponding entry in column (2) of the said Table with the dosage form and strength and unit/packaging specified respectively in the corresponding entries in columns (3) and (4) thereof: TABLE A Price Revision as per Annual Wholesale Price Index (WPI) @ 10.76607% increase. Sl. Medicines Dosage form and Strength Unit Ceiling price (wef No. 01.04.2022 with WPI @ 10.76607%) (1) (2) (3) (4) (5) 1 Dextrose Injection (25% w/v) in 100 ml pack for Per ml 0.2165 (Glucose) packages in non-glass container in plastic bottle with euro head having special features TABLE ‘B’ Sl. No. Name of Manufacturer (1) (2) 1 M/s. Otsuka Pharmaceutical India Private Ltd. 2 M/s. Denis Chem Lab Ltd. 3 M/s. Rusoma Laboratories Pvt. Ltd. Note : (a) The ceiling prices are applicable with effect from 01.04.2022 (ceiling prices are inclusive of Wholesale Price Index (WPI) @10.76607% for the year 2021 over 2020). (b) The manufacturers of scheduled formulations, selling abovesaid products/brand name of scheduled formulations at price higher than the ceiling price (plus goods and services tax as applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any. (c) The manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table (plus goods and services tax as applicable, if any), may revise the existing M.R.P. of their formulations, on the basis of WPI @ 10.76607% for year 2021 over 2020 in accordance with paragraph 16(2) of DPCO, 2013, read with para 13(2) of DPCO, 2013. (d) The manufacturers may add goods and services tax only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above said table. (e) Any other manufacturer claiming separate ceiling price for Dextrose (Glucose) Injection (25% w/v) in 100 ml pack for packages in non-glass container in plastic bottle with euro head having special features like (i) self collapsibility and self-sealability (ii) not having air-vent and (iii) there is no chance of contamination during manufacture/ infusion/ admixing levels shall apply to NPPA for separate ceiling price approval. (f) For other special features claimed or any other pack size manufactured, the manufacturer shall approach the NPPA for specific price approval for its formulation (g) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.86 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] (h) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (i) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013. (j) The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and / or import of scheduled formulation in Form-IV of Schedule- II of the DPCO, 2013 at least six months prior to the intended date of discontinuation. (k) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955. (l) Consequent to the issue of ceiling prices of such formulations as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded. [P.N./228/96/2022/F/F. No. 8(96)/2022/D.P./NPPA-Div.-II] PRASENJIT DAS, Dy. Director आदिे नई ददल्ली, 30 माचच, 2022 का.आ. 1507(अ(.—डीपीसीओ 2013 के पैरा 19, के तहत हेपटरन इंजेक्िन 1000 आई यू/जमली और हपे टरन इंजेक्िन 5000 आई यू/जमली की कीमतें का. आ 2151 (अ( ददनांक 30.06.2020, राष्ट्रीय औषध मूल्य जनधाचरण प्राजधकरण औषध जवभाग; रसायन और उवचरक मंत्रालय भारत सरकार द्वारा जनधाचटरत की गई थी जो दक ददनांक 31.12.2020 तक या अगले आदिे तक, जो भी पहले हो” लाग ूथा और का. आ 4333 (अ( ददनांक 03.12.2020 के माध्यम से ददनाक 31.03.2021 तक या अगले आदिे तक, जो भी पहले हो लागू था, दफर का. आ 1236 (अ( ददनांक 17.03.2021 के माध्यम से ददनाक 30.09.2021 तक या अगले आदिे तक, जो भी पहले हो लाग ूथा और का. आ 3935 (अ( ददनांक 23.09.2021 के माध्यम से ददनाक 31.03.2022 तक या अगले आदिे तक, जो भी पहले हो लाग ूह ैउसे ददनांक 30.09.2022 तक या अगले आदिे तक, जो भी पहले हो, तक बढाया जाता ह ै। 2. ददनांक 03.12.2020 के जवस्ट्तार के आदिे का.आ 4333(अ(, ददनांक 17.03.2021 के जवस्ट्तार के आदेि का.आ 1236 (अ( और ददनांक 23.09.2021 के जवस्ट्तार के आदिे का.आ. 3935(अ( के साथ पढ़े गये ददनांक 30 जून, 2020 के मूल आदिे का.आ. 2151 (अ( में उजल्लजखत सभी नोट्स और अन्य सामग्री समान रूप से लाग ूरहेंग ेदकन्तु पैरा 6, नोट (क( ओर नोट (ट( को छोडकर, में "31 माचच 2022 के जलए या अगले आदिे तक जो भी पहले हो “वाक्यांि के जलए" 30 जसतंबर 2022 तक या अगले आदिे तक जो भी पहले हो” पढ़ा जाए। [पी.एन./228/96/2022/एफ/फा. सं. 8(96(/2022/डी.पी/एनपीपीए-डीवी-II] प्रसेनजजत दास, उप जनदिे क ORDER New Delhi, the 30th March, 2022 S.O. 1507(E).—The ceiling prices of Heparin Injection 1000IU/ ml and Heparin Injection 5000IU/ ml fixed under Para 19 of the DPCO, 2013 vide notification S.O. 2151(E) dated 30.06.2020 valid up to 31.12.2020 which was extended up to 31.03.2021 vide S.O. 4333(E) dated 03.12.2020, then up to[भाग II—खण् ड 3(ii)] भारत का राजपत्र : असाधारण 87 30.09.2021 vide S.O. 1236(E) dated 17.03.2021 and again extended ‘up to 31.03.2022 or until further order, whichever is earlier’ vide S.O. 3935(E) dated 23.09.2021, issued by National Pharmaceutical Pricing Authority, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India are further extended up to 30.09.2022 or until further order, whichever is earlier. 2. All the notes and other contents mentioned in the original order S.O. 2151(E) dated 30.06.2020 read with extension orders S.O. 4333(E) dated 03.12.2020, S.O. 1236(E) dated 17.03.2021 and S.O. 3935(E) dated 23.09.2021 shall remain the same and are applicable except that in Para 6, Notes (a) and Note (k) for the phrase “31st March 2022 or until further order, whichever is earlier”, it is to be read as “30th September 2022 or until further order, whichever is earlier”. [P.N./228/96/2022/F/F. No. 8(96)/2022/DP/NPPA-Div.-II] PRASENJIT DAS, Dy. Director आदिे नई ददल्ली 30 ekpZ] 2022 का.आ. 1508(अ(.—डीपीसीओ 2013 के पैरा 19 एव ं आपदा प्रबंधन अजधजनयम, 2005 की धारा 10 (2) (एल( के तहत प्रदत्त िजक्तयां जो स्ट्वास्ट््य और पटरवार कल्याण मंत्रालय के आदिे रमांक जेड-33014/45/2020-आरसीएच/भाग.फाइल-3 ददनांक 23.09.2020 द्वारा प्रदान की गयी थी, के तहत जलदक्वड मेजडकल ऑक्सीजन (एलएमओ( और ऑक्सीजन इनहले ेिन (औषधीय गैस( की कीमतें का. आ 3322 (अ( ददनांक 25.09.2020, राष्ट्रीय औषध मूल्य जनधाचरण प्राजधकरण औषध जवभाग; रसायन और उवचरक मंत्रालय भारत सरकार द्वारा जनधाचटरत की गई थी जो दक ददनांक 31.03.2021 तक या अगले आदिे तक, जो भी पहले हो” लाग ू था और का.आ. 1335 (अ( ददनांक 25.03.2021 के माध्यम से ददनाक 30.09.2021 तक या अगले आदिे तक, जो भी पहले हो लागू था, दफर का.आ. 3936 (अ( ददनांक 23.09.2021 के माध्यम से ददनाक 31.12.2021 तक या अगले आदिे तक, जो भी पहले हो लाग ूथा और का.आ. 5424 (अ( ददनांक 28.12.2021 के माध्यम से ददनाक 31.03.2022 तक या अगले आदिे तक, जो भी पहले हो लाग ू ह ै उसे ददनांक 30.06.2022 तक या अगले आदिे तक, जो भी पहले हो, तक बढाया जाता ह ै। 2. ददनांक 25.03.2021 के जवस्ट्तार के आदिे का. आ 1335 (अ(, ददनांक 23.09.2021 के जवस्ट्तार के आदिे का.आ. 3936(अ( और ददनांक 28.12.2021 के जवस्ट्तार के आदिे का. आ 5424 (अ( के साथ पढ़े गय े ददनांक 25 जसतंबर, 2020 के मूल आदिे का.आ. 3322 (अ( में उजल्लजखत सभी नोट्स और अन्य सामग्री समान रूप से लाग ूरहगें ेदकन्तु नोट (क( में "31 माचच 2022 के जलए या अगले आदिे तक जो भी पहले हो “वाक्यांि के जलए" 30 जून 2022 तक या अगले आदिे तक जो भी पहले हो” पढ़ा जाए। [dka- l-a@228@96@2022@,Q@Qk-l-a 8¼96½@2022@Mhih@,uihih,-&fMoh&II] प्रसेनजीत दास, उप जनदिे क ORDER New Delhi, the 30th March, 2022 S.O. 1508(E).—The prices of ‘Liquid Medical Oxygen (LMO)’ and ‘Oxygen Inhalation (Medicinal gas) in cylinder’ fixed under Para 19 of the DPCO, 2013 and powers conferred under section 10(2)(l) of Disaster Management Act, 2005 delegated by Ministry of Health and Family Welfare vide Order No. Z-33014/45/2020-RCH/Pt.File-3 dated 23.09.2020, vide notification S.O. 3322(E) dated 25.09.2020, issued by National Pharmaceutical Pricing Authority, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India, applicable up to ’31.03.2021 and ‘extended up to 30.09.2021 vide S.O. 1335(E) dated 25.03.2021, then extended up to 31.12.2021 vide S.O.3936(E) dated 23.09.2021 and88 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] again extended upto 31.03.2022 or until further order whichever is earlier vide S.O. 5424(E) dated 28.12.2021 are further extended upto 30.06.2022 or until further order, whichever is earlier. 2. All the notes and other contents mentioned in the original order S.O. 3322(E) dated 25.09.2020 read with S.O.1335(E) dated 25.03.2021, S.O. 3936(E) dated 23.09.2021 and S.O. 5424(E) dated 28.12.2021 shall remain the same and are applicable except that in Note (a) for the phrase “31st March 2022 or until further orders, whichever is earlier” it is to be read as “30th June 2022 or until further orders, whichever is earlier.” [P.N./228/96/2022/F/F. No. 8(96)/2022/DP/NPPA-Div.-II] PRASENJIT DAS, Dy. Director Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064 and Published by the Controller of Publications, Delhi-110054.

Continue your research

Related Documents from Ministry of Chemicals and Fertilizers